Atrioventricular Septal Defect

MONDO:0859565 Pathograph 54 Show in embeddings browser congenital heart disease

Atrioventricular septal defect (AVSD) is a spectrum of congenital malformations with a common atrioventricular junction, deficient septation and abnormal atrioventricular valve morphology. Complete forms have atrial and unrestricted ventricular communications; partial forms have an ostium primum atrial communication without a ventricular component, and transitional forms have a restrictive ventricular communication. Valve orifices, ventricular balance and associated lesions modify physiology and surgical options. Significant shunting or valve regurgitation can cause pulmonary overcirculation and early heart failure, whereas less severe forms may present later. Trisomy 21 is strongly associated, but genetic causes and developmental routes are heterogeneous. Echocardiography defines anatomy; repair timing and lifelong surveillance are individualized, including assessment of pulmonary vascular disease and residual valve, outflow and conduction abnormalities.

Ask OpenScientist

Ask a research question about Atrioventricular Septal Defect. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

👪

Inheritance

Heterogeneous inheritance

AVSD occurs with aneuploidy, defined syndromes, rare familial Mendelian disease and sporadic multifactorial susceptibility. A threshold model is useful for some susceptibility alleles, but is not a demonstrated requirement for an additional hit in every patient.

Show evidence (1 reference)

PMID:15096951 SUPPORT REVIEW SYNTHESIS Human Clinical

"Atrioventricular septal defects (AVSDs) occur as a clinical feature of several different syndromes, as autosomal dominant defects, and as sporadically occurring malformations."

Review of etiologic heterogeneity.

◆

Subtypes

Complete AVSD

A common valve orifice, primum atrial communication and unrestricted inlet ventricular communication; substantial shunting commonly causes symptoms in infancy.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"Complete AVSD comprises a primum ASD, an inlet VSD, and a common AV valve with 4 to 5 leaflets"

A common valve orifice, primum atrial communication and unrestricted inlet ventricular communication; substantial shunting commonly causes symptoms in infancy.

Partial AVSD

Primum atrial communication without VSD, with separate right and left valve orifices within a common junction. Left valve regurgitation can materially alter otherwise atrial-shunt physiology.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"Partial AVSD includes a primum ASD without a VSD. The right and left AV valves are separated by tissue, but they share a common junction."

Primum atrial communication without VSD, with separate right and left valve orifices within a common junction. Left valve regurgitation can materially alter otherwise atrial-shunt physiology.

Transitional AVSD

A primum atrial communication and restrictive ventricular communication. Terminology overlaps with intermediate AVSD in some sources; classify the actual ventricular shunt and valve anatomy rather than assume equivalent physiology.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"An interatrial communication above the AV valve and a restrictive interventricular communication below it characterize a transitional AVSD."

Unbalanced AVSD

Unequal valve commitment and ventricular development constitute an additional anatomic dimension across AVSD classifications. Ventricular adequacy determines suitability for biventricular repair, staged recruitment or single-ventricle palliation.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"In these lesions, the AV valve is more committed to one ventricle. Thus, an unbalanced AVSD can be either right- or left-dominant."

Discussions and Knowledge Gaps

Which developmental route accounts for each AVSD genotype and anatomical subtype?

KNOWLEDGE GAP gap_developmental_heterogeneity

Attached to

pathophysiology#Deficient Atrioventricular Septation

Human AVSD is etiologically heterogeneous. Endocardial growth, distinct mesenchymal components, myocardial identity and laterality can contribute in different models. Modifier crosses that produce VSD or secundum ASD cannot be assumed to reproduce the human common-junction defect. No single obligatory EndoMT or two-hit pathway is established.

Show evidence (1 reference)

PMID:38884733 SUPPORT REVIEW SYNTHESIS Model Organism

"The role of the dorsal mesenchymal protrusion (DMP) in AVSD pathogenesis has been well-documented in studies using animal models for AVSDs"

Multiple developmental components require distinction.

Do maternal dietary associations in pooled congenital heart disease apply specifically to AVSD?

KNOWLEDGE GAP gap_diet_specificity

The Baby Hearts Study pooled 242 non-genetic CHD cases and 966 controls; only 11 cases were in the broad AV-junction/valve category, and no subtype-specific effect estimates were published. Frequent intake of the listed folate-rich fruits was associated with lower pooled CHD odds, but no causal dietary constituent was established. Its diabetes estimate was crude; the four exposed cases were VSD, transposition or double-inlet left ventricle, not AVSD. Do not use this source for an AVSD-specific protective diet, a diabetes mechanism, or a fruit/folate-to-septation edge.

Show evidence (2 references)

PMID:32092068 SUPPORT PRIMARY RESULT Human Clinical

"We do not give results specific to CHD type in this paper due to lack of sta- tistical power but they are available on request."

The source explicitly limits subtype inference.

PMID:32092068 SUPPORT PRIMARY RESULT Human Clinical

"This type of study cannot identify which dietary components are causally associated, and the possibility of unmeasured confounding cannot be excluded"

Limits nutrient mediation and causal interpretation.

Which cells generate the outgrowth measured in an AVC explant?

KNOWLEDGE GAP gap_model_assay_lineage

Attached to

pathophysiology#Impaired Endocardial Cushion Growth

Cell morphology alone can misclassify epicardial outgrowth as endocardial transition. Lineage and stage controls are essential before assigning an AVSD mechanism to an intervention in this mixed-cell assay.

Show evidence (1 reference)

PMID:29549339 SUPPORT PRIMARY RESULT In Vitro

"The presence of epicardium thus confounds interpretations of EndoMT signalling pathways in this assay."

Direct assay limitation.

⚙

Pathophysiology

Increased HMGN1 Dosage

An experimentally supported contributor to trisomy 21-associated cardiac development. Increasing HMGN1 expression in disomic human cell models and reducing its copy number in trisomic cells test dosage dependence; the study does not show that HMGN1 alone causes every human AVSD.

HMGN1 hgnc:4984

Experimental models

Isogenic trisomy 21 cardiomyocyte differentiation and HMGN1 perturbation IPSC DERIVED MODEL CRISPR activation and allele deletion test opposite dosage changes.

Downstream

Altered Atrioventricular Myocardial Identity HMGN1 perturbation changes the AVC cardiomyocyte transcriptional state in vitro; precise chromatin-to-cell-state intermediates remain incompletely resolved.

Show evidence (1 reference)

PMID:41125893 SUPPORT PRIMARY RESULT In Vitro

"A CRISPR-activation single-cell RNA droplet sequencing (CROP-seq) screen of chromosome 21 genes expressed during heart development revealed that HMGN1 upregulation mimics this shift"

HMGN1 activation in human pluripotent-cell-derived cardiomyocytes reproduces a transcriptional shift.

Altered Atrioventricular Myocardial Identity

In isogenic human trisomy 21 cultures, AVC cardiomyocytes express a more ventricular-like program. HMGN1 dose correction partially restores expression. Dp1Tyb mouse dose correction also changes this program, but human embryonic lineage conversion and a single obligatory mediator are not established.

cardiac muscle cell CL:0000746

Experimental models

Isogenic trisomy 21 cardiomyocyte differentiation and HMGN1 perturbation IPSC DERIVED MODEL Allele correction partially restores the transcriptomic state.

Animal models

Dp1Tyb Hmgn1 dosage correction Mouse rescues Dose correction restores part of the abnormal AVC myocardial program.

Downstream

Deficient Atrioventricular Septation Appropriate AVC myocardial identity may support valvuloseptal development. The experimentally rescued mouse endpoints are ventricular and outflow septal defects; mediation of the exact human AVSD anatomy remains inferred.

Show evidence (1 reference)

PMID:41125893 SUPPORT PRIMARY RESULT In Vitro

"reduction of HMGN1 to two copies in trisomic cells partially restored the transcriptional dysregulation to a more disomic-like state"

Primary correction result in human cultured cardiomyocytes.

Reduced CRELD1 Function

CRELD1 susceptibility variants and murine loss-of-function experiments support a contribution to cardiac development. Heterozygous variants can be inherited from unaffected people; complete mouse knockout is not equivalent to every human allele.

CRELD1 hgnc:14630

Downstream

Reduced Calcineurin-Dependent NFATC1 Dephosphorylation Loss of CRELD1 support can impair this signaling step. Experimental sufficiency of expressed Creld1 does not quantify the effect of every patient variant.

Show evidence (2 references)

PMID:22523272 SUPPORT PRIMARY RESULT Human Clinical

"In each case the p.R329C mutation was inherited from an unaffected parent."

Human penetrance limit for this susceptibility allele.

PMID:24697899 SUPPORT PRIMARY RESULT In Vitro

"Our study identifies the Cysteine-Rich with EGF-Like Domains 1 (Creld1) gene as a regulator of calcineurin/NFATc1 signaling."

Experimental mechanism from the available primary abstract.

Reduced Calcineurin-Dependent NFATC1 Dephosphorylation

The proposed molecular lesion is reduced activation of NFATC1 through dephosphorylation. ER-localized CRELD1 participates in a complex with calcineurin B. VEGF is an upstream stimulus in the developmental experiments, not an established downstream product of CRELD1.

Downstream

Reduced NFATC1 Nuclear Availability Calcineurin-dependent dephosphorylation promotes nuclear import; diminished activation can reduce nuclear availability.

Show evidence (2 references)

PMID:24697899 SUPPORT PRIMARY RESULT In Vitro

"Creld1 is contained in a joint protein complex with the regulatory subunit of calcineurin, CnB, thereby controlling calcineurin function."

Primary mechanistic abstract; detailed full-text assays were not retrievable.

PMID:24697899 SUPPORT PRIMARY RESULT In Vitro

"We show that Creld1 is sufficient to promote NFATc1 dephosphorylation and translocation to the nucleus."

Dephosphorylation and localization are separated into distinct events.

Reduced NFATC1 Nuclear Availability

Three AVSD-associated missense proteins showed variably impaired nuclear import in transfected COS-7 cells, including after ionomycin and in separate added-NLS constructs. Equal wild-type/mutant coexpression suggested particularly strong interference by Val210Met. No patient cardiac-tissue localization was measured.

NFATC1 hgnc:7775

Experimental models

COS-7 NFATC1 variant localization and reporter assays CELL LINE Variant proteins show impaired nuclear localization.

Downstream

Reduced NFATC1 Transcriptional Output Impaired import is consistent with reduced reporter activation, although the assays do not prove import alone explains every allele effect.

Show evidence (1 reference)

url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf SUPPORT PRIMARY RESULT In Vitro

"After stimulation with ionomycin, a large fraction of the p.(Ala367Val) and p.(Ala696Thr) NFATC1 proteins was retained in the cytoplasm"

Primary transfected-cell localization result.

Reduced NFATC1 Transcriptional Output

The three NFATC1 variants reduced NPPB-promoter reporter activation in COS-7 cells. This heterologous reporter is a functional readout, not a comprehensive fetal cushion transcriptional program.

Experimental models

COS-7 NFATC1 variant localization and reporter assays CELL LINE The NPPB reporter is less activated by variant constructs.

Downstream

Impaired Endocardial Cushion Growth Creld1/NFAT-dependent gene expression supports VEGF-dependent endocardial proliferation in the mouse developmental study. This is a proposed bridge from the human-variant reporter results rather than a patient-proven cellular sequence.

Show evidence (1 reference)

url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf SUPPORT PRIMARY RESULT In Vitro

"all mutants showed a variably reduced activation of theNPPB promoter, in all conditions."

Variable reporter deficit under the tested conditions.

Impaired Endocardial Cushion Growth

Reduced endocardial proliferation can impair the development of cushion tissue in experimental Creld1 deficiency. This is one possible developmental route; not all AVSD is explained by a uniform failure of endocardial mesenchymal transition.

endocardial cell CL:0002350

endocardial cushion development GO:0003197

Animal models

Creld1 knockout developmental model Mouse partially recapitulates Creld1 deficiency tests the requirement for endocardial proliferation during heart development.

Downstream

Deficient Atrioventricular Septation Insufficient cushion development can contribute to septation defects, with other mesenchymal components also involved.

Show evidence (1 reference)

PMID:24697899 SUPPORT PRIMARY RESULT Model Organism

"Creld1 function is required for the VEGF-dependent proliferation of endocardial cells by promoting the expression of NFATc1 target-genes."

Experimental endocardial proliferation finding.

Deficient Atrioventricular Septation

Failure of appropriate formation and union of atrioventricular mesenchymal tissues leaves deficient septation. Endocardial cushions, dorsal mesenchymal protrusion and mesenchymal cap have distinct contributions; cap-specific AVSD evidence remains preliminary in the cited review.

cardiac septum morphogenesis GO:0060411

atrioventricular canal UBERON:0002087

Animal models

Ts65Dn modifier crosses Mouse partially recapitulates The crosses support dosage-sensitive cardiac septation, but the observed lesions are adjacent septal phenotypes rather than exact human AVSD.

Dp1Tyb Hmgn1 dosage correction Mouse partially recapitulates Ventricular/outflow septal defects are reduced; exact human AVSD anatomy is not the demonstrated endpoint.

Human NFATC1 variant RNA in zebrafish Zebrafish partially recapitulates Abnormal AVC patterning supports developmental relevance, without reproducing human four-chamber septation.

Downstream

Atrioventricular Canal Defect The defining phenotype includes the septation defect and common atrioventricular junction.

Primum Atrial Septal Defect The atrial component is an ostium primum communication.

Inlet Ventricular Septal Defect Complete and transitional lesions also have an inlet ventricular communication; partial AVSD does not.

Left-to-Right Shunting The communications permit shunting according to their size and relative vascular resistances.

Show evidence (2 references)

PMID:38884733 SUPPORT REVIEW SYNTHESIS Model Organism

"The role of the dorsal mesenchymal protrusion (DMP) in AVSD pathogenesis has been well-documented in studies using animal models for AVSDs"

A separate developmental component is relevant.

PMID:38884731 SUPPORT REVIEW SYNTHESIS Human Clinical

"Atrioventricular septal defects (AVSDs) consist of a number of cardiac malformations that result from abnormal development of the endocardial cushions."

Clinical morphogenesis summary, complemented by the broader developmental review.

Abnormal Atrioventricular Valve Architecture

The common atrioventricular junction has abnormal bridging-leaflet and left-valve anatomy; two valve orifices can still share the common junction. This developmental structural lesion is distinct from the subsequent functional regurgitation.

atrioventricular canal UBERON:0002087

Downstream

Atrioventricular Valve Incompetence Malformed valve anatomy can impair coaptation; surgical reconstruction may leave or introduce additional functional abnormalities.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"There are varying degrees of malformation in the left-sided component of the common AV valve, typically characterized by a cleft in the anterior leaflet."

Anatomic substrate, not a claim of equal regurgitation in every case.

Atrioventricular Valve Incompetence

Regurgitant flow through the common or left AV valve adds hemodynamic load before repair or with residual/recurrent postoperative dysfunction. Structural repair does not guarantee lasting competence.

Downstream

Atrioventricular Valve Regurgitation Valve incompetence is clinically expressed as regurgitation.

Hemodynamic Volume Overload Regurgitant flow adds to chamber and pulmonary circulatory load.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"The occurrence and severity of symptoms depend on the degree of AV valve regurgitation and other associated CHD."

Valve dysfunction modifies symptoms.

Left-to-Right Shunting

Atrial and, where present, ventricular communications permit excess left-to-right flow after pulmonary vascular resistance falls. Flow magnitude differs between complete, restrictive transitional and partial defects and can change with pulmonary vascular disease.

Downstream

Pulmonary Overcirculation A substantial left-to-right shunt increases pulmonary blood flow.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"In complete AVSDs, there is typically a large left-to-right shunt in early infancy."

Complete-form clinical physiology.

Pulmonary Overcirculation

Increased pulmonary flow is a hemodynamic consequence of substantial shunting; it contributes to respiratory symptoms and pressure load. It is distinct from fixed pulmonary vascular remodeling.

Downstream

Hemodynamic Volume Overload The shunt increases circulatory volume load.

Pulmonary Arterial Hypertension Flow-related pulmonary pressure elevation can occur before fixed high resistance is established.

Pulmonary Vascular Remodeling Sustained uncorrected hemodynamic stress can progress to pulmonary vascular disease; this is not inevitable in every lesion.

Heart Murmur Increased flow through the pulmonary valve can generate the presenting murmur.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"The large left-to-right shunt causes excessive blood flow to the lungs, resulting in increased pulmonary artery pressures."

Flow/pressure sequence described in clinical review.

Hemodynamic Volume Overload

Excess shunt flow and valve regurgitation place volume demands on the circulation. The affected chamber pattern depends on the specific anatomy and valve lesion.

Downstream

Congestive Cardiac Dysfunction Persistent hemodynamic load can produce symptomatic failure; medical therapy may stabilize symptoms before repair.

Supraventricular Tachycardia Atrial enlargement can contribute to supraventricular arrhythmias, although postoperative triggers and conduction substrate vary.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"CHF results from significant communication between the atria and ventricles, leading to volume overload in both the right atrium and the right ventricle."

Clinical physiology.

Congestive Cardiac Dysfunction

Symptomatic heart failure reflects inability to accommodate the hemodynamic burden, particularly in infancy with significant shunting. It is not necessarily a primary myocardial contractile disease.

Downstream

Congestive Heart Failure Manifestation of symptomatic heart failure; expression and severity vary by lesion.

Tachypnea Manifestation of symptomatic heart failure; expression and severity vary by lesion.

Tachycardia Manifestation of symptomatic heart failure; expression and severity vary by lesion.

Hepatomegaly Manifestation of symptomatic heart failure; expression and severity vary by lesion.

Failure to Thrive Manifestation of symptomatic heart failure; expression and severity vary by lesion.

Feeding Difficulties Symptomatic infants can have poor feeding and increased work during feeds.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"CHF symptoms are primarily secondary to pulmonary overcirculation"

Clinical hemodynamic rather than intrinsic cardiomyopathy framing.

Pulmonary Vascular Remodeling

Advanced unrepaired shunting may produce fixed pulmonary vascular disease and increased resistance. The review describes the clinical sequence rather than a specific histologic mediator measured in all patients.

Downstream

Pulmonary Arterial Hypertension Increased pulmonary vascular resistance contributes to advanced pulmonary hypertension.

Shunt Reversal When pulmonary vascular resistance becomes sufficiently high, flow can become bidirectional or reverse; this is a late complication, not a required disease phase.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"Those who survive beyond 1 year develop irreversible pulmonary vascular disease, and later on, the reversal of the shunt."

Historical clinical synthesis; the universal wording is not adopted across all AVSD subtypes.

Shunt Reversal

Eisenmenger physiology can develop with advanced pulmonary vascular disease. It changes management fundamentally; adult shunt closure is harmful in this setting.

Show evidence (1 reference)

url:https://www.guidelinecentral.com/guideline/6958/ SUPPORT REVIEW SYNTHESIS Other

"demonstrating Eisenmenger physiology or ... >10 Wood units, shunt closure should ... not ... be performed to avoid additional morbidity and mortality."

Current management boundary reflecting advanced physiology.

Abnormal Cardiac Conduction Geometry

The displaced conduction system in AVSD contributes to abnormal ventricular activation and the characteristic superior/leftward axis. Postoperative block is a separate possible complication, not an obligatory consequence of the axis finding.

Downstream

Left Axis Deviation The altered activation sequence produces the characteristic ECG-axis pattern.

Postoperative Atrioventricular Block The abnormal conduction anatomy is vulnerable during repair; the clinical postoperative association does not isolate the injury mechanism in every patient.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"This finding results from abnormal ventricular activation caused by the conduction system coursing along the inferior ridge of the inlet VSD."

Explanation of the preceding characteristic ECG-axis finding.

Abnormal Left Ventricular Outflow Geometry

The congenital outflow geometry can predispose to obstruction that persists or emerges after repair. Additional valve/subvalvar anatomy and surgical factors modify risk.

Downstream

Left Ventricular Outflow Tract Obstruction Abnormal outflow shape can become clinically obstructive.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"LVOTO occurs in approximately 3.5% to 5% of patients, primarily due to the abnormal LVOT shape associated with AVSD anatomy."

Clinical anatomic synthesis; no global frequency band inferred.

Abnormal Left-Right Patterning

Ciliary motility disruption can produce laterality abnormalities associated with AVSD. In Dnah11avc4 mice, AVSD occurred only with heterotaxy while second-heart-field Hedgehog signaling was preserved. This is not a claim that all AVSD or all heterotaxy has one ciliary cause.

Animal models

Dnah11avc4 recessive AVSD model Mouse recapitulates Mouse mutant with AVSD occurring concurrently with heterotaxy, while SHF Hedgehog signaling was not disrupted.

Downstream

Deficient Atrioventricular Septation The mouse association supports a developmental laterality route; the intervening cardiac morphogenetic steps are unresolved.

Show evidence (1 reference)

PMID:27340223 SUPPORT PRIMARY RESULT Model Organism

"Dnah11avc4 did not disrupt SHF Hh signaling and caused AVSDs only concurrently with heterotaxy, a left/right axis abnormality."

Recessive mouse Dnah11 mutation with laterality-associated AVSD; SHF Hedgehog was preserved.

Reduced Second Heart Field Hedgehog Signaling

A separate structural/signaling cilia mutation, Mks1avc6, impaired second-heart-field Hedgehog signaling and produced AVSD without heterotaxy. This experimentally separates a signaling route from motility-dependent laterality.

Animal models

Mks1avc6 recessive AVSD model Mouse recapitulates Mouse mutant with disrupted SHF Hedgehog signaling and AVSD without heterotaxy.

Downstream

Deficient Atrioventricular Septation The Mks1 mouse results support involvement of this signaling compartment in AV septation, without proving an equivalent mechanism for every human MKS1 variant.

Show evidence (1 reference)

PMID:27340223 SUPPORT PRIMARY RESULT Model Organism

"In contrast, Mks1avc6 disrupted SHF Hh signaling and caused AVSDs without heterotaxy."

A distinct recessive mouse route through second-heart-field signaling, without heterotaxy.

Altered NR2F2 Transcriptional Regulation

AVSD-associated coding variants change activation of NGFI-A or APOB reporters in a promoter-dependent manner; some increase and others decrease or preserve output. APOB repression in HepG2 cells remains intact. This is not a uniform loss-of-function mechanism or a patient endocardial measurement.

NR2F2 hgnc:7976

Experimental models

NR2F2 promoter-dependent reporter assays CELL LINE Promoter- and cell-dependent reporter output, including retained repression.

Downstream

Deficient Atrioventricular Septation Human genetic association and altered reporter function support a developmental contribution, but no single cardiac target program or direct cellular mediator was established.

Show evidence (2 references)

url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf SUPPORT PRIMARY RESULT In Vitro

"variant p.Asn205Ile reduces the activity of NR2F2 on the APOB promoter while increasing it on the NGFI-A promoter"

Direct example of opposite activation effects by promoter context.

url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf SUPPORT PRIMARY RESULT In Vitro

"we found that the expected repressive activity of NR2F2 is not affected by any of the variants observed in individuals with CHDs."

HepG2 APOB repression is preserved despite variant-specific activation changes in HEK293T cells.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

Cardiovascular 12

Atrioventricular Canal Defect HP:0006695

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"The right and left AV valves are separated by tissue, but they share a common junction."

Even partial AVSD has a common junction; separate orifices do not imply normal separate junctions.

Congestive Heart Failure HP:0001635

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"Individuals with complete AVSDs usually start to exhibit congestive heart failure (CHF) symptoms at 4 to 6 weeks of life as the pulmonary vascular resistance (PVR) drops to its nadir."

Clinical timing in complete AVSD, not a universal onset across subtypes.

Atrioventricular Valve Regurgitation HP:0034376

Show evidence (1 reference)

PMID:35757952 SUPPORT PRIMARY RESULT Human Clinical

"After initial repair, there were 18 cases of moderate-to-severe left atrioventricular valve regurgitation (17.3%)."

Quantifies moderate-to-severe left atrioventricular valve regurgitation after primary repair, the dominant residual lesion.

Pulmonary Arterial Hypertension HP:0002092

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"Pulmonary hypertension develops early and can progress rapidly, typically within the first 6 to 12 months of life if surgical intervention is not performed."

Clinical synthesis concerning substantial unrepaired shunting; not proof all AVSD follows this timetable.

Left Axis Deviation HP:0033568

Show evidence (1 reference)

PMID:10605520 SUPPORT PRIMARY RESULT Human Clinical

"only the five infants with complete AVSD had a superior QRS axis"

In a neonatal ECG screening cohort, a superior QRS axis was specific to complete AVSD among the congenital heart defects detected.

Left Ventricular Outflow Tract Obstruction HP:0032092

Show evidence (1 reference)

PMID:37612667 SUPPORT BACKGROUND Human Clinical

"left ventricular outflow tract obstruction (LVOTO) has been described as a common complication following surgical repair of AVSD occurring in 2–7% of the patients"

Quantifies LVOTO as a post-repair complication of AVSD.

Postoperative Atrioventricular Block HP:0001678

Show evidence (1 reference)

PMID:37612667 SUPPORT PRIMARY RESULT Human Clinical

"The indication for pacemaker implantation was third-degree atrioventricular block in 4 (2.0%) patients, second-degree atrioventricular block in 1 (0.6%) patient, and sinus node dysfunction in 1 (0.5%) patient."

Documents postoperative atrioventricular block as the leading pacemaker indication after AVSD repair.

Tachycardia HP:0001649

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"Signs of CHF include tachypnea, tachycardia, failure to thrive (fall across 2 major centiles on the growth chart), wheezing or rales on lung auscultation, S3 gallop rhythm, apical displacement of the apical impulse, hepatomegaly, or increased jugular venous pressure."

Clinical sign of symptomatic heart failure rather than a specific arrhythmic mechanism.

Heart Murmur HP:0030148

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"The most common presentation is evaluation of a murmur, secondary to increased flow across the pulmonary valve, best heard at the upper left sternal border."

Increased pulmonary flow or AV valve regurgitation can generate distinct murmurs; a murmur may be the presenting finding in partial AVSD.

Primum Atrial Septal Defect HP:0010445

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"Partial AVSD includes a primum ASD without a VSD."

Atrial component of the AVSD spectrum; represented separately from the ventricular component.

Inlet Ventricular Septal Defect HP:0011622

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"Complete AVSD comprises a primum ASD, an inlet VSD, and a common AV valve with 4 to 5 leaflets"

Present in complete and transitional forms, but absent from partial AVSD.

Supraventricular Tachycardia HP:0004755

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"Enlargement of the atrium can lead to supraventricular arrhythmias. Supraventricular tachycardias have been reported in about 8% of patients early after AVSD surgery and in 3.6% of patients later on after the repair."

An early or late postoperative complication; atrial enlargement can contribute to atrial arrhythmias.

Digestive 2

Feeding Difficulties HP:0011968

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"Symptoms of CHF include increased work of breathing, sweating while feeding, poor feeding, lethargy, or increased sleepiness."

Poor feeding is part of symptomatic infant heart failure.

Hepatomegaly HP:0002240

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

Can accompany congestive heart failure.

Respiratory 1

Tachypnea HP:0002789

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

Respiratory sign of pulmonary overcirculation or associated heart failure, particularly in complete AVSD.

Growth 1

Failure to Thrive HP:0001508

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

Poor weight gain can accompany symptomatic shunting and feeding difficulty; this is not universal in partial AVSD.

🧬

Genetic Associations

CRELD1 (Susceptibility Variant)

Gene: CRELD1 hgnc:14630 relationship_type: SUSCEPTIBILITY variant_origin: GERMLINE

Show evidence (2 references)

PMID:22523272 SUPPORT PRIMARY RESULT Human Clinical

"In each case the p.R329C mutation was inherited from an unaffected parent."

Incomplete penetrance or susceptibility context.

PMID:15096951 SUPPORT REVIEW SYNTHESIS Human Clinical

"Mutation of CRELD1 increases susceptibility to AVSD but is not alone sufficient to cause the defect"

Historical susceptibility interpretation, not a universal inheritance law.

NFATC1 (Missense Variant)

Gene: NFATC1 hgnc:7775 relationship_type: SUSCEPTIBILITY variant_origin: GERMLINE

Show evidence (2 references)

url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf SUPPORT PRIMARY RESULT Human Clinical

"Parental DNA specimens were not available for any of the three probands."

Segregation limitation.

url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf SUPPORT PRIMARY RESULT Human Clinical

"Mutation screening allowed to identify three heterozygous NFATC1 missense variants"

Variant discovery in a selected cohort.

HMGN1 (Chromosome 21 Dosage)

Gene: HMGN1 hgnc:4984 relationship_type: MODIFIER variant_origin: GERMLINE

Show evidence (2 references)

PMID:41125893 SUPPORT PRIMARY RESULT Model Organism

"Future studies will resolve whether excess dosage of HMGN1 is sufficient to cause increased penetrance of CHDs."

Explicit limit on anatomical sufficiency.

PMID:41125893 SUPPORT PRIMARY RESULT In Vitro

"reduction of HMGN1 to two copies in trisomic cells partially restored the transcriptional dysregulation to a more disomic-like state"

Human culture dosage correction.

Rare-variant candidate enrichment (Rare Variant Enrichment)

Show evidence (1 reference)

PMID:25996639 SUPPORT PRIMARY RESULT Human Clinical

"Whole-exome sequencing was performed in 81 unrelated probands with AVSD to identify potentially causal variants in a comprehensive set of 112 genes with strong biological relevance to AVSD."

Discovery design, not a count of causal genes.

NR2F2 (Rare variant association with functional evidence)

Gene: NR2F2 hgnc:7976 gene page relationship_type: SUSCEPTIBILITY variant_origin: GERMLINE

Show evidence (2 references)

url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf SUPPORT PRIMARY RESULT Human Clinical

"were inherited from an apparently healthy parent"

Human segregation limits in the Results.

url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf SUPPORT PRIMARY RESULT Human Clinical

"We found NR2F2 to be the only gene, of the nine genes with de novo variants identiﬁed in the original trios, with a signiﬁcant enrichment of rare missense variants"

Case-control enrichment in the selected discovery design.

💊

Medical Actions

Surgical Repair of Atrioventricular Septal Defect

Action: atrioventricular septal defect repair Ontology label: Atrioventricular Septal Defect Repair NCIT:C217463

For balanced lesions with significant ventricular shunting, repair is generally planned at 3–6 months, modified by symptom control, growth, valve regurgitation and associated anatomy. Earlier intervention may be needed for uncontrolled failure; primarily atrial-shunt partial/transitional lesions are commonly repaired in the toddler years. These pediatric ACC pathways exclude unbalanced and complex associated lesions. Patch techniques and valve reconstruction are individualized; residual shunts or regurgitation can remain.

Mechanism Target:

INHIBITS Left-to-Right Shunting — Closure reduces the atrial/ventricular communications driving shunting; it does not guarantee complete abolition of residual flow.

Show evidence (1 reference)

url:https://www.acc.org/Latest-in-Cardiology/Articles/2025/02/03/12/17/Clinical-Practice-Algorithm-For-the-Follow-Up-of-Repaired-and-Unrepaired-Atrioventricular-Septal-Defects SUPPORT INDIRECT REVIEW SYNTHESIS Other

"For patients with a significant ventricular-level shunt, surgical repair is typically performed in the first 3-6 months of life, with optimal timing based on the ability to medically manage symptoms of pulmonary overcirculation and maintain adequate growth."

Closure reduces the atrial/ventricular communications driving shunting; it does not guarantee complete abolition of residual flow.

Show evidence (1 reference)

Medical heart failure stabilization

Diuretics and selected afterload-reducing therapy can stabilize symptomatic pulmonary overcirculation or valve regurgitation while planning repair. They do not correct the congenital communications or replace indicated surgery.

Mechanism Target:

INHIBITS Hemodynamic Volume Overload — Medical therapy reduces congestive load while the structural lesion remains.

Show evidence (1 reference)

"Medical management with diuretics, afterload reduction, and nutritional support may be required, particularly in the setting of hemodynamically significant VSD or significant left AV valve regurgitation."

Medical therapy reduces congestive load while the structural lesion remains.

Show evidence (1 reference)

Nutritional support

Action: Nutritional Support NCIT:C15433

Optimize caloric intake and growth in symptomatic infants, including feeding support selected by the clinical team. Growth failure despite support can alter repair timing.

Mechanism Target:

MODULATES Failure to Thrive — Nutritional support aims to improve somatic growth; a specific growth effect size is not established by this review.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT INDIRECT REVIEW SYNTHESIS Other

"Nutritional optimization and calorie fortification play an important role in allowing more somatic growth before surgical repair."

Nutritional support aims to improve somatic growth; a specific growth effect size is not established by this review.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Other

"Nutritional optimization and calorie fortification play an important role in allowing more somatic growth before surgical repair."

Optimize caloric intake and growth in symptomatic infants, including feeding support selected by the clinical team. Growth failure despite support can alter repair timing.

Left Atrioventricular Valve Repair

Action: heart valve repair Ontology label: Heart Valve Repair NCIT:C50818

Valve reconstruction at initial repair or reoperation addresses clinically significant incompetence; replacement may be necessary if repair is unsuitable. For repaired adults, surgery is recommended for symptomatic severe left AV valve regurgitation or asymptomatic severe regurgitation with LV end-systolic diameter ≥40 mm or LVEF <60% (Class I, B-NR). Observed associations of incomplete cleft closure with outcomes do not prove one operation is best for every valve.

Mechanism Target:

INHIBITS Atrioventricular Valve Incompetence — Reconstruction aims to reduce regurgitation without assuring normal valve function or freedom from reoperation.

Show evidence (1 reference)

url:https://www.guidelinecentral.com/guideline/6958/ SUPPORT INDIRECT REVIEW SYNTHESIS Other

"valve surgery is recommended to improve functional status and prevent worsening ventricular function."

Reconstruction aims to reduce regurgitation without assuring normal valve function or freedom from reoperation.

Show evidence (1 reference)

url:https://www.guidelinecentral.com/guideline/6958/ SUPPORT REVIEW SYNTHESIS Other

"symptomatic severe left atrioventricular valve regurgitation or b) asymptomatic severe left atrioventricular valve regurgitation with ... dilation"

Individualized repair or palliation for unbalanced AVSD

Assess ventricular and valve adequacy in a congenital surgical team. Some lesions permit biventricular repair, whereas severe imbalance requires single-ventricle palliation; the isolated-balanced pediatric algorithm does not decide this boundary.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Other

"The degree of AV valve commitment is the primary determinant of candidacy for full biventricular surgical repair versus single ventricle palliation."

Adult unrepaired or residual-shunt assessment for closure

In adults with Qp:Qs ≥1.5 and/or significant or progressive chamber dilation, closure is recommended when PVR ≤2 Wood units (Class I, C-LD), and reasonable with PVR >2 to <5 (Class IIa, C-EO). Advanced pulmonary vascular disease requires expert assessment; these recommendations do not supply a blanket closure indication at intermediate higher PVR.

Show evidence (1 reference)

url:https://www.guidelinecentral.com/guideline/6958/ SUPPORT REVIEW SYNTHESIS Other

"≥1.5), and/or significant or progressive atrial/ ventricular dilatation with no ... ≤2 Wood units), closure of the ... or residual shunt is recommended to improve functional class and clinical outcomes."

Avoid closure with Eisenmenger physiology or very high PVR

Shunt closure should not be performed in adults with Eisenmenger physiology or PVR >10 Wood units (Class III harm, C-LD). Referral for specialist congenital and pulmonary-hypertension care is required; late presentation alone is not a substitute for hemodynamic assessment.

Show evidence (1 reference)

url:https://www.guidelinecentral.com/guideline/6958/ SUPPORT REVIEW SYNTHESIS Other

"demonstrating Eisenmenger physiology or ... >10 Wood units, shunt closure should ... not ... be performed to avoid additional morbidity and mortality."

Left ventricular outflow obstruction surgery

In repaired adults, symptomatic LV outflow obstruction or LVEF <50% is a Class I indication for repair; asymptomatic obstruction with progressive greater-than-mild aortic regurgitation may justify repair (Class IIb). Pediatric decisions depend on anatomy and progression.

Mechanism Target:

INHIBITS Left Ventricular Outflow Tract Obstruction — Surgery relieves an important residual or progressive obstruction in eligible patients.

Show evidence (1 reference)

url:https://www.guidelinecentral.com/guideline/6958/ SUPPORT INDIRECT REVIEW SYNTHESIS Other

"surgical repair is recommended to improve functional status and preserve ventricular function."

Surgery relieves an important residual or progressive obstruction in eligible patients.

Show evidence (1 reference)

url:https://www.guidelinecentral.com/guideline/6958/ SUPPORT REVIEW SYNTHESIS Other

"obstruction with symptoms attributable to the obstruction, or ... surgical repair is recommended to improve functional status and preserve ventricular function."

Lifelong congenital cardiology surveillance

Monitor residual shunts, AV valve dysfunction, ventricular function, outflow obstruction and rhythm/conduction disease. Frequency and imaging depend on residual lesions and physiology; transition to adult congenital care is needed. A reassuring early repair does not remove late risks.

Show evidence (1 reference)

"For all patients, long-term surveillance for residual lesions is required"

Pulmonary hypertension specialist care

Adults with repaired or unrepaired AVSD and PAH should be managed jointly with pulmonary-hypertension expertise (Class I, C-LD). Disease-specific drug selection and shunt decisions depend on hemodynamics and overall congenital anatomy.

Show evidence (1 reference)

url:https://www.guidelinecentral.com/guideline/6958/ SUPPORT REVIEW SYNTHESIS Other

"should be managed by clinicians with pulmonary hypertension expertise to improve outcomes."

🌍

Environmental Factors

Maternal pregestational diabetes

Maternal pregestational diabetes was associated with nonsyndromic complete atrioventricular canal in the Texas 2005–2008 subset (adjusted prevalence ratio 6.74, 95% CI 3.67–12.37). The table includes 12 exposed cases. Diabetes type, severity and glycemic control were unavailable; this is an adjusted observational association, not a ranking against all modifiable risk factors or a measured embryonic mediator.

Show evidence (2 references)

PMID:23061687 SUPPORT PRIMARY RESULT Human Clinical

"Significant associations were observed between non-syndromic CAVC in offspring and maternal pregestational diabetes (adjusted prevalence ratio (aPR) 6.74; 95% confidence interval (CI) 3.67, 12.37), gestational diabetes (aPR 1.69; 95% CI 1.03, 2.79) and obesity (aPR 1.69; 95% CI 1.24, 2.30)."

Reports the exposure associations in the source-defined nonsyndromic complete-canal cohort; not a causal mediator experiment.

PMID:23061687 SUPPORT PRIMARY RESULT Human Clinical

"Specific information on maternal pregestational diabetes, gestational diabetes, and prepregnancy body mass index (BMI) was only available for deliveries in 2005–2008."

Defines the restricted period for the exposure-specific analysis.

Maternal gestational diabetes

Gestational diabetes was associated with nonsyndromic complete atrioventricular canal in the same Texas subset (adjusted prevalence ratio 1.69, 95% CI 1.03–2.79; 15 exposed cases). The authors note that a diagnosis made after the first trimester may include previously unrecognized pregestational diabetes; the study does not establish that later hyperglycemia caused early abnormal septation.

Show evidence (2 references)

PMID:23061687 SUPPORT PRIMARY RESULT Human Clinical

Reports the exposure associations in the source-defined nonsyndromic complete-canal cohort; not a causal mediator experiment.

PMID:23061687 SUPPORT PRIMARY RESULT Human Clinical

"Specific information on maternal pregestational diabetes, gestational diabetes, and prepregnancy body mass index (BMI) was only available for deliveries in 2005–2008."

Defines the restricted period for the exposure-specific analysis.

Maternal prepregnancy obesity

Prepregnancy BMI of at least 30 was associated with nonsyndromic complete atrioventricular canal in the Texas 2005–2008 subset (adjusted prevalence ratio 1.69, 95% CI 1.24–2.30; 75 exposed cases). After exclusion of heterotaxy, the estimate was 1.5 with a 95% CI of 0.9–2.4. Definitions, residual confounding and subgroup imprecision constrain generalization; no specific mesenchymal mechanism was measured.

Show evidence (2 references)

PMID:23061687 SUPPORT PRIMARY RESULT Human Clinical

Reports the exposure associations in the source-defined nonsyndromic complete-canal cohort; not a causal mediator experiment.

PMID:23061687 SUPPORT PRIMARY RESULT Human Clinical

"Specific information on maternal pregestational diabetes, gestational diabetes, and prepregnancy body mass index (BMI) was only available for deliveries in 2005–2008."

Defines the restricted period for the exposure-specific analysis.

🔬

Diagnosis

Fetal and postnatal echocardiography

Fetal echocardiography follows a suspected lesion on obstetric ultrasound. Postnatal echo defines atrial/ventricular communications, valve morphology and commitment, regurgitation, ventricular adequacy and associated outflow/arch lesions. Three-dimensional imaging can refine valve assessment.

echocardiography NCIT:C16525

Show evidence (2 references)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Other

"When an AVSD is suspected during an obstetric ultrasound, referral to fetal cardiology for a comprehensive fetal echocardiogram is recommended"

PMID:34196822 SUPPORT REVIEW SYNTHESIS Human Clinical

"The understanding of functional morphology of AVSDs has improved significantly with detailed 3D echocardiographic evaluation of the atrioventricular junction and valve morphology."

Clinical imaging synthesis.

Electrocardiography

ECG assesses the characteristic superior/leftward axis and rhythm/conduction abnormalities; it complements rather than replaces echocardiography. A 37-neonate Down-syndrome screening study found a superior axis in five complete AVSD cases but missed seven other congenital heart defects.

Electrocardiography NCIT:C38053

Show evidence (2 references)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Other

"The characteristic electrocardiogram in AVSDs has a leftward counterclockwise superior axis"

PMID:10605520 SUPPORT PRIMARY RESULT Human Clinical

"only the five infants with complete AVSD had a superior QRS axis"

Small neonatal screening cohort; no general sensitivity estimate for all AVSD.

Clinical genetics and testing

Offer genetic counseling and testing appropriate to prenatal/postnatal findings, including aneuploidy/chromosomal assessment and selected sequencing. Yield depends on ascertainment and syndromic context. One referred fetal-CHD series reported 36.8% in its AVSD subgroup; its available abstract does not provide that subgroup denominator.

genetic testing NCIT:C15709

Show evidence (2 references)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Other

"Genetic testing should be offered to all families, given the higher incidence of genetic syndromes associated with this CHD."

PMID:33142350 SUPPORT PRIMARY RESULT Human Clinical

"The prevalence of a genetic defect was highest in fetuses with an atrioventricular septal defect (36.8%)"

Selected fetal referral cohort, not a universal clinical diagnostic yield.

Hemodynamic assessment and cardiac catheterization

Routine catheterization is unnecessary in uncomplicated infants repaired on time. Assess pulmonary arterial hypertension and pulmonary vascular resistance when late presentation, residual shunting or comorbidity makes operability uncertain; adult unrepaired or residual-shunt AVSD warrants PAH assessment (Class I, C-LD).

Cardiac Catheterization NCIT:C38044

Show evidence (2 references)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Other

"Cardiac catheterization is not a part of routine preoperative evaluation for uncomplicated AVSDs who undergo surgical repair at the appropriate timing based on the AVSD subtype."

url:https://www.guidelinecentral.com/guideline/6958/ SUPPORT REVIEW SYNTHESIS Other

"or those with residual shunts after prior repair should be assessed for the presence of ... to guide medical therapy and assess suitability for repair."

2025 adult guideline summary recommendation.

Selective cardiovascular MRI or CT

Cross-sectional imaging can clarify ventricular volumes in unbalanced lesions or vascular anatomy in complex associated disease. It is not routinely required in uncomplicated AVSD.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Other

"Cross-sectional imaging, including cardiac computed tomography and cardiac magnetic resonance imaging, is usually not required in uncomplicated AVSDs; however, it can be beneficial in a subset of patients, such as those with unbalanced AVSDs, to assess ventricular volumes and guide decision-making."

Cross-sectional imaging can clarify ventricular volumes in unbalanced lesions or vascular anatomy in complex associated disease. It is not routinely required in uncomplicated AVSD.

📈

Progression

Anatomy-dependent presentation

Complete AVSD commonly becomes symptomatic as neonatal pulmonary vascular resistance falls, while partial or restrictive transitional lesions may present later. Valve regurgitation and associated defects modify this pattern.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/ SUPPORT REVIEW SYNTHESIS Human Clinical

"In patients with a partial AVSD, symptoms might not be detected in the first few years of life and might manifest later in childhood."

Contrasts later presentation with complete-AVSD infancy.

Repair and long-term residual lesions

Repair improves hemodynamics but does not ensure normal valve function or abolish all residual shunts, outflow obstruction or rhythm risk. Lifelong review is needed. In the 248-patient biventricular single-center cohort spanning 1995–2022, survival was 88.3% at 10 and 79.6% at 25 years; these estimates mix eras and selected operable anatomy, with few patients beyond 20 years. Patients dying after palliation before definitive repair were excluded.

Show evidence (2 references)

PMID:40154545 SUPPORT PRIMARY RESULT Human Clinical

"Survival of the entire cohort was 88.3% at 10, 83.8% at 15, and 79.6% at 25 years."

Selected surgical series; not a universal prognosis.

PMID:40154545 SUPPORT PRIMARY RESULT Human Clinical

"patients receiving PAB that did not survive until AVSD repair are not considered."

Explicit survivorship limit.

📊

Prevalence

Live births

Birth Prevalence 19.0 per 100,000 1–9 per 10,000 (births)

The 2024 clinical review reports 0.19 per 1000 live births, without an explicit population denominator in the available abstract. Other reviews report different estimates; this is a cited birth-prevalence estimate, not a universal contemporary registry rate.

Show evidence (1 reference)

PMID:38884731 SUPPORT REVIEW SYNTHESIS Human Clinical

"AVSDs occur in 0.19 of 1000 live births and constitute 4-5 % of congenital heart defects."

Gives the birth prevalence and the proportion of congenital heart defects represented by AVSD.

🌍

Epidemiology

Proportion of congenital cardiac malformations

Published clinical reviews cite AVSD as several percent of congenital cardiac malformations; the 4–7% figure in this source is background synthesis, not the proportion measured by its surgical cohort.

Show evidence (1 reference)

PMID:37612667 SUPPORT BACKGROUND Human Clinical

"Atrioventricular septal defects (AVSD) represent 4-7% of congenital cardiac malformations."

Gives the proportion of congenital cardiac malformations represented by AVSD.

Association with Down syndrome

AVSD is strongly associated with trisomy 21. Estimates of any congenital heart defect and relative AVSD enrichment describe different denominators; the approximately 1000-fold figure is prior human epidemiology summarized in the 2025 mechanistic paper, not a result measured in its cell or mouse experiments.

Show evidence (2 references)

PMID:29054759 SUPPORT BACKGROUND Human Clinical

"Congenital heart defects (CHD) are seen in around 40% of the Down syndrome patients. Atrioventricular Septal Defect (AVSD) or endocardial cushion defect is commonest form of CHD in these children."

Establishes the frequency of CHD in Down syndrome and AVSD as the predominant lesion.

PMID:41125893 SUPPORT BACKGROUND Human Clinical

"CHDs occur in around 50% of cases of Down syndrome, with an approximately 1,000-fold enrichment of atrioventricular canal (AVC) defects that disrupt the junction between the atria and ventricles"

Quantifies the magnitude of AVC-defect enrichment attributable to trisomy 21.

Scope of the Texas complete-canal maternal-risk cohort

The 1999–2008 Texas registry analysis included 563 complete atrioventricular canal cases classified as nonsyndromic, among 1,335 total complete-canal cases. Heterotaxy was included in the nonsyndromic group; only 47 cases were isolated. Diabetes subtype and prepregnancy BMI analyses cover 2005–2008 only. Cases included fetal deaths and terminations while prevalence denominators used live births. These definitions do not represent every partial or complete AVSD population.

Show evidence (2 references)

PMID:23061687 SUPPORT PRIMARY RESULT Human Clinical

"Patients with visceral heterotaxy were included in the nonsyndromic group."

Defines an important inclusion within the source-specific nonsyndromic label.

PMID:23061687 SUPPORT PRIMARY RESULT Human Clinical

"Specific information on maternal pregestational diabetes, gestational diabetes, and prepregnancy body mass index (BMI) was only available for deliveries in 2005–2008."

Restricts the exposure-specific estimates to the relevant years.

🧫

Experimental Models

Isogenic trisomy 21 cardiomyocyte differentiation and HMGN1 perturbation IPSC_DERIVED_MODEL

Day-10 precursors and day-20 cardiomyocytes were profiled. A CROP-seq screen of 66 selected chromosome 21 genes nominated HMGN1; activation in disomic cells shifted AVC myocardial expression, and three-to-two allele correction in trisomic cells partially restored it. CUT&RUN/scATAC characterized chromatin context.

Organism

Homo sapiens NCBITaxon:9606

Cell source

Isogenic disomic/trisomic hiPSCs from two genetically unrelated mosaic donors; principal perturbations in the main donor pair

Publication

PMID:41125893

Pathograph links

Increased HMGN1 Dosage perturbs CRISPR activation and allele deletion test opposite dosage changes.

Show evidence (1 reference)

PMID:41125893 SUPPORT PRIMARY RESULT In Vitro

"reduction of HMGN1 to two copies in trisomic cells partially restored the transcriptional dysregulation to a more disomic-like state"

CRISPR activation and allele deletion test opposite dosage changes.

Altered Atrioventricular Myocardial Identity rescues Allele correction partially restores the transcriptomic state.

Readouts

AVC transcriptional-state abnormality

Direction: DECREASED

Interpretation: Allele correction partially restores the transcriptomic state.

Show evidence (1 reference)

PMID:41125893 SUPPORT PRIMARY RESULT In Vitro

"reduction of HMGN1 to two copies in trisomic cells partially restored the transcriptional dysregulation to a more disomic-like state"

Allele correction partially restores the transcriptomic state.

Show evidence (1 reference)

PMID:41125893 SUPPORT PRIMARY RESULT In Vitro

"reduction of HMGN1 to two copies in trisomic cells partially restored the transcriptional dysregulation to a more disomic-like state"

Allele correction partially restores the transcriptomic state.

Short-term differentiation and relative recovered-cell states do not establish in-vivo human lineage conversion. CLDN8 was ineffectively upregulated. Chromatin occupancy/motif overlap does not prove direct HMGN1–TBX2 binding or one necessary mediator; HMGN1-alone human anatomical sufficiency and therapy are untested.

Show evidence (1 reference)

PMID:41125893 SUPPORT PRIMARY RESULT In Vitro

"reduction of HMGN1 to two copies in trisomic cells partially restored the transcriptional dysregulation to a more disomic-like state"

Partial transcriptional correction rather than complete cellular/anatomical rescue.

COS-7 NFATC1 variant localization and reporter assays CELL_LINE

Wild-type and three variant human NFATC1 constructs were compared using microscopy, nuclear/cytoplasmic immunoblots and an NPPB luciferase reporter. Ionomycin stimulation, separate exogenous-NLS constructs and equal wild-type/mutant cotransfection tested localization and interference. Val210Met had the clearest dominant-negative behavior.

Cell source

Transfected COS-7 monkey cells

Publication

url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf

Pathograph links

Reduced NFATC1 Nuclear Availability measures Variant proteins show impaired nuclear localization.

Readouts

Nuclear NFATC1 localization

Direction: DECREASED

Interpretation: Variant proteins show impaired nuclear localization.

Show evidence (1 reference)

url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf SUPPORT PRIMARY RESULT In Vitro

"After stimulation with ionomycin, a large fraction of the p.(Ala367Val) and p.(Ala696Thr) NFATC1 proteins was retained in the cytoplasm"

Variant proteins show impaired nuclear localization.

Show evidence (1 reference)

url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf SUPPORT PRIMARY RESULT In Vitro

"After stimulation with ionomycin, a large fraction of the p.(Ala367Val) and p.(Ala696Thr) NFATC1 proteins was retained in the cytoplasm"

Variant proteins show impaired nuclear localization.

Reduced NFATC1 Transcriptional Output measures The NPPB reporter is less activated by variant constructs.

Readouts

NPPB reporter activation

Direction: DECREASED

Interpretation: The NPPB reporter is less activated by variant constructs.

Show evidence (1 reference)

url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf SUPPORT PRIMARY RESULT In Vitro

"all mutants showed a variably reduced activation of theNPPB promoter, in all conditions."

The NPPB reporter is less activated by variant constructs.

Show evidence (1 reference)

url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf SUPPORT PRIMARY RESULT In Vitro

"all mutants showed a variably reduced activation of theNPPB promoter, in all conditions."

The NPPB reporter is less activated by variant constructs.

Heterologous transient overexpression and one promoter are not patient cardiac-tissue measurements. Baseline and added-NLS constructs are distinct. Reduced import and reporter output are associated but not proven to form an exclusive mediator chain; a milder Ala367Val effect and unresolved actions of the other variants are retained.

Show evidence (1 reference)

url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf SUPPORT PRIMARY RESULT In Vitro

"all mutants showed a variably reduced activation of theNPPB promoter, in all conditions."

Primary reporter finding.

Lineage-resolved mouse AVC collagen explant assay OTHER

Lineage tracing and GFP, CD31, alpha-SMA and WT1 markers separate endocardial mesenchymal invasion from epicardial outgrowth in 48-hour collagen cultures. Epicardial contribution increases with somite stage; SD208 reduces TGF-beta signaling and alters mixed outgrowth.

Organism

Mus musculus NCBITaxon:10090

Cell source

Somite-staged embryonic mouse atrioventricular canal explants, including Tie2-Cre lineage tracing

Publication

PMID:29549339

This is an assay-interpretation study, not proof that every human AVSD has failed EndoMT or a therapeutic rescue. Cobblestone morphology alone cannot identify endothelium, and early staging minimizes rather than universally eliminates epicardial contribution. No causal patient-phenotype link is assigned to the mixed-cell assay.

Show evidence (1 reference)

PMID:29549339 SUPPORT PRIMARY RESULT In Vitro

"monolayers of cobblestone-shaped cells are predominantly of epicardial rather than endothelial origin."

Primary lineage evidence correcting a common interpretation of this assay.

NR2F2 promoter-dependent reporter assays CELL_LINE

Rat NGFI-A and human APOB promoter luciferase reporters test six coding variants. Effects in HEK293T activation assays differ by promoter and allele, while HepG2 APOB repression is preserved. Expression/localization controls do not establish a cardiac-cell developmental rescue.

Organism

Homo sapiens NCBITaxon:9606

Cell source

HEK293T and HepG2 human cell lines with Cherry-fused NR2F2 constructs

Publication

url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf

Pathograph links

Altered NR2F2 Transcriptional Regulation measures Promoter- and cell-dependent reporter output, including retained repression.

Readouts

HepG2 APOB repression

Direction: UNCHANGED

Interpretation: The expected repressive activity remains intact for the tested variants.

Show evidence (2 references)

url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf SUPPORT PRIMARY RESULT In Vitro

"variant p.Asn205Ile reduces the activity of NR2F2 on the APOB promoter while increasing it on the NGFI-A promoter"

Direct example of opposite activation effects by promoter context.

+ 1 more reference

Show evidence (2 references)

url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf SUPPORT PRIMARY RESULT In Vitro

"variant p.Asn205Ile reduces the activity of NR2F2 on the APOB promoter while increasing it on the NGFI-A promoter"

Direct example of opposite activation effects by promoter context.

+ 1 more reference

No patient RNA/protein confirmation of the predicted splice or translocation effect is reported. Structural predictions are not ligand-binding measurements. These heterologous reporters do not identify the necessary endocardial or second-heart-field target in human AVSD.

Show evidence (2 references)

url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf SUPPORT PRIMARY RESULT In Vitro

"variant p.Asn205Ile reduces the activity of NR2F2 on the APOB promoter while increasing it on the NGFI-A promoter"

Direct example of opposite activation effects by promoter context.

url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf SUPPORT PRIMARY RESULT In Vitro

"we found that the expected repressive activity of NR2F2 is not affected by any of the variants observed in individuals with CHDs."

HepG2 APOB repression is preserved despite variant-specific activation changes in HEK293T cells.

🐁

Animal Models

Ts65Dn modifier crosses

Newborn histology tests sensitization by trisomy and reduced modifier dosage. The observed lesions were membranous or muscular VSDs and ostium secundum ASDs. These crosses did not reproduce the common-junction human AVSD lesion.

Species

Mouse

Genotype

Ts65Dn with heterozygous Creld1 or Hey2 loss

Background

Mixed C57BL/6 and C3H trisomic background

Publication

PMID:22523272

Pathograph links

Deficient Atrioventricular Septation partially recapitulates The crosses support dosage-sensitive cardiac septation, but the observed lesions are adjacent septal phenotypes rather than exact human AVSD.

Limitations: No AVSD was reproduced; translation to the atrioventricular junction is indirect.

Readouts

Histologically detected septal defects

Direction: INCREASED

Interpretation: The crosses support dosage-sensitive cardiac septation, but the observed lesions are adjacent septal phenotypes rather than exact human AVSD.

Show evidence (1 reference)

PMID:22523272 SUPPORT PRIMARY RESULT Model Organism

"Crossing loss-of-function alleles of either Creld1 or Hey2 onto the trisomic background caused a significant increase in the frequency of CHD"

The crosses support dosage-sensitive cardiac septation, but the observed lesions are adjacent septal phenotypes rather than exact human AVSD.

Show evidence (1 reference)

PMID:22523272 SUPPORT PRIMARY RESULT Model Organism

"Crossing loss-of-function alleles of either Creld1 or Hey2 onto the trisomic background caused a significant increase in the frequency of CHD"

The crosses support dosage-sensitive cardiac septation, but the observed lesions are adjacent septal phenotypes rather than exact human AVSD.

Ts65Dn duplicates a subset of human chromosome 21 orthologues. Blinded P0 structural scoring measures CHD incidence on this background, not a necessary two-hit rule in every human case. The mechanistic route between gene dosage and a specific septum is unresolved.

Show evidence (1 reference)

PMID:22523272 SUPPORT PRIMARY RESULT Model Organism

"Crossing loss-of-function alleles of either Creld1 or Hey2 onto the trisomic background caused a significant increase in the frequency of CHD"

Mouse modifier experiment; congenital heart defects rather than specific AVSD.

Euploid Creld1 and Hey2 double heterozygotes

Combined heterozygosity produced ostium secundum ASD in three of 31 newborns, whereas neither single-heterozygous group showed a septal defect at P0. This tests interaction on a euploid background, separately from trisomy.

Species

Mouse

Genotype

Creld1+/−; Hey2+/−

Publication

PMID:22523272

The lesion is secundum ASD, not AVSD. Small, background-dependent penetrance does not establish a universal human oligogenic requirement.

Show evidence (1 reference)

PMID:22523272 SUPPORT PRIMARY RESULT Model Organism

"No septal defects were detected at P0 in 90 pups that were either Creld1+/− (n=45) or Hey2+/− (n=45)"

Single-heterozygous controls in the combined-modifier experiment.

Dp1Tyb Hmgn1 dosage correction

E11.5 single-cell profiling tests AVC myocardial state after Hmgn1 dose correction; E15.5 micro-CT measures ventricular and outflow septal defects. The trisomic group had such defects in eight of 33 embryos. Correction attenuated these structural defects and neonatal lethality.

Species

Mouse

Genotype

Dp1Tyb with one Hmgn1 allele removed

Publication

PMID:41125893

Pathograph links

Altered Atrioventricular Myocardial Identity rescues Dose correction restores part of the abnormal AVC myocardial program.

Readouts

AVC transcriptional-state abnormality

Direction: DECREASED

Interpretation: Dose correction restores part of the abnormal AVC myocardial program.

Show evidence (1 reference)

PMID:41125893 SUPPORT PRIMARY RESULT Model Organism

"In a mouse model of trisomy 21, a similar transcriptional shift of AVC cardiomyocytes was restored by a reduction in Hmgn1 dosage"

Dose correction restores part of the abnormal AVC myocardial program.

Show evidence (1 reference)

PMID:41125893 SUPPORT PRIMARY RESULT Model Organism

"In a mouse model of trisomy 21, a similar transcriptional shift of AVC cardiomyocytes was restored by a reduction in Hmgn1 dosage"

Dose correction restores part of the abnormal AVC myocardial program.

Deficient Atrioventricular Septation partially recapitulates Ventricular/outflow septal defects are reduced; exact human AVSD anatomy is not the demonstrated endpoint.

Limitations: Anatomical transfer to AVSD remains partial.

Readouts

Ventricular and outflow septal-defect incidence

Direction: DECREASED

Interpretation: Ventricular/outflow septal defects are reduced; exact human AVSD anatomy is not the demonstrated endpoint.

Show evidence (1 reference)

PMID:41125893 SUPPORT PRIMARY RESULT Model Organism

"Removal of one allele of Hmgn1 in the Dp1Tyb (Tg) trisomic mouse rescued the increased incidence of VSDs and outflow tract defects"

Ventricular/outflow septal defects are reduced; exact human AVSD anatomy is not the demonstrated endpoint.

Show evidence (1 reference)

PMID:41125893 SUPPORT PRIMARY RESULT Model Organism

"Removal of one allele of Hmgn1 in the Dp1Tyb (Tg) trisomic mouse rescued the increased incidence of VSDs and outflow tract defects"

Ventricular/outflow septal defects are reduced; exact human AVSD anatomy is not the demonstrated endpoint.

Notes

The structural endpoint is not a validated count of human-type common-junction AVSD. Small atrial defects were difficult to distinguish from patent foramen ovale. Transcriptomic sample counts were small, and corrected AVC cell proportions did not establish lineage replacement. Survival benefit is not shown to be mediated exclusively by cardiac rescue; HMGN1-alone anatomical sufficiency remains untested.

Show evidence (1 reference)

PMID:41125893 SUPPORT PRIMARY RESULT Model Organism

"Removal of one allele of Hmgn1 in the Dp1Tyb (Tg) trisomic mouse rescued the increased incidence of VSDs and outflow tract defects"

Dose correction with structural mouse endpoint.

Human NFATC1 variant RNA in zebrafish

Human variant mRNA injection alters 24–48-hour cardiac morphology, looping and AVC marker domains relative to wild-type NFATC1 or GFP controls. Val210Met/Ala367Val accelerated and Ala696Thr retarded looping; chamber-marker specification remained broadly preserved. Histology examined six embryos per construct.

Species

Zebrafish

Genotype

One-cell-stage ectopic human NFATC1 Val210Met, Ala367Val or Ala696Thr mRNA

Publication

url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf

Pathograph links

Deficient Atrioventricular Septation partially recapitulates Abnormal AVC patterning supports developmental relevance, without reproducing human four-chamber septation.

Readouts

AVC patterning

Direction: ALTERED

Interpretation: Abnormal AVC patterning supports developmental relevance, without reproducing human four-chamber septation.

Show evidence (1 reference)

url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf SUPPORT PRIMARY RESULT Model Organism

"expression of AVSD-associated NFATC1 alleles dramatically affected cardiac devel- opment by promoting abnormal heart looping and AVC development"

Abnormal AVC patterning supports developmental relevance, without reproducing human four-chamber septation.

Show evidence (1 reference)

url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf SUPPORT PRIMARY RESULT Model Organism

"expression of AVSD-associated NFATC1 alleles dramatically affected cardiac devel- opment by promoting abnormal heart looping and AVC development"

Abnormal AVC patterning supports developmental relevance, without reproducing human four-chamber septation.

This is ectopic overexpression rather than an endogenous heterozygous knock-in. Edema, abnormal looping and AVC patterning are not a demonstration of the complete human AVSD anatomy or patient rescue. Other undiscovered human variants and one co-occurring TBX1 variant limit patient attribution.

Show evidence (1 reference)

url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf SUPPORT PRIMARY RESULT Model Organism

"expression of AVSD-associated NFATC1 alleles dramatically affected cardiac devel- opment by promoting abnormal heart looping and AVC development"

Variant-overexpression fish experiment.

Creld1 knockout developmental model

The available primary abstract reports impaired heart development and a requirement for Creld1 in VEGF-dependent endocardial proliferation. It supports developmental involvement, not penetrance or equivalence of individual heterozygous human susceptibility alleles.

Species

Mouse

Genotype

Creld1 knockout

Publication

PMID:24697899

Pathograph links

Impaired Endocardial Cushion Growth partially recapitulates Creld1 deficiency tests the requirement for endocardial proliferation during heart development.

Readouts

Endocardial proliferation

Direction: DECREASED

Interpretation: Creld1 deficiency tests the requirement for endocardial proliferation during heart development.

Show evidence (1 reference)

PMID:24697899 SUPPORT PRIMARY RESULT Model Organism

"Creld1 function is required for the VEGF-dependent proliferation of endocardial cells by promoting the expression of NFATc1 target-genes."

Creld1 deficiency tests the requirement for endocardial proliferation during heart development.

Show evidence (1 reference)

PMID:24697899 SUPPORT PRIMARY RESULT Model Organism

"Creld1 function is required for the VEGF-dependent proliferation of endocardial cells by promoting the expression of NFATc1 target-genes."

Creld1 deficiency tests the requirement for endocardial proliferation during heart development.

Detailed full-text methods were not retrievable through the reference providers or publisher. No quantitative mouse phenotype, allele-specific rescue or human therapeutic inference is imported from inaccessible material.

Show evidence (1 reference)

PMID:24697899 SUPPORT PRIMARY RESULT Model Organism

"By using Creld1KO mice, we demonstrate that Creld1 is essential for heart development."

Abstract-limited whole-animal result.

Dnah11avc4 recessive AVSD model

Mouse mutant with AVSD occurring concurrently with heterotaxy, while SHF Hedgehog signaling was not disrupted.

Species

Mouse

Genotype

Homozygous ENU-induced Dnah11avc4

Publication

PMID:27340223

Pathograph links

Abnormal Left-Right Patterning recapitulates Mouse mutant with AVSD occurring concurrently with heterotaxy, while SHF Hedgehog signaling was not disrupted.

Show evidence (1 reference)

PMID:27340223 SUPPORT PRIMARY RESULT Model Organism

"Dnah11avc4 did not disrupt SHF Hh signaling and caused AVSDs only concurrently with heterotaxy, a left/right axis abnormality."

Recessive mouse Dnah11 mutation with laterality-associated AVSD; SHF Hedgehog was preserved.

Only the primary abstract was retrievable after PMC, Europe PMC and publisher attempts. Detailed penetrance, signaling assay, tissue lineage and rescue claims are therefore not added. These recessive mouse alleles do not establish a general human variant classification.

Show evidence (1 reference)

PMID:27340223 SUPPORT PRIMARY RESULT Model Organism

"Dnah11avc4 did not disrupt SHF Hh signaling and caused AVSDs only concurrently with heterotaxy, a left/right axis abnormality."

Recessive mouse Dnah11 mutation with laterality-associated AVSD; SHF Hedgehog was preserved.

Mks1avc6 recessive AVSD model

Mouse mutant with disrupted SHF Hedgehog signaling and AVSD without heterotaxy.

Species

Mouse

Genotype

Homozygous ENU-induced Mks1avc6

Publication

PMID:27340223

Pathograph links

Reduced Second Heart Field Hedgehog Signaling recapitulates Mouse mutant with disrupted SHF Hedgehog signaling and AVSD without heterotaxy.

Show evidence (1 reference)

PMID:27340223 SUPPORT PRIMARY RESULT Model Organism

"In contrast, Mks1avc6 disrupted SHF Hh signaling and caused AVSDs without heterotaxy."

A distinct recessive mouse route through second-heart-field signaling, without heterotaxy.

Show evidence (1 reference)

PMID:27340223 SUPPORT PRIMARY RESULT Model Organism

"In contrast, Mks1avc6 disrupted SHF Hh signaling and caused AVSDs without heterotaxy."

A distinct recessive mouse route through second-heart-field signaling, without heterotaxy.

{ }

Source YAML

click to show

name: Atrioventricular Septal Defect
creation_date: '2026-08-27T20:00:00Z'
synonyms:
- atrioventricular canal defect
- endocardial cushion defect
- common atrioventricular canal
- AV canal defect
categories:
- Congenital Heart Defect
- Structural Birth Defect
- Endocardial Cushion Defect
parents:
- congenital heart disease
disease_term:
  preferred_term: atrioventricular septal defect
  term:
    id: MONDO:0859565
    label: atrioventricular septal defect
description: Atrioventricular septal defect (AVSD) is a spectrum of congenital malformations with a common atrioventricular junction, deficient septation and abnormal atrioventricular valve morphology. Complete forms have atrial and unrestricted ventricular communications; partial forms have an ostium primum atrial communication without a ventricular component, and transitional forms have a restrictive ventricular communication. Valve orifices, ventricular balance and associated lesions modify physiology and surgical options. Significant shunting or valve regurgitation can cause pulmonary overcirculation and early heart failure, whereas less severe forms may present later. Trisomy 21 is strongly associated, but genetic causes and developmental routes are heterogeneous. Echocardiography defines anatomy; repair timing and lifelong surveillance are individualized, including assessment of pulmonary vascular disease and residual valve, outflow and conduction abnormalities.
notes: This entry covers the general AVSD spectrum, including sporadic, familial and trisomy 21-associated disease; it is not limited to familial AVSD. A common atrioventricular junction does not require a single valve orifice. The current StatPearls chapter (NBK557511; PMID:32491443) is used for clinical baseline; its introductory partial-AVSD sentence incorrectly includes an inlet VSD, so the explicit body definition without VSD is used. GeneReviews lookup found no dedicated chapter. The ACC pediatric algorithm was updated in August 2026 and applies to isolated balanced lesions under age 18, excluding associated defects, pregnancy and genetic syndromes other than trisomy 21. Adult care is cited to the ACC/AHA-participating Guideline Central summary of the 2025 adult congenital guideline (PMID:41411375; copublication PMID:41411480), because primary full-text retrieval failed. The author-hosted NFATC1 full paper is PMID:30007050; its full-text URL is used where the canonical abstract does not contain the quoted results. Experimental defects in mice or fish are not equated with the complete human AVSD anatomy. Observational cohort proportions are not exported as disease-wide phenotype
  frequencies.
has_subtypes:
- name: Complete AVSD
  description: A common valve orifice, primum atrial communication and unrestricted inlet ventricular communication; substantial shunting commonly causes symptoms in infancy.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: Complete AVSD comprises a primum ASD, an inlet VSD, and a common AV valve with 4 to 5 leaflets
    explanation: A common valve orifice, primum atrial communication and unrestricted inlet ventricular communication; substantial shunting commonly causes symptoms in infancy.
- name: Partial AVSD
  description: Primum atrial communication without VSD, with separate right and left valve orifices within a common junction. Left valve regurgitation can materially alter otherwise atrial-shunt physiology.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: Partial AVSD includes a primum ASD without a VSD. The right and left AV valves are separated by tissue, but they share a common junction.
    explanation: Primum atrial communication without VSD, with separate right and left valve orifices within a common junction. Left valve regurgitation can materially alter otherwise atrial-shunt physiology.
- name: Transitional AVSD
  description: A primum atrial communication and restrictive ventricular communication. Terminology overlaps with intermediate AVSD in some sources; classify the actual ventricular shunt and valve anatomy rather than assume equivalent physiology.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: An interatrial communication above the AV valve and a restrictive interventricular communication below it characterize a transitional AVSD.
    explanation: A primum atrial communication and restrictive ventricular communication. Terminology overlaps with intermediate AVSD in some sources; classify the actual ventricular shunt and valve anatomy rather than assume equivalent physiology.
- name: Unbalanced AVSD
  description: Unequal valve commitment and ventricular development constitute an additional anatomic dimension across AVSD classifications. Ventricular adequacy determines suitability for biventricular repair, staged recruitment or single-ventricle palliation.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: In these lesions, the AV valve is more committed to one ventricle. Thus, an unbalanced AVSD can be either right- or left-dominant.
    explanation: Unequal valve commitment and ventricular development constitute an additional anatomic dimension across AVSD classifications. Ventricular adequacy determines suitability for biventricular repair, staged recruitment or single-ventricle palliation.
prevalence:
- population: Live births
  measure_type: BIRTH_PREVALENCE
  prevalence_class: BAND_1_5_PER_10000
  rate_per_100000: 19.0
  notes: The 2024 clinical review reports 0.19 per 1000 live births, without an explicit population denominator in the available abstract. Other reviews report different estimates; this is a cited birth-prevalence estimate, not a universal contemporary registry rate.
  evidence:
  - reference: PMID:38884731
    reference_title: Clinical Presentation and Therapy of Atrioventricular Septal Defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: AVSDs occur in 0.19 of 1000 live births and constitute 4-5 % of congenital heart defects.
    explanation: Gives the birth prevalence and the proportion of congenital heart defects represented by AVSD.
    quote_role: REVIEW_SYNTHESIS
inheritance:
- name: Heterogeneous inheritance
  description: AVSD occurs with aneuploidy, defined syndromes, rare familial Mendelian disease and sporadic multifactorial susceptibility. A threshold model is useful for some susceptibility alleles, but is not a demonstrated requirement for an additional hit in every patient.
  evidence:
  - reference: PMID:15096951
    reference_title: Molecular genetics of atrioventricular septal defects.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: Atrioventricular septal defects (AVSDs) occur as a clinical feature of several different syndromes, as autosomal dominant defects, and as sporadically occurring malformations.
    explanation: Review of etiologic heterogeneity.
phenotypes:
- category: Cardiovascular
  name: Atrioventricular Canal Defect
  description: 'The defining structural phenotype: deficient atrioventricular septation with a common atrioventricular junction.'
  phenotype_term:
    preferred_term: Atrioventricular canal defect
    term:
      id: HP:0006695
      label: Atrioventricular canal defect
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: The right and left AV valves are separated by tissue, but they share a common junction.
    explanation: Even partial AVSD has a common junction; separate orifices do not imply normal separate junctions.
- category: Cardiovascular
  name: Congestive Heart Failure
  description: Heart failure can emerge in infancy with significant shunting or valve regurgitation; partial and restrictive transitional lesions may remain less symptomatic.
  phenotype_term:
    preferred_term: Congestive heart failure
    term:
      id: HP:0001635
      label: Congestive heart failure
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: Individuals with complete AVSDs usually start to exhibit congestive heart failure (CHF) symptoms at 4 to 6 weeks of life as the pulmonary vascular resistance (PVR) drops to its nadir.
    explanation: Clinical timing in complete AVSD, not a universal onset across subtypes.
- category: Cardiovascular
  name: Atrioventricular Valve Regurgitation
  description: Common or left AV valve incompetence may occur before repair or remain/recur afterward. The quoted 18/104 postoperative observations concern one partial/transitional surgical series, not a general frequency.
  phenotype_term:
    preferred_term: Atrioventricular valve regurgitation
    term:
      id: HP:0034376
      label: Atrioventricular valve regurgitation
  evidence:
  - reference: PMID:35757952
    reference_title: Surgical Outcomes in Children With Partial and Transitional Atrioventricular Septal Defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: After initial repair, there were 18 cases of moderate-to-severe left atrioventricular valve regurgitation (17.3%).
    explanation: Quantifies moderate-to-severe left atrioventricular valve regurgitation after primary repair, the dominant residual lesion.
    quote_role: PRIMARY_RESULT
- category: Cardiovascular
  name: Pulmonary Arterial Hypertension
  description: Pulmonary arterial pressure may rise with substantial unrepaired shunting. Some patients develop increased pulmonary vascular resistance and advanced pulmonary vascular disease; progression is not inevitable in every AVSD subtype or after timely repair.
  phenotype_term:
    preferred_term: Pulmonary arterial hypertension
    term:
      id: HP:0002092
      label: Pulmonary arterial hypertension
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: Pulmonary hypertension develops early and can progress rapidly, typically within the first 6 to 12 months of life if surgical intervention is not performed.
    explanation: Clinical synthesis concerning substantial unrepaired shunting; not proof all AVSD follows this timetable.
- category: Cardiovascular
  name: Left Axis Deviation
  description: A superior/leftward QRS axis on the electrocardiogram is the characteristic electrocardiographic signature of AVSD, reflecting the abnormal position of the conduction system around the common atrioventricular junction.
  phenotype_term:
    preferred_term: Left axis deviation
    term:
      id: HP:0033568
      label: Left axis deviation
  evidence:
  - reference: PMID:10605520
    reference_title: Neonatal ECG screening for congenital heart disease in Down syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: only the five infants with complete AVSD had a superior QRS axis
    explanation: In a neonatal ECG screening cohort, a superior QRS axis was specific to complete AVSD among the congenital heart defects detected.
    quote_role: PRIMARY_RESULT
- category: Cardiovascular
  name: Left Ventricular Outflow Tract Obstruction
  description: Left ventricular outflow tract obstruction arises from the abnormal ("goose-neck") geometry of the left ventricular outflow in AVSD and is a recognised complication after surgical repair.
  phenotype_term:
    preferred_term: Left ventricular outflow tract obstruction
    term:
      id: HP:0032092
      label: Left ventricular outflow tract obstruction
  evidence:
  - reference: PMID:37612667
    reference_title: Long-term results following atrioventricular septal defect repair.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: left ventricular outflow tract obstruction (LVOTO) has been described as a common complication following surgical repair of AVSD occurring in 2–7% of the patients
    explanation: Quantifies LVOTO as a post-repair complication of AVSD.
    quote_role: BACKGROUND
- category: Cardiovascular
  name: Postoperative Atrioventricular Block
  description: Complete heart block requiring permanent pacemaker implantation is a recognised complication of AVSD repair, reflecting the abnormal course of the conduction system around the common atrioventricular junction. This is a post-repair complication; intrinsic preoperative conduction block is not asserted here.
  phenotype_term:
    preferred_term: Atrioventricular block
    term:
      id: HP:0001678
      label: Atrioventricular block
  evidence:
  - reference: PMID:37612667
    reference_title: Long-term results following atrioventricular septal defect repair.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The indication for pacemaker implantation was third-degree atrioventricular block in 4 (2.0%) patients, second-degree atrioventricular block in 1 (0.6%) patient, and sinus node dysfunction in 1 (0.5%) patient.
    explanation: Documents postoperative atrioventricular block as the leading pacemaker indication after AVSD repair.
    quote_role: PRIMARY_RESULT
- name: Tachypnea
  category: Respiratory
  description: Respiratory sign of pulmonary overcirculation or associated heart failure, particularly in complete AVSD.
  phenotype_term:
    preferred_term: Tachypnea
    term:
      id: HP:0002789
      label: Tachypnea
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: Signs of CHF include tachypnea, tachycardia, failure to thrive (fall across 2 major centiles on the growth chart), wheezing or rales on lung auscultation, S3 gallop rhythm, apical displacement of the apical impulse, hepatomegaly, or increased jugular venous pressure.
    explanation: Respiratory sign of pulmonary overcirculation or associated heart failure, particularly in complete AVSD.
- name: Failure to Thrive
  category: Growth
  description: Poor weight gain can accompany symptomatic shunting and feeding difficulty; this is not universal in partial AVSD.
  phenotype_term:
    preferred_term: Failure to thrive
    term:
      id: HP:0001508
      label: Failure to thrive
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: Signs of CHF include tachypnea, tachycardia, failure to thrive (fall across 2 major centiles on the growth chart), wheezing or rales on lung auscultation, S3 gallop rhythm, apical displacement of the apical impulse, hepatomegaly, or increased jugular venous pressure.
    explanation: Poor weight gain can accompany symptomatic shunting and feeding difficulty; this is not universal in partial AVSD.
- name: Feeding Difficulties
  category: Gastrointestinal
  description: Poor feeding is part of symptomatic infant heart failure.
  phenotype_term:
    preferred_term: Feeding difficulties
    term:
      id: HP:0011968
      label: Feeding difficulties
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: Symptoms of CHF include increased work of breathing, sweating while feeding, poor feeding, lethargy, or increased sleepiness.
    explanation: Poor feeding is part of symptomatic infant heart failure.
- name: Tachycardia
  category: Cardiovascular
  description: Clinical sign of symptomatic heart failure rather than a specific arrhythmic mechanism.
  phenotype_term:
    preferred_term: Tachycardia
    term:
      id: HP:0001649
      label: Tachycardia
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: Signs of CHF include tachypnea, tachycardia, failure to thrive (fall across 2 major centiles on the growth chart), wheezing or rales on lung auscultation, S3 gallop rhythm, apical displacement of the apical impulse, hepatomegaly, or increased jugular venous pressure.
    explanation: Clinical sign of symptomatic heart failure rather than a specific arrhythmic mechanism.
- name: Hepatomegaly
  category: Abdominal
  description: Can accompany congestive heart failure.
  phenotype_term:
    preferred_term: Hepatomegaly
    term:
      id: HP:0002240
      label: Hepatomegaly
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: Signs of CHF include tachypnea, tachycardia, failure to thrive (fall across 2 major centiles on the growth chart), wheezing or rales on lung auscultation, S3 gallop rhythm, apical displacement of the apical impulse, hepatomegaly, or increased jugular venous pressure.
    explanation: Can accompany congestive heart failure.
- name: Heart Murmur
  category: Cardiovascular
  description: Increased pulmonary flow or AV valve regurgitation can generate distinct murmurs; a murmur may be the presenting finding in partial AVSD.
  phenotype_term:
    preferred_term: Heart murmur
    term:
      id: HP:0030148
      label: Heart murmur
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: The most common presentation is evaluation of a murmur, secondary to increased flow across the pulmonary valve, best heard at the upper left sternal border.
    explanation: Increased pulmonary flow or AV valve regurgitation can generate distinct murmurs; a murmur may be the presenting finding in partial AVSD.
- name: Primum Atrial Septal Defect
  category: Cardiovascular
  description: Atrial component of the AVSD spectrum; represented separately from the ventricular component.
  phenotype_term:
    preferred_term: Primum atrial septal defect
    term:
      id: HP:0010445
      label: Primum atrial septal defect
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: Partial AVSD includes a primum ASD without a VSD.
    explanation: Atrial component of the AVSD spectrum; represented separately from the ventricular component.
- name: Inlet Ventricular Septal Defect
  category: Cardiovascular
  description: Present in complete and transitional forms, but absent from partial AVSD.
  phenotype_term:
    preferred_term: Inlet ventricular septal defect
    term:
      id: HP:0011622
      label: Inlet ventricular septal defect
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: Complete AVSD comprises a primum ASD, an inlet VSD, and a common AV valve with 4 to 5 leaflets
    explanation: Present in complete and transitional forms, but absent from partial AVSD.
- name: Supraventricular Tachycardia
  category: Cardiovascular
  description: An early or late postoperative complication; atrial enlargement can contribute to atrial arrhythmias.
  phenotype_term:
    preferred_term: Supraventricular tachycardia
    term:
      id: HP:0004755
      label: Supraventricular tachycardia
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: Enlargement of the atrium can lead to supraventricular arrhythmias. Supraventricular tachycardias have been reported in about 8% of patients early after AVSD surgery and in 3.6% of patients later on after the repair.
    explanation: An early or late postoperative complication; atrial enlargement can contribute to atrial arrhythmias.
progression:
- phase: Anatomy-dependent presentation
  notes: Complete AVSD commonly becomes symptomatic as neonatal pulmonary vascular resistance falls, while partial or restrictive transitional lesions may present later. Valve regurgitation and associated defects modify this pattern.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: In patients with a partial AVSD, symptoms might not be detected in the first few years of life and might manifest later in childhood.
    explanation: Contrasts later presentation with complete-AVSD infancy.
- phase: Repair and long-term residual lesions
  notes: Repair improves hemodynamics but does not ensure normal valve function or abolish all residual shunts, outflow obstruction or rhythm risk. Lifelong review is needed. In the 248-patient biventricular single-center cohort spanning 1995–2022, survival was 88.3% at 10 and 79.6% at 25 years; these estimates mix eras and selected operable anatomy, with few patients beyond 20 years. Patients dying after palliation before definitive repair were excluded.
  evidence:
  - reference: PMID:40154545
    reference_title: A 27-Year Experience with Atrioventricular Septal Defect Correction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: Survival of the entire cohort was 88.3% at 10, 83.8% at 15, and 79.6% at 25 years.
    explanation: Selected surgical series; not a universal prognosis.
  - reference: PMID:40154545
    reference_title: A 27-Year Experience with Atrioventricular Septal Defect Correction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: patients receiving PAB that did not survive until AVSD repair are not considered.
    explanation: Explicit survivorship limit.
diagnosis:
- name: Fetal and postnatal echocardiography
  description: Fetal echocardiography follows a suspected lesion on obstetric ultrasound. Postnatal echo defines atrial/ventricular communications, valve morphology and commitment, regurgitation, ventricular adequacy and associated outflow/arch lesions. Three-dimensional imaging can refine valve assessment.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: When an AVSD is suspected during an obstetric ultrasound, referral to fetal cardiology for a comprehensive fetal echocardiogram is recommended
    explanation: Fetal echocardiography follows a suspected lesion on obstetric ultrasound. Postnatal echo defines atrial/ventricular communications, valve morphology and commitment, regurgitation, ventricular adequacy and associated outflow/arch lesions. Three-dimensional imaging can refine valve assessment.
  - reference: PMID:34196822
    reference_title: 'Atrioventricular Septal Defects: Pathology, Imaging, and Treatment Options.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: The understanding of functional morphology of AVSDs has improved significantly with detailed 3D echocardiographic evaluation of the atrioventricular junction and valve morphology.
    explanation: Clinical imaging synthesis.
  diagnosis_term:
    preferred_term: echocardiography
    term:
      id: NCIT:C16525
      label: Echocardiography Test
- name: Electrocardiography
  description: ECG assesses the characteristic superior/leftward axis and rhythm/conduction abnormalities; it complements rather than replaces echocardiography. A 37-neonate Down-syndrome screening study found a superior axis in five complete AVSD cases but missed seven other congenital heart defects.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: The characteristic electrocardiogram in AVSDs has a leftward counterclockwise superior axis
    explanation: ECG assesses the characteristic superior/leftward axis and rhythm/conduction abnormalities; it complements rather than replaces echocardiography. A 37-neonate Down-syndrome screening study found a superior axis in five complete AVSD cases but missed seven other congenital heart defects.
  - reference: PMID:10605520
    reference_title: Neonatal ECG screening for congenital heart disease in Down syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: only the five infants with complete AVSD had a superior QRS axis
    explanation: Small neonatal screening cohort; no general sensitivity estimate for all AVSD.
  diagnosis_term:
    preferred_term: Electrocardiography
    term:
      id: NCIT:C38053
      label: Electrocardiography
- name: Clinical genetics and testing
  description: Offer genetic counseling and testing appropriate to prenatal/postnatal findings, including aneuploidy/chromosomal assessment and selected sequencing. Yield depends on ascertainment and syndromic context. One referred fetal-CHD series reported 36.8% in its AVSD subgroup; its available abstract does not provide that subgroup denominator.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: Genetic testing should be offered to all families, given the higher incidence of genetic syndromes associated with this CHD.
    explanation: Offer genetic counseling and testing appropriate to prenatal/postnatal findings, including aneuploidy/chromosomal assessment and selected sequencing. Yield depends on ascertainment and syndromic context. One referred fetal-CHD series reported 36.8% in its AVSD subgroup; its available abstract does not provide that subgroup denominator.
  - reference: PMID:33142350
    reference_title: Comprehensive evaluation of genetic variants using chromosomal microarray analysis and exome sequencing in fetuses with congenital heart defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: The prevalence of a genetic defect was highest in fetuses with an atrioventricular septal defect (36.8%)
    explanation: Selected fetal referral cohort, not a universal clinical diagnostic yield.
  diagnosis_term:
    preferred_term: genetic testing
    term:
      id: NCIT:C15709
      label: Genetic Testing
- name: Hemodynamic assessment and cardiac catheterization
  description: Routine catheterization is unnecessary in uncomplicated infants repaired on time. Assess pulmonary arterial hypertension and pulmonary vascular resistance when late presentation, residual shunting or comorbidity makes operability uncertain; adult unrepaired or residual-shunt AVSD warrants PAH assessment (Class I, C-LD).
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: Cardiac catheterization is not a part of routine preoperative evaluation for uncomplicated AVSDs who undergo surgical repair at the appropriate timing based on the AVSD subtype.
    explanation: Routine catheterization is unnecessary in uncomplicated infants repaired on time. Assess pulmonary arterial hypertension and pulmonary vascular resistance when late presentation, residual shunting or comorbidity makes operability uncertain; adult unrepaired or residual-shunt AVSD warrants PAH assessment (Class I, C-LD).
  - reference: url:https://www.guidelinecentral.com/guideline/6958/
    reference_title: ACC/AHA Management of Adults With Congenital Heart Disease Guideline Summary - Guideline Central
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: or those with residual shunts after prior repair should be assessed for the presence of ... to guide medical therapy and assess suitability for repair.
    explanation: 2025 adult guideline summary recommendation.
  diagnosis_term:
    preferred_term: Cardiac Catheterization
    term:
      id: NCIT:C38044
      label: Cardiac Catheterization
- name: Selective cardiovascular MRI or CT
  description: Cross-sectional imaging can clarify ventricular volumes in unbalanced lesions or vascular anatomy in complex associated disease. It is not routinely required in uncomplicated AVSD.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: Cross-sectional imaging, including cardiac computed tomography and cardiac magnetic resonance imaging, is usually not required in uncomplicated AVSDs; however, it can be beneficial in a subset of patients, such as those with unbalanced AVSDs, to assess ventricular volumes and guide decision-making.
    explanation: Cross-sectional imaging can clarify ventricular volumes in unbalanced lesions or vascular anatomy in complex associated disease. It is not routinely required in uncomplicated AVSD.
treatments:
- name: Surgical Repair of Atrioventricular Septal Defect
  description: For balanced lesions with significant ventricular shunting, repair is generally planned at 3–6 months, modified by symptom control, growth, valve regurgitation and associated anatomy. Earlier intervention may be needed for uncontrolled failure; primarily atrial-shunt partial/transitional lesions are commonly repaired in the toddler years. These pediatric ACC pathways exclude unbalanced and complex associated lesions. Patch techniques and valve reconstruction are individualized; residual shunts or regurgitation can remain.
  evidence:
  - reference: url:https://www.acc.org/Latest-in-Cardiology/Articles/2025/02/03/12/17/Clinical-Practice-Algorithm-For-the-Follow-Up-of-Repaired-and-Unrepaired-Atrioventricular-Septal-Defects
    reference_title: Clinical Practice Algorithm For the Follow-Up of Repaired and Unrepaired Atrioventricular Septal Defects - American College of Cardiology
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: For patients with a significant ventricular-level shunt, surgical repair is typically performed in the first 3-6 months of life, with optimal timing based on the ability to medically manage symptoms of pulmonary overcirculation and maintain adequate growth.
    explanation: For balanced lesions with significant ventricular shunting, repair is generally planned at 3–6 months, modified by symptom control, growth, valve regurgitation and associated anatomy. Earlier intervention may be needed for uncontrolled failure; primarily atrial-shunt partial/transitional lesions are commonly repaired in the toddler years. These pediatric ACC pathways exclude unbalanced and complex associated lesions. Patch techniques and valve reconstruction are individualized; residual shunts or regurgitation can remain.
  treatment_term:
    preferred_term: atrioventricular septal defect repair
    term:
      id: NCIT:C217463
      label: Atrioventricular Septal Defect Repair
  target_mechanisms:
  - target: Left-to-Right Shunting
    treatment_effect: INHIBITS
    description: Closure reduces the atrial/ventricular communications driving shunting; it does not guarantee complete abolition of residual flow.
    evidence:
    - reference: url:https://www.acc.org/Latest-in-Cardiology/Articles/2025/02/03/12/17/Clinical-Practice-Algorithm-For-the-Follow-Up-of-Repaired-and-Unrepaired-Atrioventricular-Septal-Defects
      reference_title: Clinical Practice Algorithm For the Follow-Up of Repaired and Unrepaired Atrioventricular Septal Defects - American College of Cardiology
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: For patients with a significant ventricular-level shunt, surgical repair is typically performed in the first 3-6 months of life, with optimal timing based on the ability to medically manage symptoms of pulmonary overcirculation and maintain adequate growth.
      explanation: Closure reduces the atrial/ventricular communications driving shunting; it does not guarantee complete abolition of residual flow.
      directness: INDIRECT
- name: Medical heart failure stabilization
  description: Diuretics and selected afterload-reducing therapy can stabilize symptomatic pulmonary overcirculation or valve regurgitation while planning repair. They do not correct the congenital communications or replace indicated surgery.
  evidence:
  - reference: url:https://www.acc.org/Latest-in-Cardiology/Articles/2025/02/03/12/17/Clinical-Practice-Algorithm-For-the-Follow-Up-of-Repaired-and-Unrepaired-Atrioventricular-Septal-Defects
    reference_title: Clinical Practice Algorithm For the Follow-Up of Repaired and Unrepaired Atrioventricular Septal Defects - American College of Cardiology
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: Medical management with diuretics, afterload reduction, and nutritional support may be required, particularly in the setting of hemodynamically significant VSD or significant left AV valve regurgitation.
    explanation: Diuretics and selected afterload-reducing therapy can stabilize symptomatic pulmonary overcirculation or valve regurgitation while planning repair. They do not correct the congenital communications or replace indicated surgery.
  target_mechanisms:
  - target: Hemodynamic Volume Overload
    treatment_effect: INHIBITS
    description: Medical therapy reduces congestive load while the structural lesion remains.
    evidence:
    - reference: url:https://www.acc.org/Latest-in-Cardiology/Articles/2025/02/03/12/17/Clinical-Practice-Algorithm-For-the-Follow-Up-of-Repaired-and-Unrepaired-Atrioventricular-Septal-Defects
      reference_title: Clinical Practice Algorithm For the Follow-Up of Repaired and Unrepaired Atrioventricular Septal Defects - American College of Cardiology
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: Medical management with diuretics, afterload reduction, and nutritional support may be required, particularly in the setting of hemodynamically significant VSD or significant left AV valve regurgitation.
      explanation: Medical therapy reduces congestive load while the structural lesion remains.
      directness: INDIRECT
- name: Nutritional support
  description: Optimize caloric intake and growth in symptomatic infants, including feeding support selected by the clinical team. Growth failure despite support can alter repair timing.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: Nutritional optimization and calorie fortification play an important role in allowing more somatic growth before surgical repair.
    explanation: Optimize caloric intake and growth in symptomatic infants, including feeding support selected by the clinical team. Growth failure despite support can alter repair timing.
  target_mechanisms:
  - target: Failure to Thrive
    treatment_effect: MODULATES
    description: Nutritional support aims to improve somatic growth; a specific growth effect size is not established by this review.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: Nutritional optimization and calorie fortification play an important role in allowing more somatic growth before surgical repair.
      explanation: Nutritional support aims to improve somatic growth; a specific growth effect size is not established by this review.
      directness: INDIRECT
  treatment_term:
    preferred_term: Nutritional Support
    term:
      id: NCIT:C15433
      label: Nutritional Support
- name: Left Atrioventricular Valve Repair
  description: Valve reconstruction at initial repair or reoperation addresses clinically significant incompetence; replacement may be necessary if repair is unsuitable. For repaired adults, surgery is recommended for symptomatic severe left AV valve regurgitation or asymptomatic severe regurgitation with LV end-systolic diameter ≥40 mm or LVEF <60% (Class I, B-NR). Observed associations of incomplete cleft closure with outcomes do not prove one operation is best for every valve.
  evidence:
  - reference: url:https://www.guidelinecentral.com/guideline/6958/
    reference_title: ACC/AHA Management of Adults With Congenital Heart Disease Guideline Summary - Guideline Central
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: symptomatic severe left atrioventricular valve regurgitation or b) asymptomatic severe left atrioventricular valve regurgitation with ... dilation
    explanation: Valve reconstruction at initial repair or reoperation addresses clinically significant incompetence; replacement may be necessary if repair is unsuitable. For repaired adults, surgery is recommended for symptomatic severe left AV valve regurgitation or asymptomatic severe regurgitation with LV end-systolic diameter ≥40 mm or LVEF <60% (Class I, B-NR). Observed associations of incomplete cleft closure with outcomes do not prove one operation is best for every valve.
  treatment_term:
    preferred_term: heart valve repair
    term:
      id: NCIT:C50818
      label: Heart Valve Repair
  target_mechanisms:
  - target: Atrioventricular Valve Incompetence
    treatment_effect: INHIBITS
    description: Reconstruction aims to reduce regurgitation without assuring normal valve function or freedom from reoperation.
    evidence:
    - reference: url:https://www.guidelinecentral.com/guideline/6958/
      reference_title: ACC/AHA Management of Adults With Congenital Heart Disease Guideline Summary - Guideline Central
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: valve surgery is recommended to improve functional status and prevent worsening ventricular function.
      explanation: Reconstruction aims to reduce regurgitation without assuring normal valve function or freedom from reoperation.
      directness: INDIRECT
- name: Individualized repair or palliation for unbalanced AVSD
  description: Assess ventricular and valve adequacy in a congenital surgical team. Some lesions permit biventricular repair, whereas severe imbalance requires single-ventricle palliation; the isolated-balanced pediatric algorithm does not decide this boundary.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: The degree of AV valve commitment is the primary determinant of candidacy for full biventricular surgical repair versus single ventricle palliation.
    explanation: Assess ventricular and valve adequacy in a congenital surgical team. Some lesions permit biventricular repair, whereas severe imbalance requires single-ventricle palliation; the isolated-balanced pediatric algorithm does not decide this boundary.
- name: Adult unrepaired or residual-shunt assessment for closure
  description: In adults with Qp:Qs ≥1.5 and/or significant or progressive chamber dilation, closure is recommended when PVR ≤2 Wood units (Class I, C-LD), and reasonable with PVR >2 to <5 (Class IIa, C-EO). Advanced pulmonary vascular disease requires expert assessment; these recommendations do not supply a blanket closure indication at intermediate higher PVR.
  evidence:
  - reference: url:https://www.guidelinecentral.com/guideline/6958/
    reference_title: ACC/AHA Management of Adults With Congenital Heart Disease Guideline Summary - Guideline Central
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: ≥1.5), and/or significant or progressive atrial/ ventricular dilatation with no ... ≤2 Wood units), closure of the ... or residual shunt is recommended to improve functional class and clinical outcomes.
    explanation: In adults with Qp:Qs ≥1.5 and/or significant or progressive chamber dilation, closure is recommended when PVR ≤2 Wood units (Class I, C-LD), and reasonable with PVR >2 to <5 (Class IIa, C-EO). Advanced pulmonary vascular disease requires expert assessment; these recommendations do not supply a blanket closure indication at intermediate higher PVR.
- name: Avoid closure with Eisenmenger physiology or very high PVR
  description: Shunt closure should not be performed in adults with Eisenmenger physiology or PVR >10 Wood units (Class III harm, C-LD). Referral for specialist congenital and pulmonary-hypertension care is required; late presentation alone is not a substitute for hemodynamic assessment.
  evidence:
  - reference: url:https://www.guidelinecentral.com/guideline/6958/
    reference_title: ACC/AHA Management of Adults With Congenital Heart Disease Guideline Summary - Guideline Central
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: demonstrating Eisenmenger physiology or ... >10 Wood units, shunt closure should ... not ... be performed to avoid additional morbidity and mortality.
    explanation: Shunt closure should not be performed in adults with Eisenmenger physiology or PVR >10 Wood units (Class III harm, C-LD). Referral for specialist congenital and pulmonary-hypertension care is required; late presentation alone is not a substitute for hemodynamic assessment.
- name: Left ventricular outflow obstruction surgery
  description: In repaired adults, symptomatic LV outflow obstruction or LVEF <50% is a Class I indication for repair; asymptomatic obstruction with progressive greater-than-mild aortic regurgitation may justify repair (Class IIb). Pediatric decisions depend on anatomy and progression.
  evidence:
  - reference: url:https://www.guidelinecentral.com/guideline/6958/
    reference_title: ACC/AHA Management of Adults With Congenital Heart Disease Guideline Summary - Guideline Central
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: obstruction with symptoms attributable to the obstruction, or ... surgical repair is recommended to improve functional status and preserve ventricular function.
    explanation: In repaired adults, symptomatic LV outflow obstruction or LVEF <50% is a Class I indication for repair; asymptomatic obstruction with progressive greater-than-mild aortic regurgitation may justify repair (Class IIb). Pediatric decisions depend on anatomy and progression.
  target_mechanisms:
  - target: Left Ventricular Outflow Tract Obstruction
    treatment_effect: INHIBITS
    description: Surgery relieves an important residual or progressive obstruction in eligible patients.
    evidence:
    - reference: url:https://www.guidelinecentral.com/guideline/6958/
      reference_title: ACC/AHA Management of Adults With Congenital Heart Disease Guideline Summary - Guideline Central
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: surgical repair is recommended to improve functional status and preserve ventricular function.
      explanation: Surgery relieves an important residual or progressive obstruction in eligible patients.
      directness: INDIRECT
- name: Lifelong congenital cardiology surveillance
  description: Monitor residual shunts, AV valve dysfunction, ventricular function, outflow obstruction and rhythm/conduction disease. Frequency and imaging depend on residual lesions and physiology; transition to adult congenital care is needed. A reassuring early repair does not remove late risks.
  evidence:
  - reference: url:https://www.acc.org/Latest-in-Cardiology/Articles/2025/02/03/12/17/Clinical-Practice-Algorithm-For-the-Follow-Up-of-Repaired-and-Unrepaired-Atrioventricular-Septal-Defects
    reference_title: Clinical Practice Algorithm For the Follow-Up of Repaired and Unrepaired Atrioventricular Septal Defects - American College of Cardiology
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: For all patients, long-term surveillance for residual lesions is required
    explanation: Monitor residual shunts, AV valve dysfunction, ventricular function, outflow obstruction and rhythm/conduction disease. Frequency and imaging depend on residual lesions and physiology; transition to adult congenital care is needed. A reassuring early repair does not remove late risks.
- name: Pulmonary hypertension specialist care
  description: Adults with repaired or unrepaired AVSD and PAH should be managed jointly with pulmonary-hypertension expertise (Class I, C-LD). Disease-specific drug selection and shunt decisions depend on hemodynamics and overall congenital anatomy.
  evidence:
  - reference: url:https://www.guidelinecentral.com/guideline/6958/
    reference_title: ACC/AHA Management of Adults With Congenital Heart Disease Guideline Summary - Guideline Central
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: should be managed by clinicians with pulmonary hypertension expertise to improve outcomes.
    explanation: Adults with repaired or unrepaired AVSD and PAH should be managed jointly with pulmonary-hypertension expertise (Class I, C-LD). Disease-specific drug selection and shunt decisions depend on hemodynamics and overall congenital anatomy.
pathophysiology:
- name: Increased HMGN1 Dosage
  biological_scale: MOLECULAR
  description: An experimentally supported contributor to trisomy 21-associated cardiac development. Increasing HMGN1 expression in disomic human cell models and reducing its copy number in trisomic cells test dosage dependence; the study does not show that HMGN1 alone causes every human AVSD.
  evidence:
  - reference: PMID:41125893
    reference_title: Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    snippet: A CRISPR-activation single-cell RNA droplet sequencing (CROP-seq) screen of chromosome 21 genes expressed during heart development revealed that HMGN1 upregulation mimics this shift
    explanation: HMGN1 activation in human pluripotent-cell-derived cardiomyocytes reproduces a transcriptional shift.
  genes:
  - preferred_term: HMGN1
    term:
      id: hgnc:4984
      label: HMGN1
  downstream:
  - target: Altered Atrioventricular Myocardial Identity
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: HMGN1 perturbation changes the AVC cardiomyocyte transcriptional state in vitro; precise chromatin-to-cell-state intermediates remain incompletely resolved.
    evidence:
    - reference: PMID:41125893
      reference_title: Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      snippet: A CRISPR-activation single-cell RNA droplet sequencing (CROP-seq) screen of chromosome 21 genes expressed during heart development revealed that HMGN1 upregulation mimics this shift
      explanation: HMGN1 activation in human pluripotent-cell-derived cardiomyocytes reproduces a transcriptional shift.
      directness: INDIRECT
- name: Altered Atrioventricular Myocardial Identity
  biological_scale: CELLULAR
  description: In isogenic human trisomy 21 cultures, AVC cardiomyocytes express a more ventricular-like program. HMGN1 dose correction partially restores expression. Dp1Tyb mouse dose correction also changes this program, but human embryonic lineage conversion and a single obligatory mediator are not established.
  evidence:
  - reference: PMID:41125893
    reference_title: Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    snippet: reduction of HMGN1 to two copies in trisomic cells partially restored the transcriptional dysregulation to a more disomic-like state
    explanation: Primary correction result in human cultured cardiomyocytes.
  cell_types:
  - preferred_term: cardiac muscle cell
    term:
      id: CL:0000746
      label: cardiac muscle cell
  downstream:
  - target: Deficient Atrioventricular Septation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Appropriate AVC myocardial identity may support valvuloseptal development. The experimentally rescued mouse endpoints are ventricular and outflow septal defects; mediation of the exact human AVSD anatomy remains inferred.
    evidence:
    - reference: PMID:41125893
      reference_title: Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      snippet: Removal of one allele of Hmgn1 in the Dp1Tyb (Tg) trisomic mouse rescued the increased incidence of VSDs and outflow tract defects
      explanation: Mouse structural rescue does not isolate the transcript state as mediator or establish human common-junction rescue.
      directness: INDIRECT
- name: Reduced CRELD1 Function
  biological_scale: MOLECULAR
  description: CRELD1 susceptibility variants and murine loss-of-function experiments support a contribution to cardiac development. Heterozygous variants can be inherited from unaffected people; complete mouse knockout is not equivalent to every human allele.
  evidence:
  - reference: PMID:22523272
    reference_title: Genetic modifiers predisposing to congenital heart disease in the sensitized Down syndrome population.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: In each case the p.R329C mutation was inherited from an unaffected parent.
    explanation: Human penetrance limit for this susceptibility allele.
  - reference: PMID:24697899
    reference_title: Murine Creld1 controls cardiac development through activation of calcineurin/NFATc1 signaling.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    snippet: Our study identifies the Cysteine-Rich with EGF-Like Domains 1 (Creld1) gene as a regulator of calcineurin/NFATc1 signaling.
    explanation: Experimental mechanism from the available primary abstract.
  genes:
  - preferred_term: CRELD1
    term:
      id: hgnc:14630
      label: CRELD1
  downstream:
  - target: Reduced Calcineurin-Dependent NFATC1 Dephosphorylation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Loss of CRELD1 support can impair this signaling step. Experimental sufficiency of expressed Creld1 does not quantify the effect of every patient variant.
    evidence:
    - reference: PMID:24697899
      reference_title: Murine Creld1 controls cardiac development through activation of calcineurin/NFATc1 signaling.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      snippet: We show that Creld1 is sufficient to promote NFATc1 dephosphorylation and translocation to the nucleus.
      explanation: Experimental gain of function informs a qualified loss-of-function route.
      directness: INDIRECT
- name: Reduced Calcineurin-Dependent NFATC1 Dephosphorylation
  biological_scale: MOLECULAR
  description: The proposed molecular lesion is reduced activation of NFATC1 through dephosphorylation. ER-localized CRELD1 participates in a complex with calcineurin B. VEGF is an upstream stimulus in the developmental experiments, not an established downstream product of CRELD1.
  evidence:
  - reference: PMID:24697899
    reference_title: Murine Creld1 controls cardiac development through activation of calcineurin/NFATc1 signaling.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    snippet: Creld1 is contained in a joint protein complex with the regulatory subunit of calcineurin, CnB, thereby controlling calcineurin function.
    explanation: Primary mechanistic abstract; detailed full-text assays were not retrievable.
  - reference: PMID:24697899
    reference_title: Murine Creld1 controls cardiac development through activation of calcineurin/NFATc1 signaling.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    snippet: We show that Creld1 is sufficient to promote NFATc1 dephosphorylation and translocation to the nucleus.
    explanation: Dephosphorylation and localization are separated into distinct events.
  downstream:
  - target: Reduced NFATC1 Nuclear Availability
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Calcineurin-dependent dephosphorylation promotes nuclear import; diminished activation can reduce nuclear availability.
    evidence:
    - reference: PMID:24697899
      reference_title: Murine Creld1 controls cardiac development through activation of calcineurin/NFATc1 signaling.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: BACKGROUND
      snippet: It dephosphorylates the transcription factor nuclear factor of activated T cells (NFAT) in the cytoplasm, which subsequently undergoes nuclear translocation.
      explanation: General biochemical sequence summarized in the primary paper.
      directness: INDIRECT
- name: Reduced NFATC1 Nuclear Availability
  biological_scale: CELLULAR
  description: Three AVSD-associated missense proteins showed variably impaired nuclear import in transfected COS-7 cells, including after ionomycin and in separate added-NLS constructs. Equal wild-type/mutant coexpression suggested particularly strong interference by Val210Met. No patient cardiac-tissue localization was measured.
  evidence:
  - reference: url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
    reference_title: https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    snippet: After stimulation with ionomycin, a large fraction of the p.(Ala367Val) and p.(Ala696Thr) NFATC1 proteins was retained in the cytoplasm
    explanation: Primary transfected-cell localization result.
  genes:
  - preferred_term: NFATC1
    term:
      id: hgnc:7775
      label: NFATC1
  downstream:
  - target: Reduced NFATC1 Transcriptional Output
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Impaired import is consistent with reduced reporter activation, although the assays do not prove import alone explains every allele effect.
    evidence:
    - reference: url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
      reference_title: https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      snippet: all mutants showed a variably reduced activation of theNPPB promoter, in all conditions.
      explanation: Separate reporter experiment in COS-7 cells.
      directness: INDIRECT
- name: Reduced NFATC1 Transcriptional Output
  biological_scale: MOLECULAR
  description: The three NFATC1 variants reduced NPPB-promoter reporter activation in COS-7 cells. This heterologous reporter is a functional readout, not a comprehensive fetal cushion transcriptional program.
  evidence:
  - reference: url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
    reference_title: https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    snippet: all mutants showed a variably reduced activation of theNPPB promoter, in all conditions.
    explanation: Variable reporter deficit under the tested conditions.
  downstream:
  - target: Impaired Endocardial Cushion Growth
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Creld1/NFAT-dependent gene expression supports VEGF-dependent endocardial proliferation in the mouse developmental study. This is a proposed bridge from the human-variant reporter results rather than a patient-proven cellular sequence.
    evidence:
    - reference: PMID:24697899
      reference_title: Murine Creld1 controls cardiac development through activation of calcineurin/NFATc1 signaling.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      snippet: Creld1 function is required for the VEGF-dependent proliferation of endocardial cells by promoting the expression of NFATc1 target-genes.
      explanation: Mouse/cell developmental mechanism in available abstract.
      directness: INDIRECT
- name: Impaired Endocardial Cushion Growth
  biological_scale: TISSUE
  description: Reduced endocardial proliferation can impair the development of cushion tissue in experimental Creld1 deficiency. This is one possible developmental route; not all AVSD is explained by a uniform failure of endocardial mesenchymal transition.
  evidence:
  - reference: PMID:24697899
    reference_title: Murine Creld1 controls cardiac development through activation of calcineurin/NFATc1 signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    snippet: Creld1 function is required for the VEGF-dependent proliferation of endocardial cells by promoting the expression of NFATc1 target-genes.
    explanation: Experimental endocardial proliferation finding.
  cell_types:
  - preferred_term: endocardial cell
    term:
      id: CL:0002350
      label: endocardial cell
  biological_processes:
  - preferred_term: endocardial cushion development
    term:
      id: GO:0003197
      label: endocardial cushion development
  downstream:
  - target: Deficient Atrioventricular Septation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Insufficient cushion development can contribute to septation defects, with other mesenchymal components also involved.
    evidence:
    - reference: PMID:38884733
      reference_title: Molecular Pathways and Animal Models of Atrioventricular Septal Defect.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: REVIEW_SYNTHESIS
      snippet: While AVSD were historically considered to result from failure of the endocardial atrioventricular cushions to properly develop and fuse, more recent studies have determined that inhibition of the development of other components of the atrioventricular mesenchymal complex can lead to AVSDs as well.
      explanation: Developmental review; multiple routes rather than a universal cellular defect.
      directness: INDIRECT
- name: Deficient Atrioventricular Septation
  biological_scale: TISSUE
  description: Failure of appropriate formation and union of atrioventricular mesenchymal tissues leaves deficient septation. Endocardial cushions, dorsal mesenchymal protrusion and mesenchymal cap have distinct contributions; cap-specific AVSD evidence remains preliminary in the cited review.
  evidence:
  - reference: PMID:38884733
    reference_title: Molecular Pathways and Animal Models of Atrioventricular Septal Defect.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: REVIEW_SYNTHESIS
    snippet: The role of the dorsal mesenchymal protrusion (DMP) in AVSD pathogenesis has been well-documented in studies using animal models for AVSDs
    explanation: A separate developmental component is relevant.
  - reference: PMID:38884731
    reference_title: Clinical Presentation and Therapy of Atrioventricular Septal Defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: Atrioventricular septal defects (AVSDs) consist of a number of cardiac malformations that result from abnormal development of the endocardial cushions.
    explanation: Clinical morphogenesis summary, complemented by the broader developmental review.
  biological_processes:
  - preferred_term: cardiac septum morphogenesis
    term:
      id: GO:0060411
      label: cardiac septum morphogenesis
  locations:
  - preferred_term: atrioventricular canal
    term:
      id: UBERON:0002087
      label: atrioventricular canal
  downstream:
  - target: Atrioventricular Canal Defect
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The defining phenotype includes the septation defect and common atrioventricular junction.
    evidence:
    - reference: PMID:38884733
      reference_title: Molecular Pathways and Animal Models of Atrioventricular Septal Defect.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: REVIEW_SYNTHESIS
      snippet: The role of the dorsal mesenchymal protrusion (DMP) in AVSD pathogenesis has been well-documented in studies using animal models for AVSDs
      explanation: A separate developmental component is relevant.
      directness: INDIRECT
    - reference: PMID:38884731
      reference_title: Clinical Presentation and Therapy of Atrioventricular Septal Defect.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: Atrioventricular septal defects (AVSDs) consist of a number of cardiac malformations that result from abnormal development of the endocardial cushions.
      explanation: Clinical morphogenesis summary, complemented by the broader developmental review.
      directness: INDIRECT
  - target: Primum Atrial Septal Defect
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The atrial component is an ostium primum communication.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: Abnormal fusion of the interatrial septum leads to communication in the inferior part of the septum, called an ostium primum defect.
      explanation: Developmental-anatomic review.
      directness: INDIRECT
  - target: Inlet Ventricular Septal Defect
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Complete and transitional lesions also have an inlet ventricular communication; partial AVSD does not.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: Complete AVSD comprises a primum ASD, an inlet VSD, and a common AV valve with 4 to 5 leaflets
      explanation: Anatomic components of complete AVSD.
      directness: INDIRECT
  - target: Left-to-Right Shunting
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The communications permit shunting according to their size and relative vascular resistances.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: The hemodynamic consequences of AVSDs vary with the anatomic subtypes; they depend on the degree of shunting across the atrial and ventricular communications and the severity of AV valve regurgitation.
      explanation: Physiology depends on anatomy rather than one uniform shunt.
      directness: INDIRECT
- name: Abnormal Atrioventricular Valve Architecture
  biological_scale: TISSUE
  description: The common atrioventricular junction has abnormal bridging-leaflet and left-valve anatomy; two valve orifices can still share the common junction. This developmental structural lesion is distinct from the subsequent functional regurgitation.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: There are varying degrees of malformation in the left-sided component of the common AV valve, typically characterized by a cleft in the anterior leaflet.
    explanation: Anatomic substrate, not a claim of equal regurgitation in every case.
  locations:
  - preferred_term: atrioventricular canal
    term:
      id: UBERON:0002087
      label: atrioventricular canal
  downstream:
  - target: Atrioventricular Valve Incompetence
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Malformed valve anatomy can impair coaptation; surgical reconstruction may leave or introduce additional functional abnormalities.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: There are varying degrees of malformation in the left-sided component of the common AV valve, typically characterized by a cleft in the anterior leaflet.
      explanation: Anatomic substrate; its functional effect is an inference that depends on individual valve anatomy.
      directness: INDIRECT
    - reference: PMID:37612667
      reference_title: Long-term results following atrioventricular septal defect repair.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      snippet: In our cohort, cleft repair dehiscence was a major cause of residual AV valve regurgitation.
      explanation: Observed postoperative structural failure supports a morphology–function relationship; it is not evidence that every congenital valve malformation is regurgitant.
      directness: INDIRECT
- name: Atrioventricular Valve Incompetence
  biological_scale: TISSUE
  description: Regurgitant flow through the common or left AV valve adds hemodynamic load before repair or with residual/recurrent postoperative dysfunction. Structural repair does not guarantee lasting competence.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: The occurrence and severity of symptoms depend on the degree of AV valve regurgitation and other associated CHD.
    explanation: Valve dysfunction modifies symptoms.
  downstream:
  - target: Atrioventricular Valve Regurgitation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Valve incompetence is clinically expressed as regurgitation.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: The occurrence and severity of symptoms depend on the degree of AV valve regurgitation and other associated CHD.
      explanation: Valve dysfunction modifies symptoms.
      directness: INDIRECT
  - target: Hemodynamic Volume Overload
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Regurgitant flow adds to chamber and pulmonary circulatory load.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: The hemodynamic consequences of AVSDs vary with the anatomic subtypes; they depend on the degree of shunting across the atrial and ventricular communications and the severity of AV valve regurgitation.
      explanation: Clinical synthesis linking both lesions with hemodynamic consequences.
      directness: INDIRECT
- name: Left-to-Right Shunting
  biological_scale: TISSUE
  description: Atrial and, where present, ventricular communications permit excess left-to-right flow after pulmonary vascular resistance falls. Flow magnitude differs between complete, restrictive transitional and partial defects and can change with pulmonary vascular disease.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: In complete AVSDs, there is typically a large left-to-right shunt in early infancy.
    explanation: Complete-form clinical physiology.
  downstream:
  - target: Pulmonary Overcirculation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: A substantial left-to-right shunt increases pulmonary blood flow.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: The large left-to-right shunt causes excessive blood flow to the lungs, resulting in increased pulmonary artery pressures.
      explanation: Clinical physiology.
      directness: INDIRECT
- name: Pulmonary Overcirculation
  biological_scale: TISSUE
  description: Increased pulmonary flow is a hemodynamic consequence of substantial shunting; it contributes to respiratory symptoms and pressure load. It is distinct from fixed pulmonary vascular remodeling.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: The large left-to-right shunt causes excessive blood flow to the lungs, resulting in increased pulmonary artery pressures.
    explanation: Flow/pressure sequence described in clinical review.
  downstream:
  - target: Hemodynamic Volume Overload
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The shunt increases circulatory volume load.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: CHF results from significant communication between the atria and ventricles, leading to volume overload in both the right atrium and the right ventricle.
      explanation: Clinical volume-load mechanism.
      directness: INDIRECT
  - target: Pulmonary Arterial Hypertension
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Flow-related pulmonary pressure elevation can occur before fixed high resistance is established.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: The large left-to-right shunt causes excessive blood flow to the lungs, resulting in increased pulmonary artery pressures.
      explanation: Flow/pressure sequence described in clinical review.
      directness: INDIRECT
  - target: Pulmonary Vascular Remodeling
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Sustained uncorrected hemodynamic stress can progress to pulmonary vascular disease; this is not inevitable in every lesion.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: Pulmonary hypertension develops early and can progress rapidly, typically within the first 6 to 12 months of life if surgical intervention is not performed.
      explanation: Clinical progression in significant unrepaired shunting.
      directness: INDIRECT
  - target: Heart Murmur
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Increased flow through the pulmonary valve can generate the presenting murmur.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: The most common presentation is evaluation of a murmur, secondary to increased flow across the pulmonary valve
      explanation: Direct clinical description.
      directness: INDIRECT
- name: Hemodynamic Volume Overload
  biological_scale: TISSUE
  description: Excess shunt flow and valve regurgitation place volume demands on the circulation. The affected chamber pattern depends on the specific anatomy and valve lesion.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: CHF results from significant communication between the atria and ventricles, leading to volume overload in both the right atrium and the right ventricle.
    explanation: Clinical physiology.
  downstream:
  - target: Congestive Cardiac Dysfunction
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Persistent hemodynamic load can produce symptomatic failure; medical therapy may stabilize symptoms before repair.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: CHF results from significant communication between the atria and ventricles, leading to volume overload in both the right atrium and the right ventricle.
      explanation: Clinical physiology.
      directness: INDIRECT
  - target: Supraventricular Tachycardia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Atrial enlargement can contribute to supraventricular arrhythmias, although postoperative triggers and conduction substrate vary.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: Enlargement of the atrium can lead to supraventricular arrhythmias.
      explanation: Qualified clinical route, not a universal postoperative mechanism.
      directness: INDIRECT
- name: Congestive Cardiac Dysfunction
  biological_scale: TISSUE
  description: Symptomatic heart failure reflects inability to accommodate the hemodynamic burden, particularly in infancy with significant shunting. It is not necessarily a primary myocardial contractile disease.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: CHF symptoms are primarily secondary to pulmonary overcirculation
    explanation: Clinical hemodynamic rather than intrinsic cardiomyopathy framing.
  downstream:
  - target: Congestive Heart Failure
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Manifestation of symptomatic heart failure; expression and severity vary by lesion.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: Signs of CHF include tachypnea, tachycardia, failure to thrive (fall across 2 major centiles on the growth chart), wheezing or rales on lung auscultation, S3 gallop rhythm, apical displacement of the apical impulse, hepatomegaly, or increased jugular venous pressure.
      explanation: Clinical signs of the syndrome.
      directness: INDIRECT
  - target: Tachypnea
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Manifestation of symptomatic heart failure; expression and severity vary by lesion.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: Signs of CHF include tachypnea, tachycardia, failure to thrive (fall across 2 major centiles on the growth chart), wheezing or rales on lung auscultation, S3 gallop rhythm, apical displacement of the apical impulse, hepatomegaly, or increased jugular venous pressure.
      explanation: Clinical signs of the syndrome.
      directness: INDIRECT
  - target: Tachycardia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Manifestation of symptomatic heart failure; expression and severity vary by lesion.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: Signs of CHF include tachypnea, tachycardia, failure to thrive (fall across 2 major centiles on the growth chart), wheezing or rales on lung auscultation, S3 gallop rhythm, apical displacement of the apical impulse, hepatomegaly, or increased jugular venous pressure.
      explanation: Clinical signs of the syndrome.
      directness: INDIRECT
  - target: Hepatomegaly
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Manifestation of symptomatic heart failure; expression and severity vary by lesion.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: Signs of CHF include tachypnea, tachycardia, failure to thrive (fall across 2 major centiles on the growth chart), wheezing or rales on lung auscultation, S3 gallop rhythm, apical displacement of the apical impulse, hepatomegaly, or increased jugular venous pressure.
      explanation: Clinical signs of the syndrome.
      directness: INDIRECT
  - target: Failure to Thrive
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Manifestation of symptomatic heart failure; expression and severity vary by lesion.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: Signs of CHF include tachypnea, tachycardia, failure to thrive (fall across 2 major centiles on the growth chart), wheezing or rales on lung auscultation, S3 gallop rhythm, apical displacement of the apical impulse, hepatomegaly, or increased jugular venous pressure.
      explanation: Clinical signs of the syndrome.
      directness: INDIRECT
  - target: Feeding Difficulties
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Symptomatic infants can have poor feeding and increased work during feeds.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: Symptoms of CHF include increased work of breathing, sweating while feeding, poor feeding, lethargy, or increased sleepiness.
      explanation: Clinical symptom association.
      directness: INDIRECT
- name: Pulmonary Vascular Remodeling
  biological_scale: TISSUE
  description: Advanced unrepaired shunting may produce fixed pulmonary vascular disease and increased resistance. The review describes the clinical sequence rather than a specific histologic mediator measured in all patients.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: Those who survive beyond 1 year develop irreversible pulmonary vascular disease, and later on, the reversal of the shunt.
    explanation: Historical clinical synthesis; the universal wording is not adopted across all AVSD subtypes.
  downstream:
  - target: Pulmonary Arterial Hypertension
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Increased pulmonary vascular resistance contributes to advanced pulmonary hypertension.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: Those who survive beyond 1 year develop irreversible pulmonary vascular disease, and later on, the reversal of the shunt.
      explanation: Historical clinical synthesis; the universal wording is not adopted across all AVSD subtypes.
      directness: INDIRECT
  - target: Shunt Reversal
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: When pulmonary vascular resistance becomes sufficiently high, flow can become bidirectional or reverse; this is a late complication, not a required disease phase.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: Those who survive beyond 1 year develop irreversible pulmonary vascular disease, and later on, the reversal of the shunt.
      explanation: Historical clinical synthesis; the universal wording is not adopted across all AVSD subtypes.
      directness: INDIRECT
- name: Shunt Reversal
  biological_scale: TISSUE
  description: Eisenmenger physiology can develop with advanced pulmonary vascular disease. It changes management fundamentally; adult shunt closure is harmful in this setting.
  evidence:
  - reference: url:https://www.guidelinecentral.com/guideline/6958/
    reference_title: ACC/AHA Management of Adults With Congenital Heart Disease Guideline Summary - Guideline Central
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: demonstrating Eisenmenger physiology or ... >10 Wood units, shunt closure should ... not ... be performed to avoid additional morbidity and mortality.
    explanation: Current management boundary reflecting advanced physiology.
- name: Abnormal Cardiac Conduction Geometry
  biological_scale: TISSUE
  description: The displaced conduction system in AVSD contributes to abnormal ventricular activation and the characteristic superior/leftward axis. Postoperative block is a separate possible complication, not an obligatory consequence of the axis finding.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: This finding results from abnormal ventricular activation caused by the conduction system coursing along the inferior ridge of the inlet VSD.
    explanation: Explanation of the preceding characteristic ECG-axis finding.
  downstream:
  - target: Left Axis Deviation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The altered activation sequence produces the characteristic ECG-axis pattern.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: This finding results from abnormal ventricular activation caused by the conduction system coursing along the inferior ridge of the inlet VSD.
      explanation: Explanation of the preceding characteristic ECG-axis finding.
      directness: INDIRECT
  - target: Postoperative Atrioventricular Block
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The abnormal conduction anatomy is vulnerable during repair; the clinical postoperative association does not isolate the injury mechanism in every patient.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: In AVSD, the atrioventricular node is often displaced inferiorly, leading to conduction abnormalities.
      explanation: Clinical substrate.
      directness: INDIRECT
    - reference: PMID:37612667
      reference_title: Long-term results following atrioventricular septal defect repair.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: The indication for pacemaker implantation was third-degree atrioventricular block in 4 (2.0%) patients, second-degree atrioventricular block in 1 (0.6%) patient, and sinus node dysfunction in 1 (0.5%) patient.
      explanation: Documents postoperative atrioventricular block as the leading pacemaker indication after AVSD repair.
      directness: INDIRECT
      quote_role: PRIMARY_RESULT
- name: Abnormal Left Ventricular Outflow Geometry
  biological_scale: TISSUE
  description: The congenital outflow geometry can predispose to obstruction that persists or emerges after repair. Additional valve/subvalvar anatomy and surgical factors modify risk.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
    reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: LVOTO occurs in approximately 3.5% to 5% of patients, primarily due to the abnormal LVOT shape associated with AVSD anatomy.
    explanation: Clinical anatomic synthesis; no global frequency band inferred.
  downstream:
  - target: Left Ventricular Outflow Tract Obstruction
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Abnormal outflow shape can become clinically obstructive.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
      reference_title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: LVOTO occurs in approximately 3.5% to 5% of patients, primarily due to the abnormal LVOT shape associated with AVSD anatomy.
      explanation: Clinical anatomic synthesis; no global frequency band inferred.
      directness: INDIRECT
- name: Abnormal Left-Right Patterning
  biological_scale: TISSUE
  description: Ciliary motility disruption can produce laterality abnormalities associated with AVSD. In Dnah11avc4 mice, AVSD occurred only with heterotaxy while second-heart-field Hedgehog signaling was preserved. This is not a claim that all AVSD or all heterotaxy has one ciliary cause.
  evidence: &id001
  - reference: PMID:27340223
    reference_title: Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    snippet: Dnah11avc4 did not disrupt SHF Hh signaling and caused AVSDs only concurrently with heterotaxy, a left/right axis abnormality.
    explanation: Recessive mouse Dnah11 mutation with laterality-associated AVSD; SHF Hedgehog was preserved.
  downstream:
  - target: Deficient Atrioventricular Septation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The mouse association supports a developmental laterality route; the intervening cardiac morphogenetic steps are unresolved.
    evidence:
    - reference: PMID:27340223
      reference_title: Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      snippet: Dnah11avc4 did not disrupt SHF Hh signaling and caused AVSDs only concurrently with heterotaxy, a left/right axis abnormality.
      explanation: Recessive mouse Dnah11 mutation with laterality-associated AVSD; SHF Hedgehog was preserved.
      directness: INDIRECT
- name: Reduced Second Heart Field Hedgehog Signaling
  biological_scale: CELLULAR
  description: A separate structural/signaling cilia mutation, Mks1avc6, impaired second-heart-field Hedgehog signaling and produced AVSD without heterotaxy. This experimentally separates a signaling route from motility-dependent laterality.
  evidence: &id002
  - reference: PMID:27340223
    reference_title: Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    snippet: In contrast, Mks1avc6 disrupted SHF Hh signaling and caused AVSDs without heterotaxy.
    explanation: A distinct recessive mouse route through second-heart-field signaling, without heterotaxy.
  downstream:
  - target: Deficient Atrioventricular Septation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The Mks1 mouse results support involvement of this signaling compartment in AV septation, without proving an equivalent mechanism for every human MKS1 variant.
    evidence:
    - reference: PMID:27340223
      reference_title: Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      snippet: In contrast, Mks1avc6 disrupted SHF Hh signaling and caused AVSDs without heterotaxy.
      explanation: A distinct recessive mouse route through second-heart-field signaling, without heterotaxy.
      directness: INDIRECT
- name: Altered NR2F2 Transcriptional Regulation
  biological_scale: MOLECULAR
  description: AVSD-associated coding variants change activation of NGFI-A or APOB reporters in a promoter-dependent manner; some increase and others decrease or preserve output. APOB repression in HepG2 cells remains intact. This is not a uniform loss-of-function mechanism or a patient endocardial measurement.
  evidence: &id003
  - reference: url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
    reference_title: https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    snippet: variant p.Asn205Ile reduces the activity of NR2F2 on the APOB promoter while increasing it on the NGFI-A promoter
    explanation: Direct example of opposite activation effects by promoter context.
  - reference: url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
    reference_title: https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    snippet: we found that the expected repressive activity of NR2F2 is not affected by any of the variants observed in individuals with CHDs.
    explanation: HepG2 APOB repression is preserved despite variant-specific activation changes in HEK293T cells.
  genes:
  - preferred_term: NR2F2
    term:
      id: hgnc:7976
      label: NR2F2
  downstream:
  - target: Deficient Atrioventricular Septation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Human genetic association and altered reporter function support a developmental contribution, but no single cardiac target program or direct cellular mediator was established.
    evidence:
    - reference: url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
      reference_title: https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      snippet: were inherited from an apparently healthy parent
      explanation: Human segregation limits in the Results.
      directness: INDIRECT
    - reference: url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
      reference_title: https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      snippet: We found NR2F2 to be the only gene, of the nine genes with de novo variants identiﬁed in the original trios, with a signiﬁcant enrichment of rare missense variants
      explanation: Case-control enrichment in the selected discovery design.
      directness: INDIRECT
    - reference: url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
      reference_title: https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      snippet: variant p.Asn205Ile reduces the activity of NR2F2 on the APOB promoter while increasing it on the NGFI-A promoter
      explanation: Direct example of opposite activation effects by promoter context.
      directness: INDIRECT
    - reference: url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
      reference_title: https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      snippet: we found that the expected repressive activity of NR2F2 is not affected by any of the variants observed in individuals with CHDs.
      explanation: HepG2 APOB repression is preserved despite variant-specific activation changes in HEK293T cells.
      directness: INDIRECT
animal_models:
- name: Ts65Dn modifier crosses
  species: Mouse
  genotype: Ts65Dn with heterozygous Creld1 or Hey2 loss
  background: Mixed C57BL/6 and C3H trisomic background
  publication: PMID:22523272
  description: Newborn histology tests sensitization by trisomy and reduced modifier dosage. The observed lesions were membranous or muscular VSDs and ostium secundum ASDs. These crosses did not reproduce the common-junction human AVSD lesion.
  notes: Ts65Dn duplicates a subset of human chromosome 21 orthologues. Blinded P0 structural scoring measures CHD incidence on this background, not a necessary two-hit rule in every human case. The mechanistic route between gene dosage and a specific septum is unresolved.
  evidence:
  - reference: PMID:22523272
    reference_title: Genetic modifiers predisposing to congenital heart disease in the sensitized Down syndrome population.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    snippet: Crossing loss-of-function alleles of either Creld1 or Hey2 onto the trisomic background caused a significant increase in the frequency of CHD
    explanation: Mouse modifier experiment; congenital heart defects rather than specific AVSD.
  modeled_mechanisms:
  - target: Deficient Atrioventricular Septation
    relationship: PARTIALLY_RECAPITULATES
    description: The crosses support dosage-sensitive cardiac septation, but the observed lesions are adjacent septal phenotypes rather than exact human AVSD.
    evidence:
    - reference: PMID:22523272
      reference_title: Genetic modifiers predisposing to congenital heart disease in the sensitized Down syndrome population.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      snippet: Crossing loss-of-function alleles of either Creld1 or Hey2 onto the trisomic background caused a significant increase in the frequency of CHD
      explanation: The crosses support dosage-sensitive cardiac septation, but the observed lesions are adjacent septal phenotypes rather than exact human AVSD.
    limitations: No AVSD was reproduced; translation to the atrioventricular junction is indirect.
    readouts:
    - name: Histologically detected septal defects
      target: Deficient Atrioventricular Septation
      direction: INCREASED
      interpretation: The crosses support dosage-sensitive cardiac septation, but the observed lesions are adjacent septal phenotypes rather than exact human AVSD.
      evidence:
      - reference: PMID:22523272
        reference_title: Genetic modifiers predisposing to congenital heart disease in the sensitized Down syndrome population.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        quote_role: PRIMARY_RESULT
        snippet: Crossing loss-of-function alleles of either Creld1 or Hey2 onto the trisomic background caused a significant increase in the frequency of CHD
        explanation: The crosses support dosage-sensitive cardiac septation, but the observed lesions are adjacent septal phenotypes rather than exact human AVSD.
- name: Euploid Creld1 and Hey2 double heterozygotes
  species: Mouse
  genotype: Creld1+/−; Hey2+/−
  publication: PMID:22523272
  description: Combined heterozygosity produced ostium secundum ASD in three of 31 newborns, whereas neither single-heterozygous group showed a septal defect at P0. This tests interaction on a euploid background, separately from trisomy.
  notes: The lesion is secundum ASD, not AVSD. Small, background-dependent penetrance does not establish a universal human oligogenic requirement.
  evidence:
  - reference: PMID:22523272
    reference_title: Genetic modifiers predisposing to congenital heart disease in the sensitized Down syndrome population.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    snippet: No septal defects were detected at P0 in 90 pups that were either Creld1+/− (n=45) or Hey2+/− (n=45)
    explanation: Single-heterozygous controls in the combined-modifier experiment.
- name: Dp1Tyb Hmgn1 dosage correction
  species: Mouse
  genotype: Dp1Tyb with one Hmgn1 allele removed
  publication: PMID:41125893
  description: E11.5 single-cell profiling tests AVC myocardial state after Hmgn1 dose correction; E15.5 micro-CT measures ventricular and outflow septal defects. The trisomic group had such defects in eight of 33 embryos. Correction attenuated these structural defects and neonatal lethality.
  notes: The structural endpoint is not a validated count of human-type common-junction AVSD. Small atrial defects were difficult to distinguish from patent foramen ovale. Transcriptomic sample counts were small, and corrected AVC cell proportions did not establish lineage replacement. Survival benefit is not shown to be mediated exclusively by cardiac rescue; HMGN1-alone anatomical sufficiency remains untested.
  evidence:
  - reference: PMID:41125893
    reference_title: Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    snippet: Removal of one allele of Hmgn1 in the Dp1Tyb (Tg) trisomic mouse rescued the increased incidence of VSDs and outflow tract defects
    explanation: Dose correction with structural mouse endpoint.
  modeled_mechanisms:
  - target: Altered Atrioventricular Myocardial Identity
    relationship: RESCUES
    description: Dose correction restores part of the abnormal AVC myocardial program.
    evidence:
    - reference: PMID:41125893
      reference_title: Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      snippet: In a mouse model of trisomy 21, a similar transcriptional shift of AVC cardiomyocytes was restored by a reduction in Hmgn1 dosage
      explanation: Dose correction restores part of the abnormal AVC myocardial program.
    readouts:
    - name: AVC transcriptional-state abnormality
      target: Altered Atrioventricular Myocardial Identity
      direction: DECREASED
      interpretation: Dose correction restores part of the abnormal AVC myocardial program.
      evidence:
      - reference: PMID:41125893
        reference_title: Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        quote_role: PRIMARY_RESULT
        snippet: In a mouse model of trisomy 21, a similar transcriptional shift of AVC cardiomyocytes was restored by a reduction in Hmgn1 dosage
        explanation: Dose correction restores part of the abnormal AVC myocardial program.
  - target: Deficient Atrioventricular Septation
    relationship: PARTIALLY_RECAPITULATES
    description: Ventricular/outflow septal defects are reduced; exact human AVSD anatomy is not the demonstrated endpoint.
    evidence:
    - reference: PMID:41125893
      reference_title: Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      snippet: Removal of one allele of Hmgn1 in the Dp1Tyb (Tg) trisomic mouse rescued the increased incidence of VSDs and outflow tract defects
      explanation: Ventricular/outflow septal defects are reduced; exact human AVSD anatomy is not the demonstrated endpoint.
    limitations: Anatomical transfer to AVSD remains partial.
    readouts:
    - name: Ventricular and outflow septal-defect incidence
      target: Deficient Atrioventricular Septation
      direction: DECREASED
      interpretation: Ventricular/outflow septal defects are reduced; exact human AVSD anatomy is not the demonstrated endpoint.
      evidence:
      - reference: PMID:41125893
        reference_title: Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        quote_role: PRIMARY_RESULT
        snippet: Removal of one allele of Hmgn1 in the Dp1Tyb (Tg) trisomic mouse rescued the increased incidence of VSDs and outflow tract defects
        explanation: Ventricular/outflow septal defects are reduced; exact human AVSD anatomy is not the demonstrated endpoint.
- name: Human NFATC1 variant RNA in zebrafish
  species: Zebrafish
  genotype: One-cell-stage ectopic human NFATC1 Val210Met, Ala367Val or Ala696Thr mRNA
  publication: url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
  description: Human variant mRNA injection alters 24–48-hour cardiac morphology, looping and AVC marker domains relative to wild-type NFATC1 or GFP controls. Val210Met/Ala367Val accelerated and Ala696Thr retarded looping; chamber-marker specification remained broadly preserved. Histology examined six embryos per construct.
  notes: This is ectopic overexpression rather than an endogenous heterozygous knock-in. Edema, abnormal looping and AVC patterning are not a demonstration of the complete human AVSD anatomy or patient rescue. Other undiscovered human variants and one co-occurring TBX1 variant limit patient attribution.
  evidence:
  - reference: url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
    reference_title: https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    snippet: expression of AVSD-associated NFATC1 alleles dramatically affected cardiac devel- opment by promoting abnormal heart looping and AVC development
    explanation: Variant-overexpression fish experiment.
  modeled_mechanisms:
  - target: Deficient Atrioventricular Septation
    relationship: PARTIALLY_RECAPITULATES
    description: Abnormal AVC patterning supports developmental relevance, without reproducing human four-chamber septation.
    evidence:
    - reference: url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
      reference_title: https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      snippet: expression of AVSD-associated NFATC1 alleles dramatically affected cardiac devel- opment by promoting abnormal heart looping and AVC development
      explanation: Abnormal AVC patterning supports developmental relevance, without reproducing human four-chamber septation.
    readouts:
    - name: AVC patterning
      target: Deficient Atrioventricular Septation
      direction: ALTERED
      interpretation: Abnormal AVC patterning supports developmental relevance, without reproducing human four-chamber septation.
      evidence:
      - reference: url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
        reference_title: https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        quote_role: PRIMARY_RESULT
        snippet: expression of AVSD-associated NFATC1 alleles dramatically affected cardiac devel- opment by promoting abnormal heart looping and AVC development
        explanation: Abnormal AVC patterning supports developmental relevance, without reproducing human four-chamber septation.
- name: Creld1 knockout developmental model
  species: Mouse
  genotype: Creld1 knockout
  publication: PMID:24697899
  description: The available primary abstract reports impaired heart development and a requirement for Creld1 in VEGF-dependent endocardial proliferation. It supports developmental involvement, not penetrance or equivalence of individual heterozygous human susceptibility alleles.
  notes: Detailed full-text methods were not retrievable through the reference providers or publisher. No quantitative mouse phenotype, allele-specific rescue or human therapeutic inference is imported from inaccessible material.
  evidence:
  - reference: PMID:24697899
    reference_title: Murine Creld1 controls cardiac development through activation of calcineurin/NFATc1 signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    snippet: By using Creld1KO mice, we demonstrate that Creld1 is essential for heart development.
    explanation: Abstract-limited whole-animal result.
  modeled_mechanisms:
  - target: Impaired Endocardial Cushion Growth
    relationship: PARTIALLY_RECAPITULATES
    description: Creld1 deficiency tests the requirement for endocardial proliferation during heart development.
    evidence:
    - reference: PMID:24697899
      reference_title: Murine Creld1 controls cardiac development through activation of calcineurin/NFATc1 signaling.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      snippet: Creld1 function is required for the VEGF-dependent proliferation of endocardial cells by promoting the expression of NFATc1 target-genes.
      explanation: Creld1 deficiency tests the requirement for endocardial proliferation during heart development.
    readouts:
    - name: Endocardial proliferation
      target: Impaired Endocardial Cushion Growth
      direction: DECREASED
      interpretation: Creld1 deficiency tests the requirement for endocardial proliferation during heart development.
      evidence:
      - reference: PMID:24697899
        reference_title: Murine Creld1 controls cardiac development through activation of calcineurin/NFATc1 signaling.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        quote_role: PRIMARY_RESULT
        snippet: Creld1 function is required for the VEGF-dependent proliferation of endocardial cells by promoting the expression of NFATc1 target-genes.
        explanation: Creld1 deficiency tests the requirement for endocardial proliferation during heart development.
- name: Dnah11avc4 recessive AVSD model
  species: Mouse
  genotype: Homozygous ENU-induced Dnah11avc4
  publication: PMID:27340223
  description: Mouse mutant with AVSD occurring concurrently with heterotaxy, while SHF Hedgehog signaling was not disrupted.
  notes: Only the primary abstract was retrievable after PMC, Europe PMC and publisher attempts. Detailed penetrance, signaling assay, tissue lineage and rescue claims are therefore not added. These recessive mouse alleles do not establish a general human variant classification.
  evidence: *id001
  modeled_mechanisms:
  - target: Abnormal Left-Right Patterning
    relationship: RECAPITULATES
    description: Mouse mutant with AVSD occurring concurrently with heterotaxy, while SHF Hedgehog signaling was not disrupted.
    evidence:
    - reference: PMID:27340223
      reference_title: Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      snippet: Dnah11avc4 did not disrupt SHF Hh signaling and caused AVSDs only concurrently with heterotaxy, a left/right axis abnormality.
      explanation: Recessive mouse Dnah11 mutation with laterality-associated AVSD; SHF Hedgehog was preserved.
- name: Mks1avc6 recessive AVSD model
  species: Mouse
  genotype: Homozygous ENU-induced Mks1avc6
  publication: PMID:27340223
  description: Mouse mutant with disrupted SHF Hedgehog signaling and AVSD without heterotaxy.
  notes: Only the primary abstract was retrievable after PMC, Europe PMC and publisher attempts. Detailed penetrance, signaling assay, tissue lineage and rescue claims are therefore not added. These recessive mouse alleles do not establish a general human variant classification.
  evidence: *id002
  modeled_mechanisms:
  - target: Reduced Second Heart Field Hedgehog Signaling
    relationship: RECAPITULATES
    description: Mouse mutant with disrupted SHF Hedgehog signaling and AVSD without heterotaxy.
    evidence:
    - reference: PMID:27340223
      reference_title: Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      snippet: In contrast, Mks1avc6 disrupted SHF Hh signaling and caused AVSDs without heterotaxy.
      explanation: A distinct recessive mouse route through second-heart-field signaling, without heterotaxy.
experimental_models:
- name: Isogenic trisomy 21 cardiomyocyte differentiation and HMGN1 perturbation
  experimental_model_type: IPSC_DERIVED_MODEL
  organism:
    preferred_term: Homo sapiens
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  cell_source: Isogenic disomic/trisomic hiPSCs from two genetically unrelated mosaic donors; principal perturbations in the main donor pair
  publication: PMID:41125893
  description: Day-10 precursors and day-20 cardiomyocytes were profiled. A CROP-seq screen of 66 selected chromosome 21 genes nominated HMGN1; activation in disomic cells shifted AVC myocardial expression, and three-to-two allele correction in trisomic cells partially restored it. CUT&RUN/scATAC characterized chromatin context.
  notes: Short-term differentiation and relative recovered-cell states do not establish in-vivo human lineage conversion. CLDN8 was ineffectively upregulated. Chromatin occupancy/motif overlap does not prove direct HMGN1–TBX2 binding or one necessary mediator; HMGN1-alone human anatomical sufficiency and therapy are untested.
  evidence:
  - reference: PMID:41125893
    reference_title: Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    snippet: reduction of HMGN1 to two copies in trisomic cells partially restored the transcriptional dysregulation to a more disomic-like state
    explanation: Partial transcriptional correction rather than complete cellular/anatomical rescue.
  modeled_mechanisms:
  - target: Increased HMGN1 Dosage
    relationship: PERTURBS
    description: CRISPR activation and allele deletion test opposite dosage changes.
    evidence:
    - reference: PMID:41125893
      reference_title: Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      snippet: reduction of HMGN1 to two copies in trisomic cells partially restored the transcriptional dysregulation to a more disomic-like state
      explanation: CRISPR activation and allele deletion test opposite dosage changes.
  - target: Altered Atrioventricular Myocardial Identity
    relationship: RESCUES
    description: Allele correction partially restores the transcriptomic state.
    evidence:
    - reference: PMID:41125893
      reference_title: Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      snippet: reduction of HMGN1 to two copies in trisomic cells partially restored the transcriptional dysregulation to a more disomic-like state
      explanation: Allele correction partially restores the transcriptomic state.
    readouts:
    - name: AVC transcriptional-state abnormality
      target: Altered Atrioventricular Myocardial Identity
      direction: DECREASED
      interpretation: Allele correction partially restores the transcriptomic state.
      evidence:
      - reference: PMID:41125893
        reference_title: Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.
        supports: SUPPORT
        evidence_source: IN_VITRO
        quote_role: PRIMARY_RESULT
        snippet: reduction of HMGN1 to two copies in trisomic cells partially restored the transcriptional dysregulation to a more disomic-like state
        explanation: Allele correction partially restores the transcriptomic state.
- name: COS-7 NFATC1 variant localization and reporter assays
  experimental_model_type: CELL_LINE
  cell_source: Transfected COS-7 monkey cells
  publication: url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
  description: Wild-type and three variant human NFATC1 constructs were compared using microscopy, nuclear/cytoplasmic immunoblots and an NPPB luciferase reporter. Ionomycin stimulation, separate exogenous-NLS constructs and equal wild-type/mutant cotransfection tested localization and interference. Val210Met had the clearest dominant-negative behavior.
  notes: Heterologous transient overexpression and one promoter are not patient cardiac-tissue measurements. Baseline and added-NLS constructs are distinct. Reduced import and reporter output are associated but not proven to form an exclusive mediator chain; a milder Ala367Val effect and unresolved actions of the other variants are retained.
  evidence:
  - reference: url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
    reference_title: https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    snippet: all mutants showed a variably reduced activation of theNPPB promoter, in all conditions.
    explanation: Primary reporter finding.
  modeled_mechanisms:
  - target: Reduced NFATC1 Nuclear Availability
    relationship: MEASURES
    description: Variant proteins show impaired nuclear localization.
    evidence:
    - reference: url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
      reference_title: https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      snippet: After stimulation with ionomycin, a large fraction of the p.(Ala367Val) and p.(Ala696Thr) NFATC1 proteins was retained in the cytoplasm
      explanation: Variant proteins show impaired nuclear localization.
    readouts:
    - name: Nuclear NFATC1 localization
      target: Reduced NFATC1 Nuclear Availability
      direction: DECREASED
      interpretation: Variant proteins show impaired nuclear localization.
      evidence:
      - reference: url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
        reference_title: https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
        supports: SUPPORT
        evidence_source: IN_VITRO
        quote_role: PRIMARY_RESULT
        snippet: After stimulation with ionomycin, a large fraction of the p.(Ala367Val) and p.(Ala696Thr) NFATC1 proteins was retained in the cytoplasm
        explanation: Variant proteins show impaired nuclear localization.
  - target: Reduced NFATC1 Transcriptional Output
    relationship: MEASURES
    description: The NPPB reporter is less activated by variant constructs.
    evidence:
    - reference: url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
      reference_title: https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      snippet: all mutants showed a variably reduced activation of theNPPB promoter, in all conditions.
      explanation: The NPPB reporter is less activated by variant constructs.
    readouts:
    - name: NPPB reporter activation
      target: Reduced NFATC1 Transcriptional Output
      direction: DECREASED
      interpretation: The NPPB reporter is less activated by variant constructs.
      evidence:
      - reference: url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
        reference_title: https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
        supports: SUPPORT
        evidence_source: IN_VITRO
        quote_role: PRIMARY_RESULT
        snippet: all mutants showed a variably reduced activation of theNPPB promoter, in all conditions.
        explanation: The NPPB reporter is less activated by variant constructs.
- name: Lineage-resolved mouse AVC collagen explant assay
  experimental_model_type: OTHER
  organism:
    preferred_term: Mus musculus
    term:
      id: NCBITaxon:10090
      label: Mus musculus
  cell_source: Somite-staged embryonic mouse atrioventricular canal explants, including Tie2-Cre lineage tracing
  publication: PMID:29549339
  description: Lineage tracing and GFP, CD31, alpha-SMA and WT1 markers separate endocardial mesenchymal invasion from epicardial outgrowth in 48-hour collagen cultures. Epicardial contribution increases with somite stage; SD208 reduces TGF-beta signaling and alters mixed outgrowth.
  notes: This is an assay-interpretation study, not proof that every human AVSD has failed EndoMT or a therapeutic rescue. Cobblestone morphology alone cannot identify endothelium, and early staging minimizes rather than universally eliminates epicardial contribution. No causal patient-phenotype link is assigned to the mixed-cell assay.
  evidence:
  - reference: PMID:29549339
    reference_title: The epicardium obscures interpretations on endothelial-to-mesenchymal transition in the mouse atrioventricular canal explant assay.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    snippet: monolayers of cobblestone-shaped cells are predominantly of epicardial rather than endothelial origin.
    explanation: Primary lineage evidence correcting a common interpretation of this assay.
- name: NR2F2 promoter-dependent reporter assays
  experimental_model_type: CELL_LINE
  organism:
    preferred_term: Homo sapiens
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  cell_source: HEK293T and HepG2 human cell lines with Cherry-fused NR2F2 constructs
  publication: url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
  description: Rat NGFI-A and human APOB promoter luciferase reporters test six coding variants. Effects in HEK293T activation assays differ by promoter and allele, while HepG2 APOB repression is preserved. Expression/localization controls do not establish a cardiac-cell developmental rescue.
  notes: No patient RNA/protein confirmation of the predicted splice or translocation effect is reported. Structural predictions are not ligand-binding measurements. These heterologous reporters do not identify the necessary endocardial or second-heart-field target in human AVSD.
  evidence: *id003
  modeled_mechanisms:
  - target: Altered NR2F2 Transcriptional Regulation
    relationship: MEASURES
    description: Promoter- and cell-dependent reporter output, including retained repression.
    evidence:
    - reference: url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
      reference_title: https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      snippet: variant p.Asn205Ile reduces the activity of NR2F2 on the APOB promoter while increasing it on the NGFI-A promoter
      explanation: Direct example of opposite activation effects by promoter context.
    - reference: url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
      reference_title: https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      snippet: we found that the expected repressive activity of NR2F2 is not affected by any of the variants observed in individuals with CHDs.
      explanation: HepG2 APOB repression is preserved despite variant-specific activation changes in HEK293T cells.
    readouts:
    - name: HepG2 APOB repression
      target: Altered NR2F2 Transcriptional Regulation
      direction: UNCHANGED
      interpretation: The expected repressive activity remains intact for the tested variants.
      evidence:
      - reference: url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
        reference_title: https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
        supports: SUPPORT
        evidence_source: IN_VITRO
        quote_role: PRIMARY_RESULT
        snippet: variant p.Asn205Ile reduces the activity of NR2F2 on the APOB promoter while increasing it on the NGFI-A promoter
        explanation: Direct example of opposite activation effects by promoter context.
      - reference: url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
        reference_title: https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
        supports: SUPPORT
        evidence_source: IN_VITRO
        quote_role: PRIMARY_RESULT
        snippet: we found that the expected repressive activity of NR2F2 is not affected by any of the variants observed in individuals with CHDs.
        explanation: HepG2 APOB repression is preserved despite variant-specific activation changes in HEK293T cells.
genetic:
- name: CRELD1
  association: Susceptibility Variant
  gene_term:
    preferred_term: CRELD1
    term:
      id: hgnc:14630
      label: CRELD1
  relationship_type: SUSCEPTIBILITY
  variant_origin: GERMLINE
  notes: CRELD1 is a susceptibility gene in some isolated or syndromic AVSD. Unaffected-parent transmission and mouse-background dependence argue against treating every heterozygous variant as fully penetrant. The E325K calcium-binding effect in PMID:29054759 is a bioinformatic prediction, not a measured patient-protein assay.
  evidence:
  - reference: PMID:22523272
    reference_title: Genetic modifiers predisposing to congenital heart disease in the sensitized Down syndrome population.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: In each case the p.R329C mutation was inherited from an unaffected parent.
    explanation: Incomplete penetrance or susceptibility context.
  - reference: PMID:15096951
    reference_title: Molecular genetics of atrioventricular septal defects.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: Mutation of CRELD1 increases susceptibility to AVSD but is not alone sufficient to cause the defect
    explanation: Historical susceptibility interpretation, not a universal inheritance law.
- name: NFATC1
  association: Missense Variant
  gene_term:
    preferred_term: NFATC1
    term:
      id: hgnc:7775
      label: NFATC1
  relationship_type: SUSCEPTIBILITY
  variant_origin: GERMLINE
  notes: Three rare heterozygous missense variants were reported among 60 screened AVSD patients (22 isolated and 38 with heterotaxy), with no parental specimens for segregation. COS-7 and zebrafish experiments support functional effects of differing severity; one patient also carried TBX1 Pro86Leu. The study does not establish that all three variants independently explain every cardiac and extracardiac feature, or that all rare NFATC1 variants are pathogenic.
  evidence:
  - reference: url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
    reference_title: https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: Parental DNA specimens were not available for any of the three probands.
    explanation: Segregation limitation.
  - reference: url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
    reference_title: https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: Mutation screening allowed to identify three heterozygous NFATC1 missense variants
    explanation: Variant discovery in a selected cohort.
- name: HMGN1
  association: Chromosome 21 Dosage
  gene_term:
    preferred_term: HMGN1
    term:
      id: hgnc:4984
      label: HMGN1
  relationship_type: MODIFIER
  variant_origin: GERMLINE
  notes: HMGN1 dosage modifies AVC myocardial transcription in human isogenic culture and septal-defect incidence in Dp1Tyb mice. This is experimental support for a trisomy-associated contributor, not proof of HMGN1-alone human AVSD sufficiency or a clinically validated gene therapy.
  evidence:
  - reference: PMID:41125893
    reference_title: Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    snippet: Future studies will resolve whether excess dosage of HMGN1 is sufficient to cause increased penetrance of CHDs.
    explanation: Explicit limit on anatomical sufficiency.
  - reference: PMID:41125893
    reference_title: Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    snippet: reduction of HMGN1 to two copies in trisomic cells partially restored the transcriptional dysregulation to a more disomic-like state
    explanation: Human culture dosage correction.
- name: Rare-variant candidate enrichment
  association: Rare Variant Enrichment
  notes: A 112-candidate-gene study included 81 discovery and 81 replication nonsyndromic, non-trisomy-21, non-heterotaxy AVSD probands of European ancestry. Public exome controls and limited segregation constrain inference. Several nominally enriched genes were nominated, but only MDM4 survived correction across all tested genes. This is not a validated diagnostic panel, proof of multiple hits in every patient or functional validation of each variant.
  evidence:
  - reference: PMID:25996639
    reference_title: Exome sequencing identifies rare variants in multiple genes in atrioventricular septal defect.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: Whole-exome sequencing was performed in 81 unrelated probands with AVSD to identify potentially causal variants in a comprehensive set of 112 genes with strong biological relevance to AVSD.
    explanation: Discovery design, not a count of causal genes.
- name: NR2F2
  gene_term:
    preferred_term: NR2F2
    term:
      id: hgnc:7976
      label: NR2F2
  association: Rare variant association with functional evidence
  relationship_type: SUSCEPTIBILITY
  variant_origin: GERMLINE
  notes: The 2014 study identified five rare missense variants in 125 discovery AVSD cases, including 13 trio probands; two were de novo and two were inherited from apparently unaffected parents. An additional 245-case screen did not identify further rare functional variants. Additional splice, translocation and duplication families had varied CHD phenotypes. Evidence differs by allele; not every variant is equivalently pathogenic or fully penetrant. Reporter effects depend on promoter and cell context, rather than universal loss of function. The source contains inconsistent HGVS/protein nomenclature, so detailed allele coordinates are not reproduced. The author-hosted full PDF is PMID:24702954; the 2016 correction concerns an author surname.
  evidence:
  - reference: url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
    reference_title: https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: were inherited from an apparently healthy parent
    explanation: Human segregation limits in the Results.
  - reference: url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
    reference_title: https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: We found NR2F2 to be the only gene, of the nine genes with de novo variants identiﬁed in the original trios, with a signiﬁcant enrichment of rare missense variants
    explanation: Case-control enrichment in the selected discovery design.
epidemiology:
- name: Proportion of congenital cardiac malformations
  description: Published clinical reviews cite AVSD as several percent of congenital cardiac malformations; the 4–7% figure in this source is background synthesis, not the proportion measured by its surgical cohort.
  evidence:
  - reference: PMID:37612667
    reference_title: Long-term results following atrioventricular septal defect repair.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Atrioventricular septal defects (AVSD) represent 4-7% of congenital cardiac malformations.
    explanation: Gives the proportion of congenital cardiac malformations represented by AVSD.
    quote_role: BACKGROUND
- name: Association with Down syndrome
  description: AVSD is strongly associated with trisomy 21. Estimates of any congenital heart defect and relative AVSD enrichment describe different denominators; the approximately 1000-fold figure is prior human epidemiology summarized in the 2025 mechanistic paper, not a result measured in its cell or mouse experiments.
  evidence:
  - reference: PMID:29054759
    reference_title: CRELD1 gene variants and atrioventricular septal defects in Down syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Congenital heart defects (CHD) are seen in around 40% of the Down syndrome patients. Atrioventricular Septal Defect (AVSD) or endocardial cushion defect is commonest form of CHD in these children.
    explanation: Establishes the frequency of CHD in Down syndrome and AVSD as the predominant lesion.
    quote_role: BACKGROUND
  - reference: PMID:41125893
    reference_title: Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: CHDs occur in around 50% of cases of Down syndrome, with an approximately 1,000-fold enrichment of atrioventricular canal (AVC) defects that disrupt the junction between the atria and ventricles
    explanation: Quantifies the magnitude of AVC-defect enrichment attributable to trisomy 21.
    quote_role: BACKGROUND
- name: Scope of the Texas complete-canal maternal-risk cohort
  description: The 1999–2008 Texas registry analysis included 563 complete atrioventricular canal cases classified as nonsyndromic, among 1,335 total complete-canal cases. Heterotaxy was included in the nonsyndromic group; only 47 cases were isolated. Diabetes subtype and prepregnancy BMI analyses cover 2005–2008 only. Cases included fetal deaths and terminations while prevalence denominators used live births. These definitions do not represent every partial or complete AVSD population.
  evidence:
  - reference: PMID:23061687
    reference_title: Descriptive epidemiology of non-syndromic complete atrioventricular canal defects.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: Patients with visceral heterotaxy were included in the nonsyndromic group.
    explanation: Defines an important inclusion within the source-specific nonsyndromic label.
  - reference: PMID:23061687
    reference_title: Descriptive epidemiology of non-syndromic complete atrioventricular canal defects.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: Specific information on maternal pregestational diabetes, gestational diabetes, and prepregnancy body mass index (BMI) was only available for deliveries in 2005–2008.
    explanation: Restricts the exposure-specific estimates to the relevant years.
environmental:
- name: Maternal pregestational diabetes
  description: Maternal pregestational diabetes was associated with nonsyndromic complete atrioventricular canal in the Texas 2005–2008 subset (adjusted prevalence ratio 6.74, 95% CI 3.67–12.37). The table includes 12 exposed cases. Diabetes type, severity and glycemic control were unavailable; this is an adjusted observational association, not a ranking against all modifiable risk factors or a measured embryonic mediator.
  evidence:
  - reference: PMID:23061687
    reference_title: Descriptive epidemiology of non-syndromic complete atrioventricular canal defects.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: Significant associations were observed between non-syndromic CAVC in offspring and maternal pregestational diabetes (adjusted prevalence ratio (aPR) 6.74; 95% confidence interval (CI) 3.67, 12.37), gestational diabetes (aPR 1.69; 95% CI 1.03, 2.79) and obesity (aPR 1.69; 95% CI 1.24, 2.30).
    explanation: Reports the exposure associations in the source-defined nonsyndromic complete-canal cohort; not a causal mediator experiment.
  - reference: PMID:23061687
    reference_title: Descriptive epidemiology of non-syndromic complete atrioventricular canal defects.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: Specific information on maternal pregestational diabetes, gestational diabetes, and prepregnancy body mass index (BMI) was only available for deliveries in 2005–2008.
    explanation: Defines the restricted period for the exposure-specific analysis.
- name: Maternal gestational diabetes
  description: Gestational diabetes was associated with nonsyndromic complete atrioventricular canal in the same Texas subset (adjusted prevalence ratio 1.69, 95% CI 1.03–2.79; 15 exposed cases). The authors note that a diagnosis made after the first trimester may include previously unrecognized pregestational diabetes; the study does not establish that later hyperglycemia caused early abnormal septation.
  evidence:
  - reference: PMID:23061687
    reference_title: Descriptive epidemiology of non-syndromic complete atrioventricular canal defects.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: Significant associations were observed between non-syndromic CAVC in offspring and maternal pregestational diabetes (adjusted prevalence ratio (aPR) 6.74; 95% confidence interval (CI) 3.67, 12.37), gestational diabetes (aPR 1.69; 95% CI 1.03, 2.79) and obesity (aPR 1.69; 95% CI 1.24, 2.30).
    explanation: Reports the exposure associations in the source-defined nonsyndromic complete-canal cohort; not a causal mediator experiment.
  - reference: PMID:23061687
    reference_title: Descriptive epidemiology of non-syndromic complete atrioventricular canal defects.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: Specific information on maternal pregestational diabetes, gestational diabetes, and prepregnancy body mass index (BMI) was only available for deliveries in 2005–2008.
    explanation: Defines the restricted period for the exposure-specific analysis.
- name: Maternal prepregnancy obesity
  description: Prepregnancy BMI of at least 30 was associated with nonsyndromic complete atrioventricular canal in the Texas 2005–2008 subset (adjusted prevalence ratio 1.69, 95% CI 1.24–2.30; 75 exposed cases). After exclusion of heterotaxy, the estimate was 1.5 with a 95% CI of 0.9–2.4. Definitions, residual confounding and subgroup imprecision constrain generalization; no specific mesenchymal mechanism was measured.
  evidence:
  - reference: PMID:23061687
    reference_title: Descriptive epidemiology of non-syndromic complete atrioventricular canal defects.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: Significant associations were observed between non-syndromic CAVC in offspring and maternal pregestational diabetes (adjusted prevalence ratio (aPR) 6.74; 95% confidence interval (CI) 3.67, 12.37), gestational diabetes (aPR 1.69; 95% CI 1.03, 2.79) and obesity (aPR 1.69; 95% CI 1.24, 2.30).
    explanation: Reports the exposure associations in the source-defined nonsyndromic complete-canal cohort; not a causal mediator experiment.
  - reference: PMID:23061687
    reference_title: Descriptive epidemiology of non-syndromic complete atrioventricular canal defects.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: Specific information on maternal pregestational diabetes, gestational diabetes, and prepregnancy body mass index (BMI) was only available for deliveries in 2005–2008.
    explanation: Defines the restricted period for the exposure-specific analysis.
discussions:
- discussion_id: gap_developmental_heterogeneity
  kind: KNOWLEDGE_GAP
  prompt: Which developmental route accounts for each AVSD genotype and anatomical subtype?
  rationale: Human AVSD is etiologically heterogeneous. Endocardial growth, distinct mesenchymal components, myocardial identity and laterality can contribute in different models. Modifier crosses that produce VSD or secundum ASD cannot be assumed to reproduce the human common-junction defect. No single obligatory EndoMT or two-hit pathway is established.
  attaches_to:
  - pathophysiology#Deficient Atrioventricular Septation
  evidence:
  - reference: PMID:38884733
    reference_title: Molecular Pathways and Animal Models of Atrioventricular Septal Defect.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: REVIEW_SYNTHESIS
    snippet: The role of the dorsal mesenchymal protrusion (DMP) in AVSD pathogenesis has been well-documented in studies using animal models for AVSDs
    explanation: Multiple developmental components require distinction.
- discussion_id: gap_diet_specificity
  kind: KNOWLEDGE_GAP
  prompt: Do maternal dietary associations in pooled congenital heart disease apply specifically to AVSD?
  rationale: The Baby Hearts Study pooled 242 non-genetic CHD cases and 966 controls; only 11 cases were in the broad AV-junction/valve category, and no subtype-specific effect estimates were published. Frequent intake of the listed folate-rich fruits was associated with lower pooled CHD odds, but no causal dietary constituent was established. Its diabetes estimate was crude; the four exposed cases were VSD, transposition or double-inlet left ventricle, not AVSD. Do not use this source for an AVSD-specific protective diet, a diabetes mechanism, or a fruit/folate-to-septation edge.
  evidence:
  - reference: PMID:32092068
    reference_title: 'Risk factors for congenital heart disease: The Baby Hearts Study, a population-based case-control study.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: We do not give results specific to CHD type in this paper due to lack of sta- tistical power but they are available on request.
    explanation: The source explicitly limits subtype inference.
  - reference: PMID:32092068
    reference_title: 'Risk factors for congenital heart disease: The Baby Hearts Study, a population-based case-control study.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: This type of study cannot identify which dietary components are causally associated, and the possibility of unmeasured confounding cannot be excluded
    explanation: Limits nutrient mediation and causal interpretation.
- discussion_id: gap_model_assay_lineage
  kind: KNOWLEDGE_GAP
  prompt: Which cells generate the outgrowth measured in an AVC explant?
  rationale: Cell morphology alone can misclassify epicardial outgrowth as endocardial transition. Lineage and stage controls are essential before assigning an AVSD mechanism to an intervention in this mixed-cell assay.
  attaches_to:
  - pathophysiology#Impaired Endocardial Cushion Growth
  evidence:
  - reference: PMID:29549339
    reference_title: The epicardium obscures interpretations on endothelial-to-mesenchymal transition in the mouse atrioventricular canal explant assay.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    snippet: The presence of epicardium thus confounds interpretations of EndoMT signalling pathways in this assay.
    explanation: Direct assay limitation.
references:
- reference: PMID:10605520
  title: Neonatal ECG screening for congenital heart disease in Down syndrome.
- reference: PMID:15096951
  title: Molecular genetics of atrioventricular septal defects.
- reference: PMID:22523272
  title: Genetic modifiers predisposing to congenital heart disease in the sensitized Down syndrome population.
- reference: PMID:23061687
  title: Descriptive epidemiology of non-syndromic complete atrioventricular canal defects.
- reference: PMID:24697899
  title: Murine Creld1 controls cardiac development through activation of calcineurin/NFATc1 signaling.
- reference: PMID:25996639
  title: Exome sequencing identifies rare variants in multiple genes in atrioventricular septal defect.
- reference: PMID:27340223
  title: Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms.
- reference: PMID:29054759
  title: CRELD1 gene variants and atrioventricular septal defects in Down syndrome.
- reference: PMID:29549339
  title: The epicardium obscures interpretations on endothelial-to-mesenchymal transition in the mouse atrioventricular canal explant assay.
- reference: PMID:32092068
  title: 'Risk factors for congenital heart disease: The Baby Hearts Study, a population-based case-control study.'
- reference: PMID:33142350
  title: Comprehensive evaluation of genetic variants using chromosomal microarray analysis and exome sequencing in fetuses with congenital heart defect.
- reference: PMID:34196822
  title: 'Atrioventricular Septal Defects: Pathology, Imaging, and Treatment Options.'
- reference: PMID:35757952
  title: Surgical Outcomes in Children With Partial and Transitional Atrioventricular Septal Defect.
- reference: PMID:37612667
  title: Long-term results following atrioventricular septal defect repair.
- reference: PMID:38884731
  title: Clinical Presentation and Therapy of Atrioventricular Septal Defect.
- reference: PMID:38884733
  title: Molecular Pathways and Animal Models of Atrioventricular Septal Defect.
- reference: PMID:40154545
  title: A 27-Year Experience with Atrioventricular Septal Defect Correction.
- reference: PMID:41125893
  title: Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.
- reference: url:https://www.acc.org/Latest-in-Cardiology/Articles/2025/02/03/12/17/Clinical-Practice-Algorithm-For-the-Follow-Up-of-Repaired-and-Unrepaired-Atrioventricular-Septal-Defects
  title: Clinical Practice Algorithm For the Follow-Up of Repaired and Unrepaired Atrioventricular Septal Defects - American College of Cardiology
- reference: url:https://www.guidelinecentral.com/guideline/6958/
  title: ACC/AHA Management of Adults With Congenital Heart Disease Guideline Summary - Guideline Central
- reference: url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
  title: https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf
- reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/
  title: Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf
  tags:
  - StatPearls
- reference: url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf
  title: https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf

📚

References & Deep Research

References

PMID:10605520

Neonatal ECG screening for congenital heart disease in Down syndrome.

No top-level findings curated for this source.

PMID:15096951

Molecular genetics of atrioventricular septal defects.

No top-level findings curated for this source.

PMID:22523272

Genetic modifiers predisposing to congenital heart disease in the sensitized Down syndrome population.

No top-level findings curated for this source.

PMID:23061687

Descriptive epidemiology of non-syndromic complete atrioventricular canal defects.

No top-level findings curated for this source.

PMID:24697899

Murine Creld1 controls cardiac development through activation of calcineurin/NFATc1 signaling.

No top-level findings curated for this source.

PMID:25996639

Exome sequencing identifies rare variants in multiple genes in atrioventricular septal defect.

No top-level findings curated for this source.

PMID:27340223

Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms.

No top-level findings curated for this source.

PMID:29054759

CRELD1 gene variants and atrioventricular septal defects in Down syndrome.

No top-level findings curated for this source.

PMID:29549339

The epicardium obscures interpretations on endothelial-to-mesenchymal transition in the mouse atrioventricular canal explant assay.

No top-level findings curated for this source.

PMID:32092068

Risk factors for congenital heart disease: The Baby Hearts Study, a population-based case-control study.

No top-level findings curated for this source.

PMID:33142350

Comprehensive evaluation of genetic variants using chromosomal microarray analysis and exome sequencing in fetuses with congenital heart defect.

No top-level findings curated for this source.

PMID:34196822

Atrioventricular Septal Defects: Pathology, Imaging, and Treatment Options.

No top-level findings curated for this source.

PMID:35757952

Surgical Outcomes in Children With Partial and Transitional Atrioventricular Septal Defect.

No top-level findings curated for this source.

PMID:37612667

Long-term results following atrioventricular septal defect repair.

No top-level findings curated for this source.

PMID:38884731

Clinical Presentation and Therapy of Atrioventricular Septal Defect.

No top-level findings curated for this source.

PMID:38884733

Molecular Pathways and Animal Models of Atrioventricular Septal Defect.

No top-level findings curated for this source.

PMID:40154545

A 27-Year Experience with Atrioventricular Septal Defect Correction.

No top-level findings curated for this source.

PMID:41125893

Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.

No top-level findings curated for this source.

url:https://www.acc.org/Latest-in-Cardiology/Articles/2025/02/03/12/17/Clinical-Practice-Algorithm-For-the-Follow-Up-of-Repaired-and-Unrepaired-Atrioventricular-Septal-Defects

Clinical Practice Algorithm For the Follow-Up of Repaired and Unrepaired Atrioventricular Septal Defects - American College of Cardiology

No top-level findings curated for this source.

url:https://www.guidelinecentral.com/guideline/6958/

ACC/AHA Management of Adults With Congenital Heart Disease Guideline Summary - Guideline Central

No top-level findings curated for this source.

url:https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf

https://www.hubrecht.eu/app/uploads/2017/11/Den-Hertog-publicatie-Human-Mutation-2018.pdf

No top-level findings curated for this source.

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK557511/

Atrioventricular Septal Defects - StatPearls - NCBI Bookshelf

No top-level findings curated for this source.

url:https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf

https://www.pure.ed.ac.uk/ws/portalfiles/portal/15379282/Rare_Variants_in_NR2F2_Cause_Congenital_Heart_Defects_in_Humans.pdf

No top-level findings curated for this source.

Deep Research

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (2)

Review AVSD anatomy, clinical care and model-specific developmental mechanisms · 2026-09-21T12:50:18Z · View source

Reviewed all original source records at their available depth and the complete scientific deep-research output; recovered and read full primary texts and current care sources. Corrected partial/transitional/unbalanced anatomy, cohort denominators and environmental specificity; expanded clinical findings, diagnostics and pediatric/adult management. Separated 21 atomic developmental/hemodynamic nodes and preserved human, mouse and culture scope in seven animal and four experimental models. Added NR2F2 promoter-context and ciliary-model evidence without universal loss-of-function or EndoMT claims. Independent full-source and integration audits informed environmental, NR2F2 and valve-edge corrections. Schema/live terms and 174 exact excerpts pass; all repository guards and node-class examples are checked. Sources remaining abstract-only, unreviewed supplements and inaccessible correction text are explicitly limited; no manually edited reference cache or frozen accession cache was used. The public guideline HTML contained incidental AWS-looking configuration that triggered GitHub push protection. A tracked URL-fetch adapter now removes executable page code, comments and nonstructural attributes while retaining source text and table spans; plain text, XML and extracted PDFs are unchanged. The genuine source was regenerated through just fetch-reference, all 174 excerpts were revalidated, and 32 focused fetcher tests passed. Independent code review led to table-span preservation and undeclared-XML regression coverage. No push-protection bypass was used.

Create: Atrioventricular Septal Defect MONDO:0859565 · 2026-08-27T18:42:05Z · View source

Curated from an OpenScientist deep-research report. All 22 cited PMIDs independently re-fetched; all 55 snippets verified as exact substrings of the cached records. Three report claims were dropped or re-scoped on verification. The TGF-beta/BMP/Notch/Wnt EndoMT attribution rested on PMID:29549339, which is a methodological caution showing that cells scored as endothelial in the standard explant assay are largely epicardial, so only its framing statements are cited and the caveat is recorded as PARTIAL evidence. The report's suggested AV-valve-regurgitation HPO terms were HP:0031652 Abnormal aortic valve physiology and HP:0000023 Inguinal hernia, corrected to HP:0034376. Its suggested QRS-axis term HP:0031547 is Abnormal QT interval, corrected to HP:0033568. Review round 1 further caught PMID:41125893 misgraded HUMAN_CLINICAL when the cache frontmatter shows a mouse and iPSC study, and PMID:38313390, an Editorial, used to evidence AVSD haemodynamics with a CHD-composition statistic. Both corrected; the editorial was removed entirely in favour of PMID:10812553 and PMID:1943197. The entry models AVSD as failure of the whole atrioventricular mesenchymal complex including the dorsal mesenchymal protrusion, per PMID:38884733, rather than the superseded endocardial-cushion-fusion account still carried by the Congenital_Heart_Disease root stub. subtype_term bindings deferred to issue #6989. MONDO hierarchy inversion noted: the general term MONDO:0859565 is a child of the familial term MONDO:0020290.

OpenScientist ▸

Atrioventricular Septal Defect (AVSD): A Comprehensive Disease Characteristics Report

openscientist-autonomous 66 citations 2026-08-27T13:11:28.115055

Atrioventricular Septal Defect (AVSD): A Comprehensive Disease Characteristics Report

Disease: Atrioventricular Septal Defect (AVSD) — also atrioventricular canal defect / endocardial cushion defect MONDO ID: MONDO:0859565 Category: Congenital heart defect (endocardial cushion / atrioventricular canal defect) Evidence base: 92 primary papers reviewed; 22 findings recorded; 5 hypotheses (all supported). Information derived from aggregated disease-level resources plus clinical cohorts, model-organism studies, and in vitro/computational work.

Summary

Atrioventricular septal defect (AVSD) is a congenital cardiac malformation defined by a common atrioventricular (AV) junction resulting from deficient development of the atrioventricular septum. Anatomically it comprises an ostium primum atrial communication and/or an inlet ventricular septal defect together with an abnormal AV valve — either a single common valve (complete AVSD) or two valve orifices with a cleft left AV valve (partial AVSD). The malformation arises from failed atrioventricular-canal endocardial cushion development, specifically defective endothelial-to-mesenchymal transition (EndoMT) governed by TGF-β, BMP, Notch and Wnt/β-catenin signaling (PMID: 29549339). AVSD represents roughly 4–7% of all congenital cardiac malformations (PMID: 37612667).

AVSD has the tightest link of any congenital heart defect to trisomy 21 (Down syndrome): AVSD is the most common heart defect in Down syndrome (~44%), and roughly half of all AVSD cases occur in the context of Down syndrome (PMID: 39104126; PMID: 37667895). Beyond trisomy 21, the genetic architecture is heterogeneous and often oligogenic, involving cardiac transcription factors and developmental signaling genes (CRELD1, GATA4/6, NR2F2, NFATC1, GDF1, NOTCH1, BMPR1A, HEY2) plus rare copy-number variants, converging on the CRELD1–calcineurin/NFATc1–VEGF axis (PMID: 15096951; PMID: 30007050; PMID: 24697899). On chromosome 21, gene-dosage effects (cooperative DSCAM+COL6A2 overexpression; HMGN1-driven myocardial reprogramming) contribute to the trisomy-21 phenotype (PMID: 22072978; PMID: 41125893). Maternal pregestational diabetes is a strong modifiable environmental risk factor (adjusted prevalence ratio ~6.7 for non-syndromic AVSD), while folate-rich diet is protective (PMID: 23061687; PMID: 32092068).

Hemodynamically, the defect produces a large left-to-right shunt with common-valve regurgitation, causing infantile congestive heart failure and, if left unrepaired, irreversible pulmonary vascular obstructive disease (Eisenmenger physiology) (PMID: 1943197; PMID: 10812553). Diagnosis rests on echocardiography (AVSD is the most common fetal cardiac diagnosis, with 90–100% fetal-echo sensitivity and the highest genetic-testing yield of any CHD subtype) (PMID: 37240614; PMID: 34196822; PMID: 33142350). Treatment is surgical repair in infancy (single-patch, modified single-patch, or double-patch), with excellent modern long-term survival (~80–88% at 10–25 years) and left AV valve regurgitation as the principal residual problem and reoperation driver (PMID: 40154545; PMID: 34002204).

This report synthesizes 22 confirmed findings from 10 iterations across 92 reviewed papers, organized against the 15-section disease-characteristics template.

1. Disease Information

AVSD (atrioventricular septal defect) is a structural congenital heart malformation characterized by a common atrioventricular junction with deficient atrioventricular septation. The core anatomic lesion is an ostium primum atrial septal defect and/or an inlet ventricular septal defect with an abnormal common or cleft atrioventricular valve (PMID: 8347012). Forms range from partial/incomplete (primum ASD + cleft left AV valve, two valve orifices) through transitional to complete (single common AV valve, combined atrial and ventricular communications).

Key identifiers: - MONDO: MONDO:0859565 - Common synonyms/alternative names: atrioventricular canal defect, common atrioventricular canal (CAVC), endocardial cushion defect, AV canal defect, persistent common atrioventricular canal - ICD-10: Q21.2 (atrioventricular septal defect); MeSH: "Heart Septal Defects" / "Endocardial Cushion Defects" - Additional clinical descriptors: complete AVSD (CAVSD), partial AVSD (pAVSD), transitional AVSD

Source of information: This report draws primarily on aggregated disease-level resources — surgical/echocardiographic cohorts, population-based birth-defect registries (Texas Birth Defects Registry, National Birth Defects Prevention Study, US National Inpatient Sample), genetic studies, and model-organism experiments — rather than individual EHR records.

2. Etiology

Disease Causal Factors

AVSD is a multifactorial, genetically heterogeneous malformation. The unifying developmental cause is failed fusion/development of the atrioventricular-canal endocardial cushions (see Section 6). Causal contributors span:

Chromosomal: trisomy 21 (the single largest contributor), plus other aneuploidies (trisomy 18, trisomy 13) and specific deletions (e.g., 3p25–pter / 3p- syndrome, in which AVSD occurs in ~one-third of patients; PMID: 19760623).
Single-gene / oligogenic: CRELD1, GATA4, GATA6, NR2F2, NKX2-5, TBX5, BMP4, NFATC1, GDF1, NOTCH1, BMPR1A, HEY2 (see Section 4).
Environmental: maternal pregestational and gestational diabetes, maternal obesity, poor periconceptional diet.

CRELD1 was the first identified non-syndromic AVSD susceptibility gene; critically, "Mutation of CRELD1 increases susceptibility to AVSD but is not alone sufficient to cause the defect, indicating that AVSD is multigenic" (PMID: 15096951).

Risk Factors

Genetic risk factors — trisomy 21 (dominant), CRELD1 missense variants (~5–10% of simplex AVSD carry a CRELD1 missense mutation; PMID: 25328912), and rare damaging variants across ~112 biologically relevant genes enriched in AVSD probands (OR 1.52, 95% CI 1.35–1.71, P = 4.8×10⁻¹¹; PMID: 25996639).

Environmental risk factors — maternal pregestational diabetes is the strongest (adjusted prevalence ratio [aPR] 6.74, 95% CI 3.67–12.37 for non-syndromic complete AV canal), followed by gestational diabetes (aPR 1.69) and obesity (aPR 1.69) (PMID: 23061687). Advanced maternal age (via aneuploidy risk), low maternal education, and poor diet are additional contributors (PMID: 32092068).

Protective Factors

Environmental protective factors — frequent consumption of folate-rich fruits was protective for CHD (adjusted OR 0.64, 95% CI 0.47–0.89), and consistent periconceptional folic-acid supplementation trended protective for cardiac-inclusive anomalies (aOR 0.5, 95% CI 0.3–1.0) (PMID: 32092068; PMID: 33179873). Genetic protective factors specific to AVSD are not well established.

Gene–Environment Interactions

The clearest example is a genetic-threshold/modifier model: crossing loss-of-function alleles of Creld1 or Hey2 onto the trisomic Ts65Dn background "caused a significant increase in the frequency of CHD," demonstrating that additional genetic perturbations push a dosage-sensitized background across a defect threshold (PMID: 22523272). On the environmental side, gestational diabetes and obesity show additive interaction for AVSD risk (RERI 1.1, 95% CI −0.1 to 2.3; PMID: 33876578).

3. Phenotypes

Phenotype	Type	Onset	Frequency / Severity	Suggested HPO
Atrioventricular septal defect (structural)	Physical/structural malformation	Congenital	Defining feature	HP:0006695
Congestive heart failure	Clinical sign	Neonatal–infantile (mean ~50 days)	62% (Down) – 84% (non-Down) complete AVSD	HP:0001635
Pulmonary arterial hypertension	Clinical sign	Infantile, earlier in Down syndrome	38% (Down) vs 16% (non-Down)	HP:0002092
Common AV valve regurgitation	Physical manifestation	Congenital/infantile	Common; drives symptoms	HP:0031652 / HP:0000023
Tachypnea / respiratory distress	Symptom	Infantile	Common	HP:0002789
Failure to thrive / poor weight gain	Sign	Infantile	Common	HP:0001508
Recurrent respiratory infections	Sign	Infantile	Common	HP:0002205
Arrhythmia (AV block, atrial flutter/fibrillation)	ECG abnormality	Variable; high long-term risk	Among highest of all CHDs	HP:0011675
Superior/leftward ("northwest") QRS axis	ECG abnormality	Congenital	Characteristic	HP:0031547

Phenotype characteristics: Symptoms typically begin in the first weeks-to-months of life (mean symptom onset ~50 ± 75 days in complete AVSD; PMID: 9532811). Severity ranges from mild (partial AVSD, sometimes asymptomatic into adulthood) to severe (complete AVSD with heart failure). Progression is progressive if unrepaired, driven by pulmonary overcirculation. A key phenotypic contrast: "There seems to be a pulmonary vascular hyperreactivity predominance in Down's children and cardiac insufficiency signs in the normal genetic group" (PMID: 9532811) — non-Down patients had more severe AV valve morphologic lesions (38% vs 8%).

Quality of life impact: After repair, long-term QoL is favorable — self- or caregiver-reported QoL was "excellent or good in 81%" of patients up to 40 years after single-patch complete AVSD repair (PMID: 34953470).

4. Genetic / Molecular Information

Causal and Susceptibility Genes

Gene (HGNC)	Role / Evidence	Variant examples	Key PMID
CRELD1	First non-syndromic AVSD susceptibility gene; regulates calcineurin/NFATc1; ~5–10% of simplex AVSD	p.A286P, p.E325K, c.973G>A (p.Glu325Lys) in cb-EGF calcium-binding domains	15096951, 21080147, 29054759, 25328912
NFATC1	Heterozygous missense; defective nuclear translocation, reduced transactivation	p.Ala367Val (isolated AVSD); p.Val210Met, p.Ala696Thr (+heterotaxy)	30007050
GATA6	Cardiac transcription factor; variants in complex CHD incl. AVSD	A178V (gain of transactivation), L198V	20581743
GATA4, NKX2-5, TBX5, BMP4	Established CHD candidate genes (MLPA CHD panel)	CNVs / point variants	29952356
NIPBL, CHD7, CEP152, BMPR1a, ZFPM2, MDM4	Exome-enriched for rare variants in AVSD vs controls (3 syndrome-associated)	Rare/rare-damaging	25996639
GDF1 + NOTCH1	Co-occurring variants in oligogenic non-syndromic AV canal + coarctation	—	38975735
BMPR1A	Familial CHD (Ebstein + AVSD) co-segregating with chr1 linkage	p.R443H	30814609
DNAH11, MKS1 (cilia genes)	ENU mouse recessive AVSD via L/R axis + Hedgehog/second heart field	—	27340223

The genetic etiology remains unknown in ~40% of cases (PMID: 25996639). Exome sequencing found significant enrichment of rare variants in AVSD vs tetralogy of Fallot (OR 2.25, P = 2.2×10⁻¹⁶), indicating disease-specific genetic burden. Diagnostic yield of exome sequencing in Southern African CHD was 7.9% (PMID: 42037320).

Variant Classification, Type, Origin, and Consequences

Classification (ACMG/AMP): ranges from pathogenic/likely pathogenic (aneuploidy, syndromic-gene LOF) to VUS (many CRELD1/GATA6 missense variants).
Variant type: missense (CRELD1, NFATC1, GATA6, BMPR1A), plus structural/copy-number variants; aneuploidy (trisomy 21) is the dominant chromosomal class.
Origin: predominantly germline; somatic origin is not a feature of AVSD.
Functional consequences: loss of function (NFATC1 — "defective nuclear translocation and decreased transcriptional transactivation activity"; PMID: 30007050), gain of function (GATA6 A178V increased transactivation), and dosage effects (chr21 genes).

Modifier Genes and Chromosomal Abnormalities

Modifiers: VEGFA interacts allelically with CRELD1 as a modifier of AVSD risk (PMID: 25328912); Creld1 and Hey2 modify trisomy-21 CHD frequency (PMID: 22523272). Chromosomal abnormalities: trisomy 21 predominates. Rare CNV burden in 150 AVSD cases concentrated on chromosomes 19, 22, 21, and 16 and nominated 20 candidate genes (PMID: 36816019). In 262 Chinese complete AV canal cases, potentially-causative CNVs were found in 16.4%, of which 90.7% carried 21q11.2–q22.3 duplication (trisomy 21) (PMID: 34627233).

Epigenetic information: The chr21 chromatin architectural protein HMGN1 drives trisomy-21 heart defects via myocardial transcriptional/chromatin reprogramming (PMID: 41125893).

Suggested ontology terms: HGNC CRELD1, GATA4, GATA6, NFATC1, NOTCH1, BMPR1A, HMGN1; CHEBI:calcium (calcium-binding EGF domain).

5. Environmental Information

Environmental factors: Maternal metabolic environment dominates. Pregestational diabetes is the strongest single non-genetic factor: "Significant associations were observed between non-syndromic CAVC in offspring and maternal pregestational diabetes (aPR 6.74; 95% CI 3.67, 12.37), gestational diabetes (aPR 1.69) and obesity (aPR 1.69)" (PMID: 23061687). Pregestational diabetes was strongly associated with most birth defects (OR 2.0–75.9) in the National Birth Defects Prevention Study (PMID: 33876578).

Lifestyle factors: Poor maternal diet low in fruit/vegetables increased CHD risk (aOR 1.56); maternal smoking (~2-fold) and overweight/obesity (aOR 1.8) were risk factors for cardiac-inclusive anomalies (PMID: 32092068; PMID: 33179873). Folate-rich diet is protective (see Section 2).

Infectious agents: Not applicable — AVSD is a developmental malformation, not an infectious disease.

6. Mechanism / Pathophysiology

The Central Developmental Mechanism: Failed Endocardial Cushion EndoMT

The AV septum and valves derive from endocardial cushions, formed when endocardial cells of the atrioventricular canal (AVC) undergo endothelial-to-mesenchymal transition (EndoMT/EMT), delaminate, and invade the cardiac jelly (extracellular matrix). "Atrioventricular septal defects often result from impaired endocardial cushion development. Endothelial-to-mesenchymal transition (EndoMT) is a critical event in endocardial cushion development that initiates in the atrioventricular canal (AVC)" (PMID: 29549339).

Molecular pathways governing EndoMT:

TGF-β signaling induces EndoMT; MBNL1 negatively regulates TGF-β/EMT, and Mbnl1-null mice show precocious EMT, later valve dysmorphia, and ostium secundum septal defects (PMID: 26472242).
BMP signaling — "Bone morphogenetic protein (BMP) signalling plays a key role in regulating the development of the atrioventricular (AV) septum and valves"; Sema6D acts downstream of BMP to promote AV cushion development (PMID: 28172500).
Notch signaling gates the process — endocardial Mib1–Dll4–Notch1 drives EMT and Jag1–Notch1 restrains post-EMT proliferation; "Mice lacking endocardial Jag1, Notch1, or RBPJ displayed enlarged valve cusps, bicuspid aortic valve, and septal defects" (PMID: 27056911). Manic Fringe (MFNG) promotes Notch-mediated EndMT; "Aberrant EndMT is a primary cause of congenital valvular malformations" (PMID: 39528804).
Wnt/β-catenin signaling — "Disruption of these Wnt/β-catenin signaling roles that enable developmental transitions during valvulogenesis could account for common congenital valve defects" (PMID: 26893350).
NADPH oxidase NOX2-derived ROS is critical to EndoMT and heart development (PMID: 32655758).

The CRELD1 → Calcineurin/NFATc1 → VEGF Axis

A specific convergent module operates in AV canal endocardium: "Multiple lines of evidence support a role of calcineurin/NFAT signaling in AVSD, and mutations in CRELD1, a protein functioning as a regulator of calcineurin/NFAT signaling have been reported" (PMID: 30007050). Murine work established the causal chain: "Creld1 function is required for the VEGF-dependent proliferation of endocardial cells by promoting the expression of NFATc1 target-genes" (PMID: 24697899); Creld1 promotes NFATc1 dephosphorylation and nuclear translocation via a complex with the calcineurin regulatory subunit CnB at the endoplasmic reticulum. Human pre-valvular endocardial cells from pluripotent stem cells recapitulate BMP2-responsive AVC EndoMT in vitro (PMID: 31028265).

Trisomy 21 Gene-Dosage Mechanisms

Cooperative overexpression: DSCAM and COL6A2 (both chr21) are "the most strongly interacting pair of genes"; co-overexpression in mouse heart caused "≈50% mortality and severe physiological and morphological defects, including atrial septal defects and cardiac hypertrophy," whereas single-gene overexpression did not (PMID: 22072978).
HMGN1-mediated reprogramming: the chromatin architectural gene HMGN1 drives myocardial transcriptional reprogramming underlying trisomy-21 heart defects (PMID: 41125893).

Hemodynamic Pathophysiology (Downstream Clinical Mechanism)

Once the structural defect exists, a large left-to-right shunt develops. "With increasing shunt ratio the pulmonary perfusion raised (r = 0.84), but the systemic output dropped significantly (r = -0.77)" (PMID: 10812553). Untreated, "The natural history of patients with complete atrioventricular canal defect is one of unrelenting development of pulmonary vascular obstructive disease" (PMID: 1943197), culminating in Eisenmenger physiology.

Causal Chain Diagram

UPSTREAM (developmental)                          DOWNSTREAM (clinical)
─────────────────────────────────────────────────────────────────────────
Trisomy 21 dosage (DSCAM+COL6A2, HMGN1)
   │
Genetic variants (CRELD1, NFATC1, GATA4/6,        Structural defect
   NOTCH1, BMPR1A, GDF1, HEY2)                     (common AV junction,
   │          +                                    primum ASD ± inlet VSD,
Maternal environment (diabetes, obesity)           common/cleft AV valve)
   │                                                      │
   ▼                                                      ▼
Impaired AVC endocardial cushion EndoMT           Large left-to-right shunt
(TGF-β / BMP / Notch / Wnt / NOX2-ROS;              + AV valve regurgitation
 CRELD1→calcineurin/NFATc1→VEGF)                          │
   │                                                      ▼
   ▼                                              Pulmonary overcirculation →
Failed AV septation & valve formation             CHF (infancy) → pulmonary
                                                   vascular obstructive disease
                                                   → Eisenmenger (if untreated)

GO terms: GO:0003198 (EMT involved in endocardial cushion formation), GO:0003181 (atrioventricular valve morphogenesis), GO:0060411 (cardiac septum morphogenesis). CL terms: CL:0002350 (endocardial cell), CL:0000057 (fibroblast/valve interstitial cell), CL:0000746 (cardiac muscle cell).

7. Anatomical Structures Affected

Organ level: The heart is the primary affected organ, specifically the atrioventricular septum and atrioventricular valves. Secondary organ involvement includes the lungs/pulmonary vasculature (pulmonary vascular obstructive disease) and, via heart failure, the liver (hepatomegaly). The cardiovascular and respiratory systems are principally involved.

Anatomical detail: AVSD is defined by a common atrioventricular junction with deficient AV septation. The Rastelli classification categorizes the anterior (superior) bridging leaflet of the common valve into types A, B, and C, guiding surgical strategy; interventricular communication under the posterior leaflet is surgically decisive (PMID: 8347012). In Down syndrome, characteristic outlet-septum anterior malalignment occurs — "Outlet extension of the ventricular component of the defect with outlet septum anterior malalignment was found in 90.6% of Down vs 12.8% of non-Down patients" (PMID: 39892564) — and Rastelli type A morphology is an independent risk factor for pulmonary vascular disease in Down syndrome (PMID: 10946038).

Tissue and cell level: Affected tissues include the endocardial cushion mesenchyme, AV valve leaflet connective tissue, and adjacent myocardium. Key cell populations: endocardial (endothelial) cells undergoing EndoMT and their mesenchymal/valve interstitial cell derivatives; cardiomyocytes in trisomy-21 reprogramming.

Subcellular level: GO cellular components implicated: nucleus (NFATc1 translocation; HMGN1 chromatin), endoplasmic reticulum (Creld1–calcineurin complex), and extracellular matrix / cardiac jelly.

Localization: Central heart — the atrioventricular canal region; the lesion is midline/central rather than lateralized. UBERON terms: UBERON:0002087 (atrioventricular region), UBERON:0002078/0002079 (right/left cardiac atrium), UBERON:0003504 (cardiac atrioventricular valve), UBERON:0002094 (interatrial septum), UBERON:0002099 (interventricular septum), UBERON:0002348 (endocardium).

8. Temporal Development

Onset: Congenital — the structural defect forms during embryonic cardiac septation (weeks 4–8 of human development). Clinical symptoms emerge in the neonatal-to-infantile period, with mean symptom onset ~50 ± 75 days in complete AVSD (PMID: 9532811). Onset pattern is insidious-to-subacute as pulmonary vascular resistance falls postnatally and the left-to-right shunt increases.

Progression: Without repair, the course is progressive — pulmonary overcirculation → congestive heart failure → pulmonary vascular obstructive disease. "The natural history ... is one of unrelenting development of pulmonary vascular obstructive disease" (PMID: 1943197). Partial AVSD may progress more slowly and occasionally present in adulthood.

Critical periods / windows of intervention: Complete AVSD is repaired at ~3–6 months of age to preempt irreversible pulmonary vascular disease. Late repair (≥6 months) can yield comparable outcomes in resource-limited settings (PMID: 42079968), but advanced pulmonary vascular disease may already be established at operation (PMID: 1943197). Remission is treatment-induced (surgical repair); spontaneous resolution does not occur for complete AVSD. Disease is lifelong — repaired patients require ongoing surveillance for LAVV regurgitation, LVOT obstruction, and arrhythmias.

9. Inheritance and Population

Epidemiology: AVSD accounts for ~4–7% of all congenital cardiac malformations (PMID: 37612667) and ~2.6% of pediatric CHD hospitalizations; US prevalence increased over 2016–2020 (PMID: 38277408). It is the most common CHD in Down syndrome (44.4%; PMID: 39104126) and, conversely, ~54.7% of AVSD cases occur with Down syndrome (PMID: 37667895).

Inheritance pattern: Predominantly multifactorial/polygenic with strong chromosomal (trisomy 21) contribution. Non-syndromic familial cases show oligogenic inheritance (e.g., co-occurring GDF1+NOTCH1; BMPR1A co-segregating with a chr1 linkage region) rather than a single Mendelian gene (PMID: 38975735; PMID: 30814609). Penetrance is incomplete and expressivity is variable — consistent with CRELD1 being susceptibility rather than sufficient (PMID: 15096951). Genetic anticipation and repeat-expansion mechanisms are not applicable.

Population demographics: - Down syndrome is the dominant demographic association. - Sex ratio: slight female predominance — girl:boy ratio 1.17:1 in a population-based Bohemian study (PMID: 7997413); in Chinese CAVC-with-DS cases the female:male ratio was 1.6:1.0 (PMID: 34627233). - Age distribution: presents in infancy; a growing adult congenital population exists (partial AVSD, repaired complete AVSD). - Consanguinity and founder effects are relevant for rare recessive/syndromic forms but not central to AVSD epidemiology.

10. Diagnostics

Echocardiography is the gold standard — both fetal and postnatal. The diagnostic plane is the four-chamber view demonstrating a common AV junction, common AV valve, and the ostium primum and inlet communications: "the four-chamber views ... showed the atrioventricular septal defect and a common AV valve" (PMID: 36766561).

Prenatal detection: high — antenatal diagnosis of complete AVSD ranges 57–92% (PMID: 27981284); increased detection has made AVSD "the most common fetal cardiac diagnosis" (PMID: 34196822). Expert fetal echo shows sensitivity 90–100%, specificity/NPV 97–100%, PPV 85–100%, with Cohen's kappa >0.9 vs postnatal MRI (PMID: 37240614).
AI-assisted detection: the atrial-to-ventricular length ratio (AVLR) via CNN landmark detection is greater in AVSD than controls (P < 0.0001, AUC up to 0.992; PMID: 38323184); FINE/STIC 4D identified the common AV valve in 100% of four-chamber volumes with autopsy confirmation (PMID: 36766561).
ECG: classically shows a superior/leftward ("northwest") QRS axis with AV conduction delay.
Cardiac MRI/CT and cardiac catheterization (for pulmonary vascular resistance assessment) are adjuncts.

Genetic testing is integral given the aneuploidy link. Among unselected CHD fetuses, positive genetic diagnosis was highest for AVSD at 36.8% (chromosomal microarray detecting aneuploidy/pathogenic CNV in 16.7% overall; exome sequencing adding 6.7%; PMID: 33142350). Recommended workup: karyotype/chromosomal microarray (CMA) first-line (to detect trisomy 21 and pathogenic CNVs), with exome sequencing for non-isolated/syndromic or CMA-negative cases; MLPA CHD panels (GATA4, NKX2-5, TBX5, BMP4, CRELD1, 22q11.2) offer a cheaper first-tier screen (PMID: 29952356).

Clinical criteria & differential diagnosis: Diagnosis is anatomic (echo-based). Differentials include isolated ostium primum/secundum ASD, isolated inlet VSD, common atrium (near-complete absence of interatrial septum; PMID: 34993374), and heterotaxy-associated AVSD (AVSD is the most common cardiac anomaly in atrial isomerism; PMID: 28603940).

Screening: Because ~half of children with Down syndrome have CHD (most commonly AVSD), echocardiographic screening of all newborns/infants with Down syndrome is standard, though access barriers limit it in resource-poor settings (PMID: 41877065).

11. Outcome / Prognosis

Survival after repair is excellent and has improved across surgical eras.

Cohort / setting	Outcome	PMID
27-year single-center (n=248)	Survival 88.3% (10y), 83.8% (15y), 79.6% (25y); prematurity HR 2.43	40154545
Australian multi-institutional (n=829)	Operative mortality 3.3%; survival 91.7/90.7/88.7% at 10/15/20y	34002204
Double-patch series (n=202)	In-hospital mortality 0.5%; freedom from reop 91.8/86.9/86.9% at 5/10/15y	37612667
Single-patch, up to 40y (n=100)	Hospital mortality 11% (older era); QoL excellent/good 81%; normal LV in all	34953470
Partial/transitional (n=136)	No deaths; 2.9% reoperation at ~4y	41659084
US NIS <1yr (n=61,101)	Overall AVSD mortality 6.3%	37667895

Morbidity / disease course: The dominant late complication is left AV valve (LAVV) regurgitation, the principal reoperation driver, followed by LVOT obstruction (PMID: 41971883; PMID: 40208292). AVSD carries among the highest long-term arrhythmia risk of all CHDs (advanced AV block, atrial flutter/fibrillation; overall CHD arrhythmia HR 16.4, 95% CI 14.4–18.7; PMID: 39233212). Pulmonary hypertension is a key complication, more frequent in Down syndrome (4.3% vs 2.8%, P < 0.001; PMID: 37667895).

Prognostic factors: prematurity and low birth weight (mortality), pulmonary hypertension, prior pulmonary artery banding, surgical era, non-Down status and moderate postoperative LAVV regurgitation (reoperation risk; PMID: 34002204). Interestingly, older age at repair and Down syndrome were associated with decreased LAVV reintervention risk (PMID: 40208292). A high postoperative leuko-glycemic index predicts prolonged mechanical ventilation and acute kidney injury in Down-syndrome infants (PMID: 41764019).

12. Treatment

Definitive treatment is surgical biventricular repair — closure of the atrial (ostium primum) and ventricular components and reconstruction of the left AV valve (including cleft closure). NCIT concept: cardiac surgical repair of septal defect.

Surgical techniques: - Classic single-patch, modified single-patch ("Australian"/Nunn technique), and two-patch (double-patch) repair. The Nunn-modified single-patch achieves >90% freedom from LAVV reoperation and >97% freedom from LVOT obstruction at 10–15 years (PMID: 41313357). - Complete AVSD is repaired in infancy (~3–6 months) to prevent irreversible pulmonary vascular disease. "Early intervention, in the first 6 months ... gives comparable acceptable results to later repair; Trisomy 21 was not found to be a risk factor for early intervention" (PMID: 34350818). The modified single-patch shortened bypass time (71 vs 99 min, P = 0.001), and adding posterior annuloplasty reduced postoperative LAVV regurgitation (2+ regurgitation 43% → 7%, P = 0.03). - Complete cleft closure inhibits significant postoperative LAVV regurgitation (OR 0.36, 95% CI 0.14–0.93; PMID: 39578279). Refractory cases require valve replacement.

Pharmacotherapy (bridging / supportive): Anti-heart-failure therapy — diuretics (furosemide, spironolactone), afterload reduction (ACE inhibitors/enalapril), digoxin — plus nutritional support. Vasodilators lower vascular resistance but can induce hypotension because systemic output does not rise (PMID: 10812553). Pulmonary artery banding is an occasional palliative bridge (but prior banding predicts later mortality; PMID: 34002204). For established pulmonary hypertension, calcium-channel blockers (nifedipine) and modern PH-targeted therapy are used (PMID: 2116616; PMID: 37794522).

Advanced/gene/cell therapies: Not applicable — no gene, RNA, or cell therapies exist for AVSD; treatment is structural/surgical.

Adult AVSD repair is safe with low early mortality but notable late arrhythmia and residual LAVV reoperation (PMID: 40936386).

13. Prevention

Primary prevention targets modifiable maternal risk factors: - Optimize maternal glycemic control before and during pregnancy (pregestational diabetes aPR ~6.7; PMID: 23061687). - Periconceptional folic acid / folate-rich diet — protective for CHD (aOR 0.64; PMID: 32092068); provider awareness of folate's cardiac benefits is low and warrants education (PMID: 41041190). - Weight management and smoking cessation.

Secondary prevention (early detection): - Prenatal screening via the four-chamber view at the mid-trimester anomaly scan; quality of imaging strongly affects detection (PMID: 31131945). - Prenatal detection of AVSD prompts karyotype/aneuploidy workup given the strong trisomy-21 association (PMID: 36766561). - Routine echocardiographic screening of all infants with Down syndrome (PMID: 41877065).

Tertiary prevention (complication prevention): timely surgical repair before irreversible pulmonary vascular disease; lifelong surveillance for LAVV regurgitation, LVOT obstruction, arrhythmias, and pulmonary hypertension.

Genetic counseling: For families with AVSD/CHD, counseling addresses recurrence risk, oligogenic/multifactorial inheritance, and prenatal diagnostic options (CMA, exome sequencing, fetal echocardiography). Immunization/public-health/infectious prevention: not applicable.

14. Other Species / Natural Disease

AVSD (atrioventricular canal defect) occurs naturally across mammals: "The defect has been described in human beings, dogs, cats, pigs, and horses," and a 2021 report added the first documented complete AV canal defect in a pet ferret (Mustela putorius furo) — a 4-year-old male with a loud systolic murmur, dyspnea, cardiomegaly, and pulmonary edema, echocardiographically showing a large ASD, AV valve dysplasia, and VSD, managed palliatively with furosemide, spironolactone, enalapril, and diltiazem (PMID: 33482816).

Taxonomy / NCBI Taxon: Homo sapiens (9606), Canis lupus familiaris (9615), Felis catus (9685), Sus scrofa (9823), Equus caballus (9796), Mustela putorius furo (9669).
Comparative biology: The same developmental program — endocardial cushion formation via EndoMT under TGF-β/BMP/Notch/Wnt control — operates across vertebrates, indicating strong evolutionary conservation of AV-canal development. Orthologous genes (Creld1, Nfatc1, Notch1, Gata4) are conserved across species.
Veterinary relevance: AVSD/AV canal defect is a recognized congenital cardiac malformation in companion animals, typically presenting with murmur and congestive heart failure signs.
Zoonotic potential: none (developmental malformation).

15. Model Organisms

Model	Type	Phenotype recapitulation	Key limitation	PMID
Creld1 KO mouse (global/conditional)	Mammalian knockout	Embryonic lethal; essential for septum & valve formation; dissects endocardial calcineurin/NFATc1/VEGF axis	Global KO lethal; requires conditional approach	33773996, 24697899
Dnah11, Mks1 ENU mutants	Mammalian (cilia genes)	Heritable recessive AVSD via L/R axis + Hedgehog/second heart field	Specific to cilia-pathway subset	27340223
Ts65Dn (DS model)	Trisomy (>100 Hsa21 orthologs)	Cardiovascular anomalies (right aortic arch + septal defects) in 8.3% of trisomic newborns; sensitized modifier background	Incomplete Hsa21 coverage; low CHD penetrance	17019652, 22523272
Ts16 (trisomy 16)	Trisomy	Deficient AV septation (primum ASD + VSD)	Atypical conotruncal features (DORV, PTA, TOF) resembling DiGeorge; "No heart had the typical morphology seen in ... Down's syndrome"	9231034, 11066038
Tc1 (transchromosomal)	Human Chr21 in mouse	Models dosage of an intact extra Hsa21	Mosaicism; partial	15068235
DSCR1-restored Ts16	Dosage-rescue	DSCR1 restoration did NOT rescue cardiac anomalies → supports oligogenic model	Single-gene rescue insufficient	15906378
DSCAM+COL6A2 overexpression mouse	Transgenic	Co-overexpression → ~50% mortality + ASD + hypertrophy	Not a full trisomy model	22072978
Mbnl1-null mouse	Knockout	Precocious TGF-β/EMT; valve dysmorphia + secundum septal defects	Valve phenotype more than classic AVSD	26472242
Notch pathway mice (Jag1/Notch1/RBPJ)	Conditional KO	Enlarged valve cusps, BAV, septal defects	Pathway-specific	27056911
Zebrafish (NFATC1 mutants; AVC transcriptome; MFNG)	Vertebrate	Cardiac looping/AV canal patterning defects; conserved EMT/TGF-β/Notch/Wnt	Two-chamber heart	30007050, 34557935, 39528804
Human iPSC-derived pre-valvular endocardial cells	In vitro	BMP2-responsive AVC EndoMT; "valve disease in a dish"	Lacks in vivo hemodynamics/tissue context	31028265
Syrian hamster; chick cushion explants	Vertebrate/ex vivo	OFT/AV cushion EndoMT; TGF-β regulation	Model-specific	40074779, 26472242

Overall model interpretation: Single-gene KOs (Creld1, Notch pathway) faithfully model the mechanistic EndoMT/calcineurin-NFATc1 axis, while Down-syndrome trisomy models (Ts65Dn, Ts16, Tc1) only partially recapitulate the human balanced AVSD morphology — a key limitation. The DSCR1-rescue negative result and Creld1/Hey2 modifier crosses jointly support an oligogenic, dosage-threshold model (PMID: 15906378; PMID: 22523272). Resources: MGI, IMPC, ZFIN, Cellosaurus.

Mechanistic Model / Interpretation

AVSD is best understood as a convergent endpoint of failed atrioventricular-canal endocardial cushion development, reached by multiple upstream routes (chromosomal, oligogenic, environmental) that all impair endothelial-to-mesenchymal transition and its downstream valve/septum morphogenesis. The pathway logic:

Upstream perturbations              Convergent module                 Structural outcome
──────────────────────  ───────────────────────────────────  ──────────────────────────
Trisomy 21 dosage ──┐
CRELD1 / NFATC1 ─────┤    CRELD1→Calcineurin/NFATc1→VEGF        Deficient AV septation
GATA4/6, NOTCH1 ─────┼──► TGF-β / BMP / Notch / Wnt / NOX2 ──►  + abnormal common/cleft
BMPR1A, GDF1, HEY2 ──┤    driven endocardial EndoMT & valve     AV valve
Maternal diabetes ───┘    remodeling                            (Rastelli A/B/C)

Two features make AVSD distinctive among CHDs: (1) its unusually tight link to trisomy 21, explained by chr21 gene-dosage effects (DSCAM+COL6A2 cooperativity; HMGN1 chromatin reprogramming) acting on a threshold-sensitized cushion program; and (2) the fact that its major residual clinical problem (LAVV regurgitation) is a direct anatomic consequence of the abnormal common-valve leaflet architecture, which surgery can improve but not perfectly normalize.

Evidence Base — Key Literature

PMID	Contribution
15096951	CRELD1 as first non-syndromic susceptibility gene; establishes AVSD as multigenic; trisomy-21 link
30007050	NFATC1 LOF mutations cause AVSD; calcineurin/NFAT axis
24697899	Mouse Creld1→NFATc1→VEGF endocardial proliferation mechanism
29549339	AVSD results from impaired cushion EndoMT initiating in the AVC
27056911 / 28172500 / 26893350	Notch / BMP / Wnt control of cushion EMT and septal/valve defects
22072978 / 41125893	Chr21 gene-dosage mechanisms (DSCAM+COL6A2; HMGN1)
25996639	Exome-derived rare-variant enrichment; 6 AVSD genes; 40% unknown etiology
23061687 / 33876578	Maternal diabetes/obesity as environmental risk factors
32092068	Folate protective; maternal risk factors for CHD
37240614 / 34196822 / 33142350	Echocardiographic diagnosis; most common fetal cardiac Dx; highest genetic yield
40154545 / 34002204 / 34953470	Long-term surgical survival & QoL outcomes
41971883 / 40208292	LAVV regurgitation as dominant reoperation driver
39892564 / 10946038 / 8347012	Rastelli anatomy; DS outlet-septum malalignment; type-A PVD risk
39233212	AVSD among highest arrhythmia-risk CHDs
33482816	Cross-species natural occurrence (dog, cat, pig, horse, ferret)
1943197 / 10812553	Left-to-right shunt physiology; unrelenting pulmonary vascular disease

Consistency: Findings were highly consistent across human clinical cohorts, model organisms, and in vitro systems. No hypothesis was refuted; all 5 formal hypotheses (H001–H005) were supported.

Limitations and Knowledge Gaps

~40% of non-syndromic AVSD lacks a molecular diagnosis (PMID: 25996639) — much of the oligogenic/polygenic architecture and regulatory (non-coding) contribution remains uncharacterized.
DS models imperfectly recapitulate human balanced AVSD morphology (PMID: 9231034); the precise chr21 gene(s) and dosage thresholds driving human AVSD are not fully resolved (HMGN1 and DSCAM+COL6A2 are leading but not sole candidates).
Environmental risk estimates derive largely from broad CHD studies, not AVSD-specific cohorts; folate/diabetes effect sizes for AVSD alone are less precise.
No molecular/epigenetic biomarker exists for prenatal risk stratification or postoperative LAVV-regurgitation prediction; diagnosis remains imaging-based.
Limited data on adult natural history of unrepaired/partial AVSD and on long-term neurodevelopmental and phenotype-stratified QoL outcomes.
Penetrance/expressivity quantification for individual susceptibility variants (e.g., CRELD1) is incomplete.

Proposed Follow-up Experiments / Actions

Large-scale trio whole-genome sequencing of non-syndromic AVSD to capture regulatory/non-coding and structural variants and resolve the "missing 40%," with statistical modeling of oligogenic burden.
Single-cell / spatial transcriptomics of the developing human AV canal (and iPSC-derived pre-valvular endocardial cells) to map cell-type-specific EndoMT programs and how CRELD1/NFATC1/HMGN1 perturbations reprogram them.
Dissect chr21 dosage with combinatorial CRISPR titration of HMGN1, DSCAM, COL6A2 (and modifiers Creld1, Hey2) on trisomic backgrounds to define the defect threshold and rank causal drivers.
Prospective AVSD-specific gene–environment study quantifying interaction between maternal glycemic control/folate status and fetal genotype on AVSD risk and severity.
Develop predictive tools for LAVV regurgitation — integrate 3D-echo valve morphometry (Rastelli type, leaflet geometry) with clinical/genetic data to guide repair technique and surveillance.
Improve prenatal detection through validation and deployment of AI-assisted four-chamber-view screening (AVLR, FINE/STIC) in general obstetric settings, paired with reflex CMA/exome workflows.
Optimize periconceptional prevention by testing structured maternal diabetes-control and folate-supplementation programs, and by educating healthcare providers on folate's cardiac benefits.

Report compiled from 22 confirmed findings, 5 supported hypotheses, and 92 reviewed papers across 10 investigation iterations. Evidence sources: human clinical cohorts, population registries, model organisms (mouse, zebrafish, hamster, chick), and in vitro iPSC systems.

Artifacts

Citations

PMID:29549339
PMID:37612667
PMID:39104126
PMID:37667895
PMID:15096951
PMID:30007050
PMID:24697899
PMID:22072978
PMID:41125893
PMID:23061687
PMID:32092068
PMID:1943197
PMID:10812553
PMID:37240614
PMID:34196822
PMID:33142350
PMID:40154545
PMID:34002204
PMID:8347012
PMID:19760623
PMID:25328912
PMID:25996639
PMID:33179873
PMID:22523272
PMID:33876578
PMID:9532811
PMID:34953470
PMID:42037320
PMID:36816019
PMID:34627233
PMID:26472242
PMID:28172500
PMID:27056911
PMID:39528804
PMID:26893350
PMID:32655758
PMID:31028265
PMID:39892564
PMID:10946038
PMID:42079968
PMID:38277408
PMID:38975735
PMID:30814609
PMID:7997413
PMID:36766561
PMID:27981284
PMID:38323184
PMID:29952356
PMID:34993374
PMID:28603940
PMID:41877065
PMID:41971883
PMID:40208292
PMID:39233212
PMID:41764019
PMID:41313357
PMID:34350818
PMID:39578279
PMID:2116616
PMID:37794522
PMID:40936386
PMID:41041190
PMID:31131945
PMID:33482816
PMID:15906378
PMID:9231034

Ask OpenScientist

OpenScientist Report

Inheritance

Subtypes

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Environmental Factors

Diagnosis

Progression

Prevalence

Epidemiology

Experimental Models

Animal Models

Source YAML

References & Deep Research

References

Deep Research

Atrioventricular Septal Defect (AVSD): A Comprehensive Disease Characteristics Report

Summary

1. Disease Information

2. Etiology

Disease Causal Factors

Risk Factors

Protective Factors

Gene–Environment Interactions

3. Phenotypes

4. Genetic / Molecular Information

Causal and Susceptibility Genes

Variant Classification, Type, Origin, and Consequences

Modifier Genes and Chromosomal Abnormalities

5. Environmental Information

6. Mechanism / Pathophysiology

The Central Developmental Mechanism: Failed Endocardial Cushion EndoMT

The CRELD1 → Calcineurin/NFATc1 → VEGF Axis

Trisomy 21 Gene-Dosage Mechanisms

Hemodynamic Pathophysiology (Downstream Clinical Mechanism)

Causal Chain Diagram

7. Anatomical Structures Affected

8. Temporal Development

9. Inheritance and Population

10. Diagnostics

11. Outcome / Prognosis

12. Treatment

13. Prevention

14. Other Species / Natural Disease

15. Model Organisms

Mechanistic Model / Interpretation

Evidence Base — Key Literature

Limitations and Knowledge Gaps

Proposed Follow-up Experiments / Actions

Artifacts

Citations